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Résumé 
Introduction: L'homéostasie du cholestérol est indispensable à la synthèse de la 
testostérone dans le tissu interstitiel et la production de gamètes mâles fertiles dans les 
tubules séminifères. Les facteurs enzymatiques contribuent au maintien de cet équilibre 
intracellulaire du cholestérol. L'absence d'un ou de plusieurs enzymes telles que la HMG-
CoA réductase, la HSL et l'ACAT-1 a été associée à l'infertilité masculine. Toutefois, les 
facteurs enzymatiques qui contribuent au maintien de l'équilibre intra-tissulaire du 
cholestérol n'ont pas été étudiés. Cette étude a pour but de tester l'hypothèse que le maintien 
des taux de cholestérol compatibles avec la spermatogenèse nécessite une coordination de 
la fonction intracellulaire des enzymes HMG-CoA réductase, ACAT1 et ACAT2 et la HSL. 
Méthodes: Nous avons analysé l'expression de l’ARNm et de la protéine de ces enzymes 
dans les fractions enrichies en tubules séminifères (STf) de vison durant le développement 
postnatal et le cycle reproductif annuel et dans les fractions enrichies en tissu interstitiel 
(ITf) et de STf durant le développement postnatal chez la souris. Nous avons développé 
deux nouvelles techniques pour la mesure de l’activité enzymatique de la HMG-CoA 
réductase et de celle de l'ACAT1 et ACAT2. En outre, l'immunohistochimie a été utilisée 
pour localiser les enzymes dans le testicule. Enfin, les souris génétiquement déficientes en 
HSL, en SR-BI et en CD36 ont été utilisées pour élucider la contribution de la HMG-CoA 
réductase, l'ACAT1 et l’ACAT2 et la HSL à l'homéostasie du cholestérol.  Résultats: 1) 
HMG-CoA réductase: (Vison) La variation du taux d’expression de l’ARNm de la HMG-
CoA réductase était corrélée à celle de l’isoforme de 90 kDa de la protéine HMG-CoA 
réductase durant le développement postnatal et chez l’adulte durant le cycle reproductif 
saisonnier. L’activité enzymatique de la HMG-CoA réductase augmentait de façon 
concomitante avec le taux protéinique pour atteindre son niveau le plus élevé à 240 jours 
(3.6411e-7 mol/min/µg de protéines) au cours du développement et en Février (1.2132e-6 
mol/min/µg de protéines) durant le cycle reproductif chez l’adulte. (Souris), Les niveaux 
d’expression de l’ARNm et l’activité enzymatique de la HMG-CoA réductase étaient 
maximales à 42 jours. A l’opposé, le taux protéinique diminuait au cours du 
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développement. 2) HSL: (Vison), l'expression de la protéine de 90 kDa de la HSL était 
élevée à 180- et 240 jours après la naissance, ainsi qu’en Janvier durant le cycle saisonnier 
chez l’adulte. L’activité enzymatique de la HSL augmentait durant le développement pour 
atteindre un pic à 270 jours (36,45 nM/min/µg). Chez l’adulte, l’activité enzymatique de la 
HSL était maximale en Février. (Souris) Le niveau d’expression de l'ARNm de la HSL 
augmentait significativement à 21-, 28- et 35 jours après la naissance concomitamment 
avec le taux d’expression protéinique. L’activité enzymatique de la HSL était maximale à 
42 jours suivie d’une baisse significative chez l'adulte. 3) ACAT-1 et ACAT-2: Le présent 
rapport est le premier à identifier l’expression de l'ACAT-1 et de l'ACAT-2 dans les STf de 
visons et de souris. (Vison) L’activité enzymatique de l'ACAT-2 était maximale à la 
complétion du développement à 270 jour (1190.00 CPMB/200 µg de protéines) et en 
janvier (2643 CPMB/200 µg de protéines) chez l’adulte. En revanche, l’activité 
enzymatique de l'ACAT-1 piquait à 90 jours et en août respectivement durant le 
développement et chez l’adulte. (Souris) Les niveaux d’expression de l’ARNm et la 
protéine de l'ACAT-1 diminuait au cours du développement. Le taux de l'ARNm de 
l'ACAT-2, à l’opposé du taux protéinique, augmentait au cours du développement. 
L’activité enzymatique de l’ACAT-1 diminuait au cours du développement tandis que celle 
de l'ACAT-2 augmentait pour atteindre son niveau maximal à 42 jours. 4) Souris HSL-/ -: 
Le taux d’expression de l’ARNm et l’activité enzymatique de la HMG-CoA réductase 
diminuaient significativement dans les STf de souris HSL-/- comparés aux souris HSL+/+. 
Par contre, les taux de l’ARNm et les  niveaux des activités enzymatiques de l'ACAT-1 et 
de l'ACAT-2 étaient significativement plus élevés dans les STf de souris HSL-/- comparés 
aux souris HSL+/+ 5) Souris SR-BI-/-: L'expression de l’ARNm et l'activité enzymatique 
de la HMG-CoA réductase et de l'ACAT-1 étaient plus basses dans les STf de souris SR-
BI-/- comparées aux souris SR-BI+/+. A l’opposé, le taux d'expression de l’ARNm et 
l'activité enzymatique de la HSL étaient augmentées chez les souris SR-BI-/- comparées 
aux souris SR-BI+/+. 6) Souris CD36-/-: L'expression de l’ARNm et l'activité enzymatique 
de la HMG-CoA réductase et de l'ACAT-2 étaient significativement plus faibles tandis que 
celles de la HSL et de l’ACAT-1 étaient inchangées dans les STf de souris CD36-/- 
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comparées aux souris CD36+/+. Conclusion: Nos résultats suggèrent que: 1) L'activité 
enzymatique de la HMG-CoA réductase et de la HSL sont associées à l’activité 
spermatogénétique et que ces activités ne seraient pas régulées au niveau transcriptionnel. 
2) L'ACAT-1 et de l'ACAT-2 sont exprimées dans des cellules différentes au sein des 
tubules séminifères, suggérant des fonctions distinctes pour ces deux isoformes: 
l'estérification du cholestérol libre dans les cellules germinales pour l’ACAT-1 et l’efflux 
du  cholestérol en excès dans les cellules de Sertoli au cours de la spermatogenèse pour 
l’ACAT-2. 3) La suppression génétique de la HSL diminuait la HMG-CoA réductase et 
augmentait les deux isoformes de l’ACAT, suggérant que ces enzymes jouent un rôle 
critique dans le métabolisme du cholestérol intratubulaire. 4) La suppression génétique des 
transporteurs sélectifs de cholestérol SR-BI et CD36 affecte l’expression (ARNm et 
protéine) et l’activité des enzymes HMG-CoA réductase, HSL, ACAT-1 et ACAT-2, 
suggérant l’existence d’un effet compensatoire entre facteurs enzymatiques et non-
enzymatiques du métabolisme du cholestérol dans les fractions tubulaires. Ensemble, les 
résultats de notre étude suggèrent que les enzymes impliquées dans la régulation du 
cholestérol intratubulaire agissent de concert avec les transporteurs sélectifs de cholestérol 
dans le but de maintenir l'homéostasie du cholestérol intra-tissulaire du testicule. 
 
Mots-clés: Homéostasie du cholestérol, HMG-CoA réductase, HSL, ACAT-1, ACAT-2, 
Spermatogenèse 
 
  x 
Summary 
Introduction: Cholesterol homeostasis is essential for the synthesis of testosterone in 
interstitial tissue and the production of fertile gametes in the seminiferous tubules of the 
testis. Intracelluar cholesterol equilibrium in the testis is delicately maintained and regulated 
by enzymatic factors. The absence of one or more enzymes (HMG-CoA reductase, HSL and 
ACAT) has been implicated in the development of male infertility. However, the enzymatic 
factors that contribute to the maintenance of cholesterol equilibrium have not been 
investigated. This study is to test the hypothesis that the coordinated function of 
intracellular enzymes, HMG-CoA reductase, HSL and ACAT isoforms, are the basis of a 
system that helps to maintain cholesterol equilibrium during spermatogenesis. Methods: 
We characterized mRNA and protein expression levels of these enzymes in mink 
seminiferous tubules-enriched fraction (STf) during development and the annual 
reproductive cycle; or in mouse interstitial tissue-enriched fraction (ITf) and STf during 
postnatal development. Two novel techniques were developed to measure the HMG-CoA 
reductase, HSL and ACAT activities in mink and mouse STf. Additionally, 
immunohistochemistry was used to localize the enzymes in the testis. Finally, HSL 
knockout (KO) infertile male mice and selective cholesterol transporter (SR-BI, CD36) KO 
mice were used to elucidate the contribution of HMG-CoA reductase, HSL and ACAT 
isoforms in testicular cholesterol homeostasis when the enzyme or cholesterol transport 
system was genetically impeded. Results: 1) HMG-CoA reductase: (In mink STf), 
HMG-CoA reductase mRNA levels were relatively independent of 90kDa protein 
expression during development and the seasonal cycle. HMG-CoA reductase activity 
increased independently of its protein expression and reached maximal values by day 240 
(3.6411e-7 mol/min/µg protein) during development and peaked in February (1.2132e-6 
mol/min/µg protein) during the seasonal cycle. (In mouse STf), HMG-CoA reductase 
mRNA levels and enzymatic activity peaked by 42 days before decreasing while the protein 
levels tended to decrease steadily. 2) HSL: (In mink STf), an increase of 90kDa HSL 
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protein expression by day 180- and 240 after birth as well as in January in seasonal cycle, 
was not related to the enzyme mRNA expression. HSL activity increased progressively 
through development and peaked by 270 days (36.45 nM/min/µg); another high HSL 
activity was shown in February. (In mouse STf), three significant elevations in HSL mRNA 
levels by day 21, 28, and 35 corresponded to a steady elevation of HSL protein expression 
throughout development. HSL activity peaked by day 42 but decreased remarkably in the 
adult. 3) ACAT-1 and ACAT-2: This is the first report to establish the presence of both 
ACAT-1 and ACAT-2 in the mink and mouse testis. (In mink STf), ACAT-2 activity 
reached its maximal value at 1190.00 CPMB/200µg protein by day 270 and 2643 
CPMB/200µg protein in January. In contrast, ACAT-1 activity peaked by day 90 or in 
August during the seasonal cycle. (In mouse STf), ACAT-1 mRNA and protein levels were 
both decreased throughout development; ACAT-2 mRNA levels changes in the opposite 
direction of the protein levels, increasing throughout development. ACAT-1 activity in STf 
decreased throughout the development; while ACAT-2 activity increased significantly 
during development and peaked by day 42. 4) HSL-/- mice: KO HSL gene caused a 
decrease of HMG-CoA redutase mRNA expression and enzymatic activity in STf. 
However, ACAT-1 and ACAT-2 mRNA levels and enzymatic activities significantly 
increased in STf. 5) SR-BI-/- mice: The mRNA expression and activity of HMG-CoA 
reductase as well as ACAT-1 were statistically decreased in STf; whereas HSL mRNA level 
and activity were increased. 6) CD36-/- mice: The mRNA expression and activity of HMG-
CoA reductase as well as ACAT-2 were significantly decreased in STf; while HSL and 
ACAT-1 mRNA levels and activities remained constant. Conclusion: These results 
suggest that 1) Activation of HMG-CoA reductase and HSL is associated with 
spermatogenetic activity, while the enzymatic activities may not only be regulated 
transcriptionally. 2) ACAT-1 and ACAT-2 are expressed in different cells of the tubules, 
suggesting distinct functions for these two closely related enzyme isoforms, with ACAT-1 
being related to cholesterol esterification in germ cells and with ACAT-2 being associated 
with the removal of excessive cholesterol by Sertoli cells during spermatogenesis. 3) 
Genetically blocking HSL reduced the activity of HMG-CoA reductase while increasing 
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activity of ACAT isoforms, suggesting the turn-off the enzyme in the cholesterol ester cycle 
may be essential for the accumulation of cholesterol esters in the tubules. 4) The 
dysfunction of intracellular cholesterol transporters affects regulation of the enzymes 
(HMG-CoA reductase, HSL and ACAT-1 and ACAT-2), which is presumably in response 
to compensatory extracellular cholesterol uptake. This study suggests that the enzymes 
implicated in the regulation of intracellular cholesterol may act cooperatively to maintain 
cholesterol homeostasis in testis.  
 
Keywords: cholesterol homeostasis, HMG-CoA reductase, HSL, ACAT-1, ACAT-2, 
spermatogenesis 
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                               Introduction 
1. Testis 
1.1 General structure of the testis 
Within the mammalian testis are coiled thin tubes called seminiferous tubules bound 
together by interstitial tissue. The seminiferous tubules and interstitial tissue constitute two 
morphologically and functionally distinct compartments: namely the site of germ cell 
production i.e., spermatogenesis; and the site of the primary male sex hormone production, 
such as testosterone. Inside the tubules, the various germ cells are surrounded and 
supported by the somatic Sertoli cells. The walls of the tubules are formed by peritubular 
myoid cells. Next to the myoid cells is the interstitial tissue which includes comprised of 
blood vessels, lymphatic vessels and nerves, together with the steroid-producing Leydig 
cells, macrophages, and other cells (Diagram 1). 
Diagram 1. Schematic drawing of the testis [Taken from (Salasin, 2000)] 
  2 
1.1.1 Interstitial tissue and testosterone secretion 
The connective tissue contains large, prominent Leydig cells which differentiate 
during puberty (Leydig, 1850); and it also includes a relatively important proportion of 
macrophage cells (Fawcett et al., 1973; Wing & Lin, 1977) which contacts closely with 
Leydig cells (Hutson, 1992). 25-hydroxylase in testicular macrophages converts 14C-
cholesterol to 14C-25-hydroxycholesterol (Lukyanenko et al., 2001) which is further 
synthesized to testosterone by Leydig cells (Nes et al., 2000). Leydig cells in most seasonal 
breeders undertake different appearances depending on breeding season. During breeding 
season, Leydig cells transform from an “undifferentiated” interstitial cells into active 
Leydig cells characterized by abundant smooth ER, mitochondria full of prominent tubular 
cristae, and a large number of medium sized lipid droplets. By the end of breeding season, 
Leydig cells gradually regress and losing their specific characteristics (Hochereau-de 
Reviers & Lincoln, 1978; Wing & Lin, 1977).    
 1.1.2 Seminiferous tubules and spermatogenesis  
The seminiferous epithelium is a complex stratified epithelium composed of two 
functions distinct cell types: Somatic Sertoli cells and germ cells (Diagram 1). In 1865, 
Enrico Sertoli described columnar cells extending from the basement membrane to the 
lumen of the seminiferous tubulers and enveloping the neighbouring germ cells while 
providing physical and “nursing” support (Sertoli, 1865). The Sertoli cells are a 
nonproliferating population (Clegg, 1963; Steinberger & Steinberger, 1971); and adjacent 
Sertoli cells are joined to one another by distinct types of junctions: hemidesmosomes, gap 
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and tight or occluding junctions (Pelletier & Byers, 1992; Pelletier & Friend, 1983). 
Physiological and morphological studies have established that the Sertoli- Sertoli tight 
junctions are the site of the blood-testis barrier (Pelletier & Byers, 1992). The blood-testis 
barrier divides the germinal epithelium into a basal cellular compartment adjacent to the 
basal lamina and in contact with the blood-borne substances and a luminal cellular 
compartment sequestered from the blood. Pelletier et al. (1986) demonstrated that the 
establishment of the blood-testis barrier is correlated with the development of the lumen 
and the establishment of gradients between the apical and the basolateral fluid 
compartments, and not necessarily with the presence of a particular generation of germ 
cells in the seminiferous epithelium.  
Spermatogenesis is the developmental process in seminiferous tubules whereby the 
germ cells are undergo the undifferentiated spermatogonia to spermatozoa (Clermont, 
1972). Spermatogenesis consists of three principal phases and each involving a distinct 
class of germ cells (Clermont, 1972). (1) Spermatogonial phase, the diploid spermatogonia 
proliferate by mitosis. The spermatogonia reside in the basal compartment of the 
seminiferous epithelium where they perpetuate their own numbers to give rise to 
spermatocytes (De Rooij et al., 1989; Leblond & Clermont, 1952). The germ cells located 
in the basal compartment migrate into the luminal compartment to complete meiosis and 
undergo cellular differentiation. This migration of the germ cells occurs at a precise 
moment, the early zygotene spermatocyte stage in most species (Cavicchia & Miranda, 
1988; Cavicchia & Sacerdote, 1991; Dym & Cavicchia, 1977; Dym & Cavicchia, 1978). 
(2) Meiosis: This phase is characterized by the reduction of the number of chromosomes 
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from diploid (2n) to haploid (n) (Diagram 1). (3) Spermiogenesis: Spermatids differentiate 
in this stage. The main features include formation of the acrosome, development of a 
flagellum, condensation of the chromatin and loss of residual cytoplasm containing lipids 
and organelles (Leblond & Clermont, 1952).  
1.2 Cholesterol in testis  
Previous observations showed that cholesterol is an important structural component 
of cellular membranes and myelin and the precursor of oxysterols, steroid hormones and 
bile acids (Goldstein & Brown, 1990). Cholesterol is composed of four hydrocarbon rings, 
a hydroxyl group and a hydrocarbon tail. The 4-ring region of cholesterol is the signature of 
all steroid hormones (such as testosterone in the testis) (Xu et al., 2005). The hydroxyl 
group in cholesterol converts the otherwise highly hydrophobic molecule into an 
amphiphile modecule, and orients its position in the membranes. In addition, it can mediate 
hydrogen bonding with water and possibly other membrane lipids (Bittman et al., 1994; 
Boggs, 1987). Both the hydrocarbon tail and the ring region are non-polar. These specific 
structures are critical for cholesterol solubility in fatty and oily substances while not mixing 
with water.  
In testis, cholesterol is mainly distributed in the microsomal fraction (Ichihara, 1969) 
and is involved in testosterone synthesis (Shikita & Tamaoki, 1965) and spermatogenesis 
(Armstrong, 1970). The concentration of cholesterol in testis exhibits considerable 
variations in prebubertal as well as adult animals (Aoki & Massa, 1975). Cyclic changes in 
testicular cholesterol distribution have also been detected in a seasonal mammal (Talpa 
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europaea) (Lofts & Boswell, 1960). The physiological fluctuations of testicular cholesterol 
concentration absolutely require efficient mechanisms to maintain cholesterol equilibrium 
that is crucial for normal testis functions and spermatogenesis. Recent studies on hyper- and 
hypocholesterolemia added new evidence showing the physiological significance of 
cholesterol homeostasis in the testis: hypercholesterolemia caused spermatogenesis 
inhibition (Bataineh & Nusier, 2005) and hypocholesterolmia impaired fertility (Wechsler 
et al., 2003). The regulation of intracellular cholesterol metabolism for the maintenance of 
spermatogenesis needs future investigation. 
Cholesterol participates in testosterone production and spermatogenesis 
(Armstrong, 1970). These important physiological events occur in two distinct 
compartments of testis: the interstitial tissue and seminiferous tubules.  
1.2.1 Cholesterol in the interstitial tissue 
Testosterone is synthesized and secreted in the interstitial tissue. The precursor of 
testosterone is cholesterol. The possible sources of cholesterol could be either plasma 
lipoprotein or de novo synthesized cholesterol (Fofana et al., 1996). For example, in rat 
interstitial tissue, 40% of cholesterol is derived from plasma and 60% from de novo 
synthesis (Morris & Chaikoff, 1959). Cholesterol synthesis is mediated by a series of 
enzymes located in the endoplasmic reticulum of the Leydig cells. Among these enzymes, 
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase is the rate-limiting 
enzyme which converts HMG-CoA to mevalonate, an intermediate associated with 
testosterone production (Hou et al., 1990). HMG-CoA reductase activity increased 
dramatically in agreement with the elevation of testosterone production after experimental 
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hormone treatment on cultured Leydig cells in vitro (Hou et al., 1990). HMG-CoA 
reductase activity reached highest levels at the onset of sexual maturation when testosterone 
levels reach their maximum in rat testis (Ness & Nazian, 1992). These findings suggest that 
de novo cholesterol synthesis might be the main source of testosterone production. 
On the other hand, plasma derived cholesterol for testosterone production must be 
hydrolysed by Hormone-sensitive lipase (HSL), one of the cholesteryl ester lipases that free 
esterified cholesterol (Holm et al., 2000). Observations from our lab showed that HSL 
protein levels and enzymatic activity are positively correlated with serum testosterone 
levels during development in the Guinea pig (Kabbaj et al., 2001). In addition, HSL-
enzymatic activity is high in the interstitial tissue during periods of high serum testosterone 
levels in mink testis (Kabbaj et al., 2003). Furthermore, the cholesterol ester hydrolase 
inhibition experiments showed increasing esterified cholesterol in mouse testis and 
decreasing testosterone levels in serum (Bartke et al., 1973). All these observations 
suggested HSL hydrolyses esterified cholesterol from plasma and provides free cholesterol 
for the production of testosterone.  
The process of providing free cholesterol is reversed at resting states. The excess of 
cholesterol is esterified and stored in lipid droplets by acyl-CoA: cholesterol acyltransferase 
(ACAT). The esterification activity of ACAT provides protection against excessive 
cholesterol. It has been reported that hypercholesterolemia-induced testicular damage is 
probably due to the compromised cholesterol esterification activity of ACAT (Fogari et al., 
2002). However, the role of individual isoforms of the enzyme (ACAT) in the maintenance 
of cholesterol homeostasis in the interstitial tissue has never been addressed. 
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1.2.2 Cholesterol in the seminiferous epithelium 
Cholesterol content in seminiferous tubules is indispensable for gamete 
development and fertility in most male animals (Hermo et al., 2008, Osuga et al., 2000; 
Vallet-Erdtmann et al., 2004; Wechsler et al., 2003). However, the origins of cholesterol in 
seminiferous tubules remain elusive.  
In contrast to the liver and other extrahepatic tissues which acquire cholesterol 
carried by lipoprotein in the circulation, the transport of lipoprotein cholesterol from the 
circulation to the testis is reduced because the blood-testis barrier effectively limits its 
uptake (Setchell, 1975). In fact, the basement membrane of the seminiferous tubules, which 
separates each tubule from capillaries, blocks the entry of low-density lipoprotein (LDL) 
(Fofana et al., 2000). It has been reported that Sertoli cells may possess the capacity to 
synthesize cholesterol from acetate in vitro (Wiebe & Tilbe, 1979). Thus, cholesterol 
synthesis may constitute one origin of cholesterol in the seminiferous tubules. Because of 
different metabolic demands imposed on Sertoli cells by cyclic production of germ cell, the 
ability of Sertoli cells to synthesize cholesterol must be precisely regulated. Additionally, 
close to 75% of the germ cells will die by apoptosis before reaching maturity in the normal 
testis, and most of them will be phagocytosed by Sertoli cells, leaving an accumulation of 
cellular debris including lipids and cholesterol (Pelletier & Vitale, 1994). Thus, the 
apoptotic germ cells or their cell membrane remnants become a crucial source of 
cholesterol in the seminiferous tubules. Because cholesterol is a component of all germ cell 
membranes, including spermatozoa (Pelletier & Friend, 1983a), the cyclical release of 
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spermatozoa offers a constant challenge to the homeostasis of cholesterol in the tubules that 
demands the action of regulatory mechanisms. 
An additional source of cholesterol for Sertoli cells may originate from the cyclical 
phagocytosis of esterified cholesterol-rich lipid droplets contained within the spermatids’ 
residual bodies (Pelletier & Vitale, 1994). The residual bodies are lobes of excess of 
cytoplasm that are detached from spermatozoa prior to their release from the seminiferous 
tubules (Smith & Lacy, 1959).  
 The source of cholesterol in the seminiferous tubules is different from the interstitial 
tissue. However, the observation that free cholesterol concentration in tubules equals that in 
interstitial tissue (Kabbaj et al., 2001; Kabbaj et al., 2003; Marshall, 1957) entails factors 
regulating cholesterol homeostasis to maintain this equilibrium. Enzymatic factors involved 
in cholesterol homeostasis include HMG-CoA reductase, HSL and ACAT.  
The in vitro studies on HMG-CoA reductase confirmed the high rate of acetate 
incorporation into cholesterol during spermatogenesis (Potter et al., 1981). The rate of 
acetate incorporation into cholesterol is high in pachytene spermatocytes, but returns to 
very low levels in mature spermatozoa (Potter et al., 1981). Other evidence showed that the 
rate of [14C] acetate incorporation into cholesterol increases 4- to 5-fold as spermatocytes 
mature to pachytene spermatocytes (Hou et al., 1990). These findings suggest that the 
cholesterol synthesis is closely associated with spermatocytes and meiosis. Thus, the 
function of HMG-CoA reductase in the regulation of tubular cholesterol metabolism for the 
maintenance of spermatogenesis is worth investigating. 
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It has been suggested that Sertoli cell phagosomes contain lipases that could process 
lipids borne from residual bodies and liberate the subunits or “ building blocks” necessary 
for new lipid synthesis (Kerr et al., 1984). Kabbaj et al. (2001; 2003) demonstrated that 
hormone sensitive lipase (HSL) was present in Sertoli cell lysosomes; and that HSL may 
induce hydrolysis of esterified cholesterol in the tubules to maintain optimal cholesterol 
concentrations. The present study focuses on testicular HSL because of the manifest 
importance of the enzyme in male fertility. The HSL knockout mice results in male sterility, 
suggesting a key role of the enzyme in the testis (Osuga et al., 2000). A significant rise in 
cholesterol ester levels concomitantly with the absence of cholesterol esterase activity was 
reported in HSL knockout mice testes and a decrease in testosterone concentration of 
peripheral plasma (Bartke et al., 1973; Osuga et al., 2000; Vallet-Erdtmann et al., 2004). In 
contrast, expression of transgene HSLtes in HSL-null mice provoked the restoration in 
cholesteryl ester hydrolase activity and the rescue of infertility (Vallet-Erdtmann et al., 
2004). These studies attest to the utmost biological significance of the enzyme in the 
maintenance of adequate cholesterol content in testicular cells. 
Cholesterol is indispensable to all cells; however, the cholesterol concentration must 
be regulated to prevent excessive accumulation of the compound within the cell, which 
would compromise vital cellular functions and eventually be lethal. Cholesterol 
esterification serves both as a means to store cholesterol for later use and as a detoxification 
reaction to protect cells from excess free cholesterol (Simons & Ikonen, 2000). Yet, no 
reports describe the metabolism process of the esterification of excessive cholesterol in the 
Sertoli cells or germ cells. It has been reported that acyl-CoA: Cholesterol acyltransferase 1 
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(ACAT-1), the enzyme converting cholesterol into cholesteryl esters, is expressed in testis 
(Chang et al., 1997). Thus thesis investigates the behavior and the role of ACAT-mediated 
modulation of cholesterol metabolism in testis during different phases of spermatogenic 
activity. 
1.2.3 Cholesterol in spermatozoa 
The lipidic component in spermatozoa enables specialized activities in these cells. 
For example, lipid composition is a major determinant of the membrane rigidity and 
permeability (Stubbs & Smith, 1984). A loss of cholesterol allows for changes in the 
permeability of the cell membrane which are required for the characteristic flagellar 
movement of spermatozoa and also of the fusogenic properties of the cell membranes 
associated with the acrosome reaction and fertilization (Bearer & Friend, 1982). In 
addition, the removal of membrane cholesterol and the resulting decrease in the 
cholesterol/phospholipid (C/PL) ratio in the membrane constitutes an important step of 
capacitation in human spermatozoa (Hoshi et al., 1990). 
Changes in the proportion of various lipids in spermatozoa were reported 
throughout the reproductive period (24-72 wk of age) in male chickens (Cerolini et al., 
1997). Cholesterol esters and free fatty acids increased continuously with age while the 
relative free cholesterol and triacylglycerols content showed no change in spermatozoa or 
in relation to fertility (Cerolini et al., 1997).  
Several enzymatic factors potentially involved in cholesterol homeostasis in 
spermatozoa have been detected. HSL was reported in epididymal spermatozoa (Kabbaj et 
al., 2003). And HSLtes, one of the HSL isoforms, was expressed in early and elongated 
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spermatids. HSLtes transgene expression reversed the cholesteryl ester accumulation in 
HSL-null mice (Vallet-Erdtmann et al., 2004). Expression of HSLtes and cognate 
cholesteryl ester hydrolase activity leads to a rescue of the infertility observed in HSL-
deficient male mice (Vallet-Erdtmann et al., 2004). On the other hand, male germ cells 
highly expressed the intermediates in the cholesterol biosynthetic pathway including HMG-
CoA reductase, while the role of the enzyme has not yet been evaluated (Tacer et al., 2002). 
To date, ACAT isoforms have not been detected in the spermatozoa. 
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2. Enzymatic factors regulating intracellular cholesterol to maintain 
cholesterol equilibrium in the testis 
 2.1. 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase  
  2.1.1 Composition, structure and orientation 
HMG-CoA reductase is an integral glycoprotein (Mr 90,000-97,000) of the 
endoplasmic reticulum (ER) with an extended, carboxy-terminal, and a cytosolic domain 
that harbors the catalytic site (Chin et al., 1984; Hardeman et al., 1983). HMG-CoA 
reductase is also synthesized inside the mitochondria of Leydig cells in rat (Pignataro et al., 
1983). Modeling studies (Liscum et al., 1985) on the primary structure of mammalian 
HMG CoA reductase localized the enzyme in ER membrane and suggested that NH2-
terminal of the reductase contains seven hydrophobic segments embedded in the membrane 
of ER and that the COOH-terminal of the protein, which contains a long relatively 
hydrophilic domain, extended into the cytoplasm (Liscum et al., 1985). The link region 
between NH2-terminal and COOH-terminal is composed of proteolytic sites. Hence, the 
action of endogenous and exogenous proteases can release a water-soluble 53-kDa 
fragment into the cytoplasm (Miller et al., 1989). The findings suggest that the hydrophilic 
COOH- terminal includes  the 53-kDa water-soluble enzymatically active site, while the 
NH2-terminal portion of the reductase would fix HMG-CoA reductase to the ER membrane 
(Gibson & Parker, 1986) (Diagram 2).  
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Diagram 2. Topological model of HMG-CoA reductase. This figure showed a model of the 
orientation of HMG-CoA reductse in the ER membrane. (A) HMG-CoA reductase includes two 
distinct domains: a hydrophobic N-terminal domain with eight membrane-spanning segments that 
anchor the protein to ER membranes, and a hydrophilic C-terminal domain that projects into the 
cytosol and exhibits all of the enzyme's catalytic activity. (B) Amino acid sequence and topology of 
the membrane domain of HMG-CoA reductase. The lysine residues implicated as sites of Insig-
dependent, sterol-regulated ubiquitination are highlighted in red and denoted by arrows. The YIYF 
sequence in the second membrane-spanning helix that mediates Insig binding is highlighted in 
yellow [Taken from (DeBose-Boyd, 2008)].  
 
2.1.2 Physiological roles of HMG-CoA reductase in tissue and in testis 
HMG-CoA reductase is present as a single enzyme irrespective of the species. 
HMG-CoA reductase is the rate-limiting enzyme, and catalyzes the main step in cholesterol 
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synthesis which is the conversion of HMG-CoA to mevalonate (Brown & Goldstein, 1980; 
Kennelly & Rodwell, 1985) (Diagram 3). 
                         
 
Diagram 3. The progress of biosynthesis of cholesterol. The rate-limiting step is 3-hydroxy-3-
methylglutaryl-CoA (HMG-CoA) reductase activity. Intermediates are used as attachments to 
different proteins and enzymes. CoA, coenzyme A; PP, pyrophosphate. [Taken from (DeBose-Boyd, 
2008)]. 
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The physiological significance of HMG-CoA reductase was demonstrated by the 
observation that the loss of HMG-CoA reductase resulted in cell death and early embryonic 
lethality (Nwokoro et al., 2001; Porter, 2002). Therefore, no direct in-depth study is 
feasible on the cholesterol metabolism in HMG-CoA reductase deficient animals. Instead, 
another gene, Dhcr24, knockout mice was produced (Wechsler et al., 2003). Dhcr24 
encodes the cholesterol biosynthetic enzyme desmosterol reductase which catalyses the last 
step in the cholesterol synthesis. The study showed that Dhcr 24 knocking out mice was 
associated to a marked decrease (90%) in the intracellular and plasma membrane 
cholesterol levels (Wechsler et al., 2003). Both male and female Dhcr24-/- mice were 
reported infertile (Wechsler et al., 2003). Therefore, one could speculate that HMG-CoA 
reductase contributes to the endogenous cholesterol pool which is essential for the 
production of viable germ cells in the tubules and fertile male gametes.  
 It has been reported that the liver expresses the highest level of HMG-CoA 
reductase activity in the rat, but not in the hamster, rabbit or Guinea pig in which the 
adrenals, intestine, skin and carcasses exhibited still higher levels of cholesterol synthesis 
(Hamilton et al., 1994; Ness, 1994). For decades, HMG-CoA reductase inhibitors have 
been used in the treatment and prevention of cardiovascular diseases (Davignon, 2004; 
Martens & Guibert, 1994). It has also been demonstrated that HMG-CoA reductase is 
involved in mevalonation and proteins farnesylation and geranylgeranylation, which is 
essential for cellular proliferation and survival (Duncan et al., 2005). In addition, the 
enzyme could induce human breast cancer cells grown in culture and as in tumors grown in 
  16 
nude mice (Duncan et al., 2005; Graaf et al., 2004). Therefore, HMG-CoA reductase 
inhibitors may be used for the treatment of malignancies (Brown, 2007).  
Studies on the influence of HMG-CoA reductase inhibitors in testis demonstrated 
that inhibitors of hypercholesterolemia administrated to male rats improved their 
reproductive function by providing protection against the reduced fertility induced by 
hypercholesterolemia (Shalaby et al., 2004). This observation attests to the physiological 
significance of HMG-CoA reductase in the physiology of the testis. Yet, HMG-CoA 
reductase-mediated modulation of cholesterol metabolism in the testis has not been studied. 
HMG-CoA reductase activity was reported to be highest from 21-26 days after birth in rat 
testis then, tended to decline in adulthood, suggesting a major role of HMG-CoA reductase 
in de novo cholesterol synthesis in developing testis (Ness, 1994). However, since this 
enzymatic activity measurement was performed in whole testis extracts not on components 
of individual compartments of the testis, the results do not provide precise information on 
the enzyme involved in either spermatogenesis or the production of testosterone.  
In the liver and intestine, the highest specific activity of HMG-CoA reductase was 
recorded in the endoplasmic reticulum subsfraction (Field et al., 1982; Zammit et al., 1991). 
However, the highest activity of HMG-CoA reductase in rat Leydig cells was associated 
with highly enriched mitochondrial fractions and located on the inner mitochondrial 
membrane (Pignataro et al., 1983), suggesting that much of the cholesterol biosynthesis that 
takes place in Leydig cells is carried out within the mitochondria. No studies have yet 
localized HMG-CoA reductase in the seminiferous tubules. Previous reports showed that 
the rate of [14 C] acetate incorporation into cholesterol increased with the onset of meiosis 
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(Hou et al., 1990), suggesting HMG-CoA reductase may be involved in meiosis. However, 
within the tubules where spermatozoa are generated, there is no evidence that the 
biosynthesis pathway makes a physiologically significant contribution to cholesterol in the 
tubules. Instead, the previous observation revealed the rate of acetate incorporation into 
cholesterol significantly decreased within the tubules when spermatozoa are generated 
(Potter et al., 1981). Thus the physiological significance of HMG-CoA reductase in the 
testis remains unclear.  
Recent observations open a new view into the role of the cholesterol synthesis in the 
maturing germ cells. The cholesterol biosynthetic genes are expressed discontinuously in 
the testis (Tacer et al. 2002). The testis-specific expression of pre-testis meiosis-activating 
sterol (T-MAS) genes but not post-T-MAS genes is the primary regulatory checkpoint that 
caused the accumulation of the meiosis-signaling sterol T-MAS during maturation of male 
germ cells (Diagram 4). The discrepancy between pre-MAS and post-MAS genes 
expression suggested that the principal role of male germ cells may not be to synthesize 
cholesterol but rather to produce T-MAS (Tacer et al. 2002). Thus, the development of a 
tissue-specific transcriptional regulatory system to produce a cholesterol biosynthetic 
pathway intermediate in the male gonad suggested that HMG-CoA reductase may have a 
role besides or in addition to the biosynthesis cholesterol. This hypothesis remains to be 
confirmed, and the role of Sertoli cell in the biosynthesis of cholesterol will be one of the 
focuses of my study.  
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Diagram 4 . Postlanosterol part of the pathway of biosynthesis of cholesterol. T-MAS, testis 
meiosis-activating sterol; FF-MAS, follicular fluid meiosis-activating sterol [Taken from (Tacer et 
al., 2002)]. 
 
2.1.3 Regulation of HMG-CoA reductase activity 
The mechanism of the regulation of HMG-CoA reductase activity in the testis has 
received little attention. In most tissue, HMG-CoA reductase is regulated at various levels: 
transcription, phosphorylation/dephosphorylation, translation and protein degradation 
(Panda & Devi, 2004). 
 
  19 
1) Transcription 
The mRNA level of reductase has been shown to vary in parallel with the enzyme 
activity in rat liver (Clarke et al., 1984). Feeding diets containing 2% cholesterol to Syrian 
hamsters was reported to reduce hepatic HMG-CoA reductase mRNA levels 6-fold (Gil et 
al., 1986). In addition, HMG-CoA reductase is transcribed at relatively high rate when cells 
are starved for cholesterol and other mevalonate-derived products (Luskey et al., 1983). 
Transcription is repressed by over 80% when cholesterol and other mevalonate-derived 
products are supplied (Osborne et al., 1985). However, few studies described the details of 
mRNA expression of HMG-CoA reductase gene in the testis besides the observation that 
expression of HMG-CoA reductase gene is upregulated during the maturation of the testis 
(Tacer et al., 2002).  
HMG-CoA reductase is generally regulated on the transcriptional level by 
membrane bound transcription factors of the sterol responsive element binding protein 
(SREBP). SREBPs are a family of proteins that regulate the transcription of a range of 
genes involved in the cellular uptake and metabolism of cholesterol and lipids (Brown & 
Goldstein, 1997). SREBP1 isoforms are responsible for the energy metabolism, including 
fatty acid synthesis and glucose/insulin metabolism, whereas the role of SREBP2 is in  the 
activation of genes (e.g. HMG-CoA reductase) involved in cholesterol biosynthesis 
(Shimano, 2001). 
Regulation of genes including HMG-CoA reductase in cholesterol synthesis and the 
mechanism by which cells sense the level of cholesterol have been extensively studied in 
liver. SREBP1 and 2 are synthesized as the precursor proteins residing in endoplasmic 
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reticulum (ER) membranes (Brown & Goldstein, 1997). SREBPs are bounded to SREBP 
cleavage-activating protein (SCAP), which is required for the movement of SREBPs from 
the ER to the Golgi apparatus (Goldstein et al., 2002; Horton et al., 2002). When 
cholesterol is scarce in the ER, the SREBP-SCAP complex migrates from ER to Golgi 
apparatus where SREBP is subjected to proteolysis. The cleavage of SREBP is carried out 
by 2 distinct enzymes (S1P and S2P). The result of the cleavage is the release of the N-
terminal transcriptionally active part of SREBP into the cytosol. Then the active portion of 
SREBP migrates to the nucleus where it will dimerize and form complexes with 
transcriptional coactivators leading to the activation of genes containing HMG-CoA 
reductase (Yang et al., 2002). In contrast, when cells contain sufficient levels of cholesterol, 
the SREBP-SCAP complex will be maintained in the ER. Thus, cholesterol biosynthesis 
will not be continued (Diagram 5). The cholesterol-level/SREBP-dependent transactivation 
of cholesterolgenic genes is believed to serve primarily to increase production of mRNAs 
encoding for HMG-CoA reductase and other cholesterolgenic enzymes, which causes the 
increase of cholesterol synthesis (Eberle et al., 2004; Shimano, 2002). In the testis, another 
type of regulation for HMG-CoA reductase mRNA expression was the cholesterol level-
independent/SREBP-independent regulation (Fon Tacer et al., 2003). The role of SREBP2 
in cholesterogenesis of germ cells and testis was recently investigated, when an unique 
isoform of male germ cell-enriched transcription factor SREBP2 was identified in rat and 
mouse spermatogenic cells (McPherson & Gauthier, 2004; Wang et al., 2002). The testis-
specific SREBP2 was reported to be expressed as SREBP2gc, in mouse or rat 
spermatogenic cells in a stage-dependent manner and insensitive to the levels of cholesterol 
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(Wang et al., 2002). SREBP2gc is translated as a soluble and mature form of SREBP2, 
missing the SCAP-SREBP binding domain (Wang et al., 2002) . The role of SREBP2gc is 
unclear. The physiological function of regulating HMG-CoA reductase by SREBP2gc 
remains to be elucidated. 
      
Diagram 5. Model for the cholesterol regulation of SREBP trafficking [Taken from 
(McPherson & Gauthier, 2004)]. 
 
 2) Phosphorylation/dephosphorylation  
Beg et al. suggested that the catalytic efficiency of HMG-CoA reductase might be 
regulated by phosphorylation/dephosphorylation in rat liver cytosol (Beg et al., 1973). It 
has been reported that phosphorylation of HMG-CoA reductase decreases its activity 
(Istvan et al., 2000). Phosphorylation of the enzyme is catalyzed by the reductase kinase 
(RK), which itself undergoes reversible phosphorylyation. RK is phosphorylated by a 
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cAMP-independent cytosolic kinase (RKK) or a cAMP-dependent RKK (Goldstein & 
Brown, 1990). Since cAMP is regulated by hormonal stimuli, regulation of cholesterol 
biosynthesis is hormonally controlled (Easom & Zammit, 1987). Insulin causes a decrease 
in cAMP, causing HMG-CoA reductase to be activated and cholesterol biosynthesis to be 
increased (Easom & Zammit, 1987). On the other hand, glucagon and epinephrine are 
hormones that increase the level of cAMP, which results in the HMG-CoA reductase being 
inactivated and in the cholesterol biosynthesis being decreased (Easom & Zammit, 1987). 
Alternatively, RKK is dephosphorylated by phosphoprotein phosphatase (Beg et al., 1973). 
Protein phosphatase is inhibited by phosphoprotein phosphates inhibitor 1 (PPI-1), which 
may be activated by a cAMP-dependent kinase (Beg et al., 1973). The elements required 
for modulation of HMG-CoA reductase by activation-inactivation cycles are illustrated in 
Diagram 6. However, this type of regulation for HMG-CoA reductase has not been 
confirmed in the testis.  
                  
Diagram 6. Regulation of HMG-CoA reductase by phosphorylation/dephosphorylation [Taken 
from (Michael King 2009)]. 
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 3) Translational rgulation 
One mode of post-transcriptional regulation of HMG-CoA reductase is translation. 
Interest in translation as a site for feedback regulation by dietary cholesterol emerged from 
studies showing a much greater decline in hepatic reductase immunoreactive protein than in 
mRNA levels (Ness et al., 1994). It was observed that feeding diets including 2% 
cholesterol to rats for 48h caused a 6-fold decrease in the rate of synthesis of HMG-CoA 
reductase protein (Chambers & Ness, 1998). Higgins et al. (1971) showed that the 
increasing of HMG-CoA reductase activity was accompanied by a rise in the synthesis of 
the reductase protein in rat liver and that synthesis completely stops several hours after the 
activity peaked (Higgins et al., 1971). A 200-fold increase in HMG-CoA reductase protein 
was reported within a few hours when the potent reductase inhibitors blocked the synthesis 
of mevalonate in the culture cells (Goldstein & Brown, 1990). Translational regulation of 
HMG-CoA reductase in the testis remains to be determined. 
 
  4) Protein degradation 
The level of HMG-CoA reductase protein could also be determined by changes in 
the rate of its degradation (Ness & Chambers, 2000). It was found that feeding diets 
supplemented with potential HMG-CoA reductase inhibitor, mevinolin, caused the 
increasing of the half-life of HMG-CoA reductase protein in mammalian liver (Goldstein & 
Brown, 1990). However, investigations into the molecular mechanism by which cholesterol 
exerts feedback regulation on rat testis HMG CoA reductase have led to the conclusion that 
no obvious decreases of protein levels are seen in the testes when rats are placed on diets 
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supplemented with cholesterol (Ness et al., 2001). The protein degradation of HMG-CoA 
reductase in the testis remains unclear. 
There are two mechanisms for protein degradation. The first one is the state 
transition, in which the intrinsic degradation motif is exposed to the degradation substrate 
when a stable state changes to a degraded state. In the second mechanism, the degradation 
motif is already exposed, but it is blocked by regulatory molecules and the degradation is 
inhibited. The mechanism of the degradation of HMG-CoA reductase is unclear. Hampton 
et al. (2002) presented the ubiquitin-mediated degradation of a number of ER-associated 
misfolded protein (Hampton, 2002). In 2003, Sever et al. (Sever et al., 2003) reported that 
the degradation of HMG-CoA reductase was mediated by the binding of Insig-1. As 
mentioned above, HMG-CoA reductase contains a sterol sensing domain and is negatively 
regulated by binding to Insig-1, which accelerates ubiquitination and proteasomal 
degradation of the enzyme (Song et al., 2005).  
 
  5) Nonsterol- mediated regulation of HMG-CoA reductase 
Oxysterols, such as 25-hydroxycholesterol, was shown to bind to a cytosolic protein 
in cultured cells and to act as a potent repressor at the levels of transcription (Gibbons et al 
1980). Oxylanosterols were also reported to act as potent repressors, but only at the level of 
translation (Gibbons et al., 1980; Panini et al., 1992; Taylor et al., 1984). 
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2.2 Hormone-sensitive lipase (HSL) 
Hormone-sensitive lipase (HSL) is an intracellular neutral lipase that is capable of 
catalyzing the hydrolysis of triglycerides, diglycerides, monoacylglycerols, and cholesterol 
esters and retinyl esters (Holm et al., 2000).  
2.2.1 Structure and biochemical properties 
The HSL gene is located on human chromosome 19q13.3 (Holm et al., 1988) and 
contains 9 exons (1-9) spanning approximately 11kb in humans and 10 kb in mice, 
respectively (Langin et al., 1993). These nine exons encode a mRNA of 2.8 kb (Grober et 
al., 1997) which is translated into a 775-amino acid-long protein (Langin et al., 1993) in 
human adipose tissue. Subsequently, two additional noncoding exons (A and B) spanning 
approximately 12.5 and 1.5kb were identified upstream exon 1, respectively (Grober et al., 
1997). The transcription starting site of HSL mRNA (2.8 kb) was mapped in the exon B, 
whereas exon A was represented in a minor fraction of adipocyte HSL transcripts (Grober 
et al., 1997). Two testicular forms of HSL have been characterized in human and rodent 
testes (Holst et al., 1996; Mairal et al., 2002). A testis-specific exon 15.5 kb upstream of 
exon 1 of human and rat adipocyte HSL produces a 3.9 kb testicular HSL mRNA (Holst et 
al., 1996). HSLtes mRNA is translated into 1068- and 1076-amino-acid proteins in human 
and rat (Blaise et al., 2001). Compared with rodents, where only HSLtes mRNA of 3.9 kb is 
expressed (Holst et al 1996), a second testicular mRNA, 3.3 kb mRNA was found in human 
(Mairal et al 2002) . This specific exon is located 12kb upstream of exon 1 and encodes a 
protein which is identified to the adipocyte HSL. The transcription of the HSL gene is 
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under the regulation of two promoters: the promoter upstream exon B which regulates HSL 
transcription in adipocytes and other tissues, the other promoter upstream exon T regulates 
HSL transcription specifically in the testis (Blaise et al., 2001) (Diagram 7).  
The purified human adipose HSL has a molecular weight of approximately 88 kDa 
on SDS-PAGE, corresponding to the 775-amino-acid protein with a molecular mass of 84 
kDa predicted (Langin et al., 1993). The adipose HSL in rat has an 84 kDa immunoreactive 
band seen on SDS-PAGE (Shen et al., 1999). In the testis, several protein species with 
apparent molecular weight ranging from 26 to 130 kDa are expressed (Holm et al., 1987; 
Kabbaj et al., 2001; Kraemer et al., 1993b).  These forms may come from the 3.9 kb HSL 
mRNA in rodents and form two mRNA species of 3.9 and 3.3 kb in human (Blaise et al 
2001; Holst et al 1996). The large form encodes the predicted protein of 120 kDa, HSLtes, 
whereas the 3.3 kb from encodes a small protein of 88 kDa, that is similar to the adipose 
HSL (Langin et al., 1993). 
HSL has been shown to be a muti-domain structural protein by limited proteolysis 
studies and spectroscopic analyses (Holm, 2003). HSL consists of two major structural 
domains: a C-terminal catalytic domain common to all HSL isoforms, and an N-terminal 
domain, different among all HSL isoforms. The C-terminal portion of the protein comprises 
two distinct domains, one containing the catalytic triad and a second that constitutes a 
regulatory “loop”. The regulatory loop, from residue 521 to residue 669, contains all of the 
known phosphorylation sites and is specific to HSL in rat (Holm, 2003). The function of N-
terminal domain is poorly understood but is has been implicated in protein-protein and 
protein-lipid interactions (Osterlund et al., 1996; Smith et al., 1996). It has been 
  27 
demonstrated that the N-terminal portion of the adipocyte enzyme mediates interaction with 
adipocyte lipid binding protein (ALBP), an intercellular fatty acid carrier (Shen et al., 
1999). Compared to the normal adipose HSL protein structure, HSLtes protein is composed 
of an additional 300 or 301 amino acids N-terminal in rat and human respectively (Mulder 
et al., 1999) (Diagram 7). 
 
 
Diagram 7. The structure of the human HSL gene and the corresponding protein. (A) The 
organization of human HSL gene. Testis-specific exon T encodes additional 300 amino acids at the 
N-terminus. (B,C) The primary amino acids sequences of HSL are described accordingly in (A). 
Three functional regions are given: an N-terminal protein binding domain, a C-terminal catalytic 
domain and a regulatory module contaning multiple phosphorylation sites. [Taken from (Holm et 
al., 2003)]. 
 
 
2.2.2 Cholesteryl ester hydrolase (HSL) in tissue and in testis 
 HSL is an intracellular neutral enzyme which is expressed in adipose and 
steroidogenic tissues, cardiac and skeletal muscle, macrophages, and pancreatic islets 
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(Holm et al., 1988; Kraemer & Shen, 2002). In adipose tissue, the primary action attributed 
to HSL is hydrolysis of stored triglycerols, named lypolysis (Londos et al., 1999). HSL 
plays a crucial role in regulating the accumulation of triglyceride droplets and in energy 
utilization in cardiac and skeletal muscle (Kraemer et al., 1993a; Langfort et al., 1999). The 
neutral cholesterol ester hydrolase activity purified from the adrenal gland has been shown 
to be similar to that in adipose tissue (Cook et al., 1982). However, the role of HSL in 
macrophages remains to be investigated. It has been found that the neutral cholesterol ester 
hydrolase activity does not change in peritoneal macrophages in HSL knockout mice 
(Contreras, 2002; Osuga et al., 2000); the cholesterol ester stores in HSL-deficient 
macrophages are identical to wild type macrophages. These findings hint that one or several 
additional intracellular lipases could exist and this (these) lipase(s) could in part 
compensate for the lack of HSL.  
In rat testis, HSL mRNA and protein expression showed marked developmental 
changes, and HSL mRNA levels were low in the first week after birth and increased several 
fold in the adult between days 20 and 90 (Kraemer et al., 1991). Conflicting observations 
have been reported for HSL mRNA and protein expression in testis. HSL has been reported 
in human Leydig cells by immunohistochemistry (Mairal et al., 2002) while Holst et al. 
(Holst et al., 1996) said HSL was not expressed. Studies in our laboratory revealed that 
testicular macrophages contain active HSL in mink (Kabbaj et al., 2003), which challenges 
the hypothesis regarding the function of HSL in the production of testosterone in Leydig 
cells (Mairal et al., 2002) and entails an important contribution of the testicular 
macrophages in the modulation of the amounts of the cholesterol to be used for testosterone 
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production by the Leydig cells (Kabbaj et al., 2003). Moreover, HSL has been observed in 
Sertoli cells and spermatozoa in Guinea pig (Kabbaj et al., 2001) and mink (Kabbaj et al., 
2003) and human testes (Mairal et al., 2002). In situ hybridization showed strong labeling 
of germ cells in the seminiferous tubules at stage X-XIV in rat testis (Holst et al., 1994). 
Immunohistochemistry revealed HSL immunoreactivity in the germ cells at stages XIII-
VIII in rat testis (Holst et al., 1996). The data suggested that HSL mRNA and protein were 
expressed in haploid germ cells but with a delay between mRNA and protein expression as 
many other genes expressed during spermatogenesis (Blaise et al., 1999; Blaise et al., 
2001). 
The functions of HSL have been further identified by generating HSL-null mice. 
Basal lipolysis has been reported to be unchanged in these mice (Haemmerle et al 2002; 
Mulder et al 2003). The findings suggest the presence of one or more additional 
intracellular triglyceride lipases in the adipose tissue as well as in macrophages, which 
could partly compensate for the lack of HSL (Haemmerle et al., 2002; Mulder et al., 2003; 
Osuga et al., 2000; Wang et al., 2001).  
The most striking aspect of HSL-null mice was male sterility due to oligospermia 
(Osuga et al 2000), which evidences a crucial contribution of HSL in male fertility. The 
testis weight of HSL-null mice is 40 percent lower than that of the wild type mice (Vallet-
Erdtmann et al., 2004). Decreased numbers of early and late spermatids were reported in 
the seminiferous tubules, no spermatozoa were found in the epididymes (Vallet-Erdtmann 
et al., 2004). Additionally, neither immunoreactive HSL nor neutral cholesteryl ester 
hydrolase activity was detected in testis of HSL-deficient mice (Osuga et al., 2000). 
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Therefore, it appears that HSL is responsible for all of the neutral cholesteryl hydrolase 
activity and the defect in cholesterol metabolism may contribute to the abnormalities in late 
spermatids of the knockout mice. Consistent with the lack of HSL in Leydig cells, HSL-/- 
mice have normal plasma testosterone levels, follicle-stimulating hormone and luteinizing 
hormone (Osuga et al., 2000). One could speculate that the oligospermia does not result 
from hypogonadism, but rather, result from cholesterol inequilibrium by HSL-deficiency in 
seminiferous tubules. Thus, HSL may be directly involved in the cholesterol homeostasis in 
the testis and contributed to the male fertility. 
To further elucidate the physiological significance of HSL, especially HSLtes, in 
male sterility, a transgenic mice strain (HSLtes+/+ or HSLtes+/-) expressing the human HSLtes 
under the control of its own promoter was generated, through crossing transgene animals 
with HSL-null mice. The remodeling mice show a lack of HSL in all tissues except haploid 
germ cells (Osuga et al., 2000; Vallet-Erdtmann et al., 2004). Rescue of spermatogenesis in 
HSL-/- HSLtes+/+ mice demonstrated that the lack of the mature spermatids and 
spermatozoa was due to the absence of the correct HSLtes transcription (Vallet-Erdtmann et 
al., 2004). Interestingly, the presence of two alleles of HSLtes led to a rescue of infertility 
observed in HSL-null male mice (Vallet-Erdtmann et al., 2004). The findings point to the 
unique function of HSLtes in the testis and its quantitative demand for normal 
spermatogenesis. HSL has been shown in most tissues to be crucial for the cholesteryl ester 
hydrolase (CEH) activity (Arenas et al., 2004; Kraemer & Shen, 2002). In HSL-deficient 
testis, a relationship was established between CEH activities, cholesteryl ester level and 
fertility. HSL-/- testis showed very low levels of CEH activities and accumulation of 
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cholesterol esters in the tubules (Osuga et al., 2000). On the other hand, the finding in 
HSLtes transgenic mice showed that the increasing of CEH activity was necessary to restore 
spermatozoa and resume fertility. Thus, the HSLtes transgene experiments indicated that 
male infertility in HSL deficient mice was due to the lack of expression of HSLtes, the 
testicular form of HSL in the spermatids, and suggests that the absence of spermatozoa was 
mediated in part by repressing the CEH activity.  
The studies in our laboratory extended over previous studies by showing that HSL 
activity and protein levels increased in parallel in the tubules and in the interstitial tissue 
with development but that HSL activity was higher in interstitial tissue where testosterone 
is synthesized (Kabbaj et al., 2003). In addition, our laboratory showed that the modulation 
of cholesterol metabolism in individual testicular compartments may be regulated by HSL 
isoforms expressed in distinct cells. Interstitial macrophages may be part of a system 
involved in the synthesis of steroid hormones and in the recycling of sterols in interstitium 
whereas in the tubules, recycling could be ensured by Sertoli cells. Moreover, our 
laboratory suggested that HSL may be the only cholesterol esterase in the seminiferous 
tubules (Kabbaj et al., 2001; Kabbaj et al., 2003).  
Previous studies done in our laboratory had used enzymatic digestion to generate 
the different tissue fractions (Kabbaj et al., 2001; Kabbaj et al., 2003). This might have 
caused a possible destruction of various phosphorylated forms of HSL. Recently, a 
separation technique has been developed in our laboratory and this approach apparently 
allows to be better preserve the HSL enzymatic activity and the phosphorylated forms of 
proteins (Akpovi et al., 2006). Nevertheless, the interrelationship between HSL and other 
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enzymes that directly or indirectly contribute to the cholesterol metabolism in the testis 
remains to be elucidated. Moreover, there are no data on the activities of other enzymes 
when HSL activity is either decreased or rendered inefficient. 
HSL has broad substrates, which includes retinyl esters. The absence of the function 
of retinoic acid has been described in the dysfunction of spermatogenesis. Retinoic acid is 
the acid form of vitamin A (Djakoure et al., 1996). Vitamin A– deficient male rats 
developed sterility (Griswold et al., 1989) and male sterility was the major phenotype in 
retinoic acid nuclear receptor, RARą knockout mice (Lufkin et al., 1993). However, no 
studies focussed on the impairment of retinoic acid production and spermatogenesis. 
Further studies are needed to elucidate the mechanism by which HSL deficiency results in 
male sterility. 
 
2.2.3 Regulation of HSL activity 
2.2.3.1 Transcriptional regulation 
HSL activity is modulated at the transcriptional and post-transcriptional levels. HSL 
mRNA level is correlated with the maximal lipolysis rate in human fat cells (Large et al., 
1998). Changes in adipose HSL mRNA levels have also been reported in humans with 
familial combined hyperlipidemia (Reynisdottir et al., 1995).  
During spermatogenesis, specialized transcriptional mechanisms ensure a stage-
specific gene expression in the germ cells. Some germ cell-specific transcriptional factors 
have been described and shown to function on few target genes. CREMγ is a product of the 
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CREM gene that acts as a transcriptional activator associated to the cAMP signaling 
pathway (Foulkes et al., 1992). And protamin 1, a nucleoprotein that replaces histones and 
promotes nuclear condensation, has been identified to be the target gene for CREMγ –
mediated activiation of HSLtes promoter in post-meiotic germ cells (Delmas et al., 1993).  
 
2.2.3.2 Post-transcriptional regulation 
Lipolytic and anti-lipolytic hormones as well as neurotransmitters and other effector 
molecules regulate adipocyte lipolysis. Catecholamines, adrenaline and noradrenaline 
belong to this group of hormones that are crucial for lipolysis, whereas insulin and 
adenosine are the most important anti-lipolytic stimulators (Londos et al., 1999). A well-
known mechanism regulating lipolysis is the cAMP pathway (Carmen & Victor, 2006; 
Haemmerle et al., 2003; Holm, 2003). Catecholamine  agonists bind to the β-adrenergic 
receptors, coupled to adenylate cyclase via the stimulatory G-protein, then cause an 
increase in cAMP and an activation of a cAMP-dependent protein kinase (PKA) (Holm, 
2003). The two main substrates, HSL and perilipins, are phosphorylated by PKA 
(Osterlund, 2001). PKA phosphorylation of HSL causes translocation from the cytosol to 
the lipid droplet, whereas phosphorylation of perilipin by PKA alleviates the barrier 
function of this protein and prompts its active participation in the lipolytic process (Holm, 
2003) (Diagram 8). On the other hand, other signaling pathways were also reported to be 
involved in the lipolytic response. For instance, PKC can be stimulated and mediated by 
both independent and dependent mitogen-activated protein kinases (extracellular signal 
regulated kisnases, ERK-1/2) way (Haemmerle et al., 2003; Holm, 2003) (Diagram 9).   
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Diagram 8. The classified cAMP pathway for regulation of HSL activity. TG, triglycerides; DG, 
diglycerides; MG, monoglycerides; MGL, monoglyceride lipase. [Taken from (Holm et al., 2003)]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Diagram 9. Schematic structure of phosphorylation sites of HSL. The N-terminal amino acids 
are described as a globular structure and the important serine residues can be phosphorylated by the 
different kinases are shown in the C-terminal portion. [Taken from (Kraemer & Shen, 2002)]. 
  35 
PKA phosphorylates HSL at three serine residual sites: S563, S659 and S660 
(Anthonsen et al., 1998). Activation of ERK pathway appears to be able to regulate 
adipocyte lipolysis by phosphorylating HSL on the residue S600 (Greenberg et al., 2001). 
In contrast to the activated sites of HSL seen in PKA and ERK phosphorylation, one 
additional serine residual site in HSL, S565, has been shown to be phosphorylated by other 
kinases such as Ca++/calmodulin-dependent protein kinase II and AMP-activated protein 
kinase (Garton & Yeaman 1990). Phosphorylation HSL at S565 prevents the 
phosphorylation of S563 by PKA and inactive HSL (Diagram 9) (Garton et al., 1989; 
Garton & Yeaman, 1990). 
 
2.3 Acyl-CoA: cholesterol acyltransferase 1 (ACAT-1) and 2 (ACAT-2) 
Acyl-coenzyme A: cholesterol acyltransferase (ACAT) is an ER membrane bound 
enzyme that catalyzes the transfer of a long-chain fatty acyl residue from acyl-CoA to the 
β-hydroxyl group of cholesterol to form a cholesteryl ester (Diagram 10). Two isoforms of 
the enzyme, ACAT-1 and ACAT-2 have been described (Chang et al., 1993; Chang et al., 
1998).  
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Diagram 10 . The ACAT reaction of cholesterol esterification in cells. CoA, coenzyme 
A; ACAT, Acyl-coenzyme A: cholesterol acyltransferase  [Taken from (Brown & 
Goldstein, 1986)]. 
 
2.3.1 Comparison between ACAT-1 and ACAT-2  
  1) Historical perspective 
Cholesterol esterase was first reported in the blood in 1895 (Hürthle KZ 1895). It 
was defined as lecithin: cholesterol acyltransferase (LCAT). Around the 1950’s, another 
intracellular cholesterol esterase was found in rat liver cells and was identified as acyl-
coenzyme A: cholesterol acyltransferase (ACAT) (Goodman et al., 1964). By 1993, Chang 
et al. (1993) cloned the human ACAT gene using a combination of somatic cells and 
molecular genetic approaches and they named it ACAT-1. A second mammalian acyl-
coenzyme A: cholesterol acyltransferase, named ACAT-2 was identified on the basis of its 
protein sequence homology with ACAT-1 close to the C terminal (Cases et al., 1998a).  
 
 
  37 
  2) Tissue distribution 
In human, rabbit and mouse, ACAT-1 protein has been localized in virtually all 
tissues examined including: hepatocytes, Kupffer cells, adrenal, skin cells, intestinal 
enterocytes, neurons, and macrophages (Chang et al., 1993; Pape et al., 1995; Uelmen et 
al., 1995). However, the localization of ACAT-2 was said to be restricted. In humans, 
ACAT-2 was localized in the intestinal mucosa and hepatocytes (Anderson et al., 1998; Lee 
et al., 1998), and under pathological conditions (Sakashita et al., 2003) in macrophages. 
ACAT-2 was said to be absent from testis (Fazio et al., 2001; Lee et al., 2000; Rudel et al., 
2001). The distribution of ACAT-1 and ACAT-2 was not identical in mouse and humans. 
ACAT-2 is the major isoenzyme in mouse hepatocytes, whereas in adult humans, 
hepatocyte ACAT-1 is the major isoenzyme. Additionally, ACAT-1 mRNA was reported to 
be relatively abundant in steroidogenic tissues, including the adrenal gland, testis, and 
ovary (Chang et al., 1993).  
 
  3) Structures of the gene and protein  
The human ACAT-1 gene is located on two different chromosomes (Li et al., 1999). 
The coding region and the proximal promoter are located on chromosome 1, whereas the 5’ 
noncoding region and distal promoter that control the expression of the noncoding region 
are located on chromosome 7 (Li et al., 1999). The mouse gene is located on chromosome 1 
(Uelmen et al., 1995). However, the human ACAT-2 gene is located on chromosome 12, 
and the mouse ACAT-2 gene is located on a homologous region of chromosome 15 (Cases 
et al., 1998a).  
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ACAT-1 and ACAT-2 may both contain multiple hydrophobic transmembrane 
regions consistent with their being integral membrane proteins (Joyce et al., 2000; Lin et 
al., 1999) (Diagram 11). Depending the method used, ACAT-1 was said to span the ER 
membrane 5 to 7 times (Chang et al., 1993), whereas ACAT-2 includes 5 to 10 (usually 6 
to 9) hydrophobic domains capable of serving as trans-membrane regions (Cases et al., 
1998a). 
The ACAT-1 cDNA encodes a protein of 550 amino acids in human and of 540 
amino acids in mouse (Chang et al 1993). ACAT-2 cDNAs encode proteins of 522 and 525 
amino acids, respectively (Anderson et al., 1998; Lee et al., 1998). The amino acid 
sequence of human ACAT-2 show more than 40% identity with human ACAT-1. The most 
highly conserved regions are in the carboxyl terminal. The predicted molecular weight of 
ACAT-1 is approximately 65kDa, while the molecular weight viewed in SDS-PAGE is 
roughly 50kDa (Chang et al., 1993). The predicted molecular weight of ACAT-2 is around 
50kDa, but the one viewed in SDS-PAGE is roughly 46kDa (Cases et al., 1998a). 
                                     
Diagram 11. The transmembrane topology model of ACAT-1 and ACAT-2. The histidine 
residues are depicted. [Taken from (An et al., 2006)]. 
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2.3.2 Physiological roles of ACAT-1 and ACAT-2 in tissue and in testis 
The function of ACAT is to convert cholesterol into cholesteryl esters by using a 
long chain fatty acyl conenzyme A, so as to eliminate free cholesterol in excess (Suckling 
& Stange, 1985). ACAT-1 produces cholesterol ester as cytoplasmic lipid droplets (Chang 
et al., 2001a). Cholesterol ester droplets serve as the major reservoir for free cholesterol, an 
essential component of cell membranes. In steroidogenic tissues, cholesterol ester provided 
by ACAT-1 is stored and will be used as a source of free cholesterol that will serve as the 
precursor for steroid hormones biosynthesis (Chang et al., 2001a). ACAT-2 is expressed in 
the liver and small intestine, where it esterifies newly synthesized or dietary cholesterol 
prior to incorporation into lipoproteins and thereby regulates plasma cholesterol levels 
(Cases et al., 1998a; Rudel et al., 2001).    
The functional analyses of ACAT-1 and ACAT-2 have been provided by individual 
gene-deficient mice. The phenotypes of ACAT-1 and ACAT-2 knockout mice show tissue-
specific decreases in cholesterol esterification (Meiner et al., 1996). In ACAT-1 deficient 
mice, phenotypic changes did not affect the intestine or liver. The cholesterol absorption, 
cholesterol ester formation and the incorporation of esters into nascent chylomicrons were 
normal in ACAT-1-/- mice fed a regular chow diet (Dove et al., 2006; Meiner et al., 1996). 
In addition, ACAT-1 deficient mice had normal plasma cholesterol level. The major 
findings in ACAT-1-/- mice was the lack of cholesterol ester droplets in adrenal glands and 
zona fasciculata cells of the cortex and in cultured peritoneal macrophages (Meiner et al., 
1996), suggesting functional redundancy of cholesterol esterification for steroidogenesis. 
ACAT-1-deficient macrophages promoted the formation of atherosclerosis in 
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hyperlipidemic mice (Fazio et al., 2001). ACAT-1 deficiency in macrophage had a variety 
of effects on cholesterol homeostasis including the paradoxical acceleration of foam cell 
lesions in the absence of cholesterol esterification (Meiner et al., 1996). These changes 
included decreased efflux of cellular cholesterol, increased uptake of modified lipoproteins, 
increased cholesterol biosynthesis, accumulation of membrane-bound vesicles, and 
increased turnover of lipoprotein-derived cholesterol (Dove et al., 2006).  
 On the other hand, in ACAT-2 deficient mice, cholesteryl ester formation was fully 
abolished in both the liver and small intestine with a regular chow diet feeding (Buhman et 
al., 2000), suggesting that the importance of ACAT-2 activity in regulating cholesterol 
absorption and hepatic cholesterol homeostasis might change depending on dietary 
cholesterol intake. Moreover, ACAT-2 deficiency prevented atherosclerosis in the 
apolipoprotein E null mice (Willner et al., 2003). Therefore, at present, ACAT-2 is 
considered the most potential target for treatment of coronary heart disease associated with 
hypercholesterolemia (Willner et al., 2003). 
ACAT has been studied mainly in the gut and liver. The role of individual isoforms 
of the enzyme in the maintenance of cholesterol homeostasis in the gonad has not yet been 
studied. ACAT-1 has been reported in Leydig cells where it was suggested to contribute to 
the testosterone-production (Sakashita et al., 2000). The role of ACAT-1 in the tubules has 
not been investigated. There is at present no study on whether ACAT-2 is or not expressed 
in the testis nor on its putative role in testicular cholesterol homeostasis. 
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2.3.3 Regulation of ACAT-1 and ACAT-2 activity 
 The mechanism of the regulation of ACAT1 and ACAT-2 enzymatic activity has 
not yet been studied in the testis. In other tissues, ACAT enzymatic activity was shown to 
be regulated at distinct levels: phosphorylation/dephosphorylation, transcription and post-
transcription. 
 
1) Phosphorylation/dephosphorylation 
ACAT activated by phosphorylation and inhibited by dephosphorylation in vitro as 
well as in vivo (Suckling et al., 1983b; Suckling et al., 1983a). In vitro, the ACAT 
phosphorylation by microsomal protein kinase is stimulated by ATP-Mg, whereas 
dephosphorylation may be obtained by cytosolic phosphatase. However, other studies have 
argued the role of dephosphorylation in the regulation of ACAT activity (Corton & Hardie, 
1992; Einarsson et al., 1989). Thus, the regulation of ACAT by protein phosphorylation 
cannot be completely ruled out yet. 
 
2) Transcriptional regulation 
The ACAT-1 gene is not transcriptionally regulated by cholesterol and the sterol 
regulatory element present within the promoters of many cholesterol-regulated genes, could 
not be found within the ACAT-1 gene promoters (Brown & Goldstein, 1997). Similarly to 
the ACAT-1 promoter, the sterol regulatory element also could not be found within human 
ACAT-2 promoter (Song et al., 2001). However, a recent study has identified an important 
liver-specific cis-acting element in the promoter region of ACAT2 that acts as a putative 
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binding site for the hepatic nuclear factor 1 (HNF1) (Song et al., 2006). This element serves 
as a positive regulator of ACAT-2 gene expression and is functionally active. Significantly, 
HNF1 beta expression was highest in the testis (Harries et al., 2004). Thus, one could 
speculate that HNF1 is likely involved in the regulation of ACAT-2 gene expression in the 
testis, but this remains to be confirmed.   
 
3) Post-transcriptional regulation 
Both ACAT-1 and ACAT-2 appear to be regulated by post-translational 
mechanisms (An et al., 2006; Chang et al., 1997; Chang et al., 2001b). In vitro studies on 
the regulation of ACAT-1 enzymatic activity have shown that cholesterol esterification was 
increased without showing changes in the mRNA or protein expression levels (Chang et al., 
1994; Yu et al., 1999). The mode of cholesterol-dependent regulation is by allosteric 
control of the sterol substrate (An et al., 2006; Chang et al., 1998; Chang et al., 1997; 
Chang et al., 2001b). It has been found that ACAT-1 has two distinct sterol-binding sites: a 
substrate-binding site and an allosteric-activator site (Chang et al., 1997). Combination of 
cholesterol with ACAT-1 allosteric-activator site caused a ligand-induced 
structural/configurational change in its protein, which converts the enzyme from inactive to 
active (Chang et al., 1997). ACAT-2 is also allosterically regulated by cholesterol, with 
cholesterol serving as an activator (Liu et al., 2005). The putative activator sites of ACAT 
isoforms may only recognize cholesterol (An et al., 2006; Chang et al., 1998; Chang et al., 
1997; Chang et al., 2001b; Liu et al., 2005). ACAT-2 was less likely than ACAT-1 to use 
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cholesterol as substrate because ACAT-2 is less responsive to cholesterol-dependent 
activation (Temel et al., 2003).  
The two ACAT isoforms have different substrate specificities and catalytic cores 
corresponding to their different physiological functions and specific tissue expression 
(Zhang et al., 2003). ACAT-1 was reported to esterify cholesterol and various oxysterols, 
such as 7-ketocholesterol and 7α-hydroxycholesterol, though at very low rates compared to 
cholesterol (Zhang et al., 2003). However, 25-hydroxycholesterol was esterified more 
efficiently by ACAT-2 than by ACAT-1; and ACAT-2 was more selective than ACAT-1 
relative to substrate (Liu et al., 2005).  
With regard to the ACAT active site, a conserved serine residue was reported in 
both ACAT-1 and ACAT-2 (Cases et al., 1998b). Replacing this conserved serine with 
leucine led to a loss of ACAT activity in mammalian cells, suggesting that the conserved 
serine residue may be part of the enzymatic active site (Joyce et al., 2000). Membrane 
topographical studies of ACAT-1 and ACAT-2 suggest that the putative active site ACAT-
1 serine (Ser269) is located on the cytoplasmic side of the ER, whereas the analogous 
serine residue of ACAT-2 (Ser 249) is located on the luminal side of the ER (Joyce et al., 
2000). Another conserved region in ACAT-1, ACAT-2, DGAT and 20 other enzymes have 
been identified (Hofmann, 2000). The conserved region was located on histidine 460 of 
ACAT-1 and histidine-434 of ACAT-2. H460 and H434 residues have both been located in 
the interior of the ER membrane (Guo et al., 2005). It has been confirmed that H460 is the 
key active site residue of ACAT-1 (Guo et al., 2005). The complete ACAT activity was 
completely lost when the histidine 460 gene was mutated (Guo et al., 2005; Lin et al., 
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2003). H360 and H399, cytoplasmic histidine residues, were shown to be essential for the 
catalysis of ACAT-2 (An et al., 2006) (Diagram 11). 
 
 
3. Justification of the animal models used in the study 
Two different animal models were used, mink (Mustela vison) and mouse (Mus 
musculus). The mink is a seasonal breeder, while the mouse is a continual breeder.  
3.1 Seasonal breeder animal model: mink (Mustela vison) 
Our laboratory has utilized mink (Mustela vison) as animal model since 1979 and 
has provided ample results on the cholesterol metabolism in the testis (Akpovi et al., 2006; 
Kabbaj et al., 2001; Kabbaj et al., 2003; Pelletier, 1986; Pelletier & Friend, 1986; Pelletier 
& Vitale, 1994). 
The mink has several advantages. It shows a seasonal initiation of spermatogenesis 
in addition to the initiation of spermatogenesis during post-natal development. 
Additionally, this model allows us to distinguish the dynamic expression of the enzymatic 
factors during different phases of spermatogenic activity. The mink is a seasonal breeder 
which includes an 8-month-long active spermatogenic phase that produces spermatozoa 
followed by an inactive spermatogenic phase that does not (Fig. 1). During the active 
spermatogenic phase, mitotic and meiotic activities are increased; spermatogenesis was 
completed. During the inactive phase, there is no spermatid differentiation, no meiotic 
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activity and reduced mitotic activity. The animal model allows distinguishing the 
mechanisms underlying the seasonal testicular regression from those involved during the 
natural seasonal initiation of spermatogenesis. Besides, in mink the neonatal period 
expands from birth (usually in May) to about Day 90 after birth. This is followed by 
puberty, which extends from Day 91 to Day 252 after birth; this period includes the 
completion of spermatogenesis by Day 240 after birth and the apprearance of spermatozoa 
in the epididymis some 12 days later in January. The use of the mink model provides the 
unique advantage of distinguishing factors that regulate testicular cholesterol metabolism 
during postnatal sexual maturation of the developing testis from those acting during the 
seasonal annual reproductive cycle in tehadult testis. Here, all measurements were 
performed during the neonatal period, puberty, and adulthood, thus allowing for correlation 
of a physiological event typical with a particular phase of testicular development. 
 
 3.2 Continual breeder animal model: mouse (Mus musculus) 
In most previous studies, the mouse was used because of its rapid maturation from 
birth to sexual maturity. In mouse, spermatogenesis was found to start by day 7 after birth.  
The neonatal period covers the first 7 days after birth, and it is followed by puberty, which 
lasts up until day 52 from day after birth. Spermatogenesis is completed by 35 days after 
birth (De Rooij et al., 1989). Since the 1970’s, studies already confirmed that a large 
amount of lipid droplets appeared in both seminiferous tubules and the interstitial tissue of 
the mouse, and that the lipid droplet content varied greatly with development (Bell et al., 
1971; Ohata, 1979). Being a continual breeder, the mouse shows similarities with the 
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humans. Recent technological advances have dramatically increased our ability to create 
analyses for human diseases. For instance, previous observations showed that male sterility 
in HSL-deficient mice is due to the lack of expression in spermatids of the testicular form, 
HSLtes (Vallet-Erdtmann et al., 2004). The dramatic effect of the absence of HSLtes leads to 
the question of whether mutations in the HSL gene may be the reason for male infertility in 
humans. 
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Objectives 
Cholesterol homeostasis is essential for the synthesis of testosterone in the 
interstitial tissue and the production of fertile gametes in the seminiferous tubules of the 
testis. The expression of enzymatic factors (HMG-CoA reductase, HSL and ACAT) that 
regulated cholesterol equilibrium in the testis has been recently described. The absence of 
one or more of these enzymes has been implicated in the development of male infertility. 
However, the enzymatic factors that determine the fate of cholesterol in the testis, 
especially, the inter-relation between individual enzymatic factors that directly contribute to 
the maintenance of the cholesterol equilibrium has not been extensively investigated in the 
testis. The present work is directed towards this task and aims to: 1) to elucidate the 
behaviour and the contribution of HMG-CoA reductase, ACAT-1, ACAT-2 and HSL 
in the modulation of cholesterol metabolism in each of the two compartments of the 
testis and 2) to identify the inter-relationship in the action of these enzymes in the 
maintenance of cholesterol equilibrium in the testis. My project will test the hypotheses 
(Model 1) that 1) to preserve the integrity of functions typical of each compartment of the 
testis, the three main enzymes implicated in the regulation of intracellular cholesterol have 
to act in coordination with each other in order to maintain viable cholesterol concentrations 
locally; 2) each of the two ACAT isoforms are both expressed and active in the 
seminiferous tubules and the interstitial tissue; 3) genetic HSL perturbation in the mouse 
will result in changes in the function of remaining enzymes involved in the regulation of 
the cholesterol equilibrium in the tubules; 4) the disruption of the cholesterol transporters 
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genes (SR-BI and CD36) would cause compensatory effects on the remaining enzymes 
involved in the “cholesterol ester cycle”. The project will allow identifying enzyme-
induced changes that contribute to the maintenance of cholesterol metabolism for the 
maintenance of normal spermatogenic activity. These studies will hopefully lead to a better 
understanding in male infertility where aberrant cholesterol metabolism has been 
implicated. 
 
 
                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Model 1. Schematic drawing of HMG-CoA reductase, HSL and ACAT in intracellular 
cholesterol metabolism during normal spermatogenesis. 
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Materials and methods 
1. Reagents  
 
1.1 Chemicals and enzymes 
Chemical enzymes and supplies were obtained as following: 
acetonitrile, agarose, anhydrous petroleum ether, bromophenol blue (BPB), bovine 
serum albumin (BSA), cholesteryl oleate, diaminobenzidine (DAB), dimethylsulfoxide 
(DMSO), dithiothreitol (DTT), ethylenediaminetetraacetic acid (EDTA), ethylene glycol-
bis-(-aminoethyl ether)--- N,N,N’,N’-tetraacetic acid (EGTA), glucose-6-phosphate, 
glucose-6-phosphate dehydrogenase, KCl, K2HPO4, KH2PO4, β-mercaptoethanol, ß-
nicotinamide adenine dinucleotide phosphate (ß-NADP), NaF, Na3VO4, Na4P2O7, oigo-dT, 
triphenylphosphine (Tris), (Sigma-Aldrich, Oakville, ON, Canada); acrylamide, Bio-Rad 
protein assay, nitrocellulose membranes, sodium dodecyl sulfate (SDS), SDS-PAGE 
standards (high and low range) (Bio-Rad, Mississauga, ON, Canada); aprotinin, leupeptine 
(Boehringer-Mannheim, Laval, PQ, Canada); cholesterol (ICN Biomedicals Inc. Irvine CA 
USA); Diethyl ether, heptane, hexane, Na2HPO4, trichloroacetic acid (TCA), 
tetrahydrofuran (THF), xylene (Fisher Scientific, Montreal, QC, Canada); DNase I (Rnase-
free), ECoR II, lumi-light western blotting substrate, phenylmethylsulfonyl fluoride 
(PMSF), SYBR Premix Ex TaqTM (Roche, Laval, QC, Canada); ethanol (Commercial 
Alcohols, Brampton, ON, Canada); hydrogen peroxide (H2O2), NaCl  (J.T. Baker, 
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Phillipsburg, NJ, USA); [14C]-3-Hydroxy-3-methylgluatryl coenzyme A (HMG CoA), OCS 
(Organic counting scintillant) scintillation cocktail, [14C]-oleyl-coenzyme A (oleyl CoA) 
(GE Healthcare, Baie d’Urfe, QC, Canada); isopropanol, mehylene blue (BDH, Toronto, 
ON,Canada); Film-classic Blue (EBA 45) (Universal X-ray Company of Canada Ltd., 
Dorval, QC, Canada); RNase inhibitor (Amersham Biosciences, Baie d'Urfe, QC, Canada); 
silica gel solid-phase extraction (SPE) column (Waters Corporation, Toronto, ON, Canada); 
TLC plates (silica gel 60 F254) (EMD Chemicals Inc., Gibbstown, NJ, USA); RNeasy Mini 
kit, Omniscript RT kit, Taq PCR core kit (Qiagen, Mississauga, ON, Canada).  
 
1.2 Antibodies 
As following were the sources of antibodies: 
ACAT-1 polyclonal antibody (rabbit polyclonal IgG), ACAT-2 polyclonal antibody 
(rabbit polyclonal IgG) (Cayman Chemical, Ann Arbor, MI, USA); HMG-CoA reductase 
polyclonal antibody  (rabbit polyclonal IgG) (Upstate, Lake Placid, NY, USA); HSL 
polyclonal antibody (rabbit polyclonal IgG)  (Dr. Cecilia Holm from Lund University, 
Lund, Sweden); myosin (light chain) monoclonal antibody (IgM) (Sigma-Aldrich, 
Oakville, ON, Canada); anti-rabbit IgG horseradish peroxidase-conjugated,  anti-mouse 
IgM horseradish peroxidase-conjugated, biotin-SP-conjugated affinity puried F(ab’)2 
fragment anti-rabbit IgG (H+L) (goat), HRP-conjugated streptavidin (Jackson ImmunoRes 
Lab, West Grove, PA, USA). 
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2. Apparatus 
The following instruments were utilized:  
EPSON perfection 3200 photo scanner (Epson Ltd. Hemel Hempstead, Herts, UK); 
XL-70 Beckman ultracentrifuge, OptimaTM MAX ultracentrifuge, GS-6R Beckman 
centrifuge, Life science UV/Vis spectrophotometer (DU® 530) (Beckman CoulterTM, 
Fullerton, CA, USA); Precision 180 Series Water Bath ( Precision, Winchester, VA, USA); 
β–counter (Perkin Elmer, Tri-Carb 2800 TR), Thermal Cycler GeneAmp PCR System 2400 
(Perkin Elmer, Markham, ON, Canada); IEC micro-centrifuger (IEC International 
Equipment Company, Nepean, ON Canada); Light cycler II-real time PCR equipment 
(Roche, Laval, QC, Canada); Light microscopy (Axiophot II) (Carl Zeiss, Hawthorne, NY, 
USA); Perkin Elmer GeneAmp PCR System 2400 (Garner, North Carolina USA); pH 
meter, Vortex Genie 2TM (Fisher Scientific, Montreal, QC, Canada); 2011 UV 
transilluminator (UVP Inc., Upland, CA, USA); Ultraviolet spectrophotometer (UV 160) 
(Shimadzu Scientific Instruments, Columbia, MD, USA). 
3. Softwares 
The following computer programs were used: 
Primer Premier Probe Design Software 5.0 (Premier Biosoft International, Palo 
Alto, CA, USA); Scion Image Software (Scion Corporation, Frederick, MD, USA); Sigma 
plot 7.0 software (SPSS Inc., Chicago, IL, USA); The Light cycler Software 3.5 (Roche, 
Laval, QC, Canada); Relative quantification software, version 1.01 (Roche, Laval, QC, 
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Canada); Alphalmager 2200 (documentation & analysis system) (Alpha Innotech 
Corporation, San Leandro, CA, USA). 
4. Animals 
Mink (Mustela vison, a seasonal breeder) and mouse (Mus musculus, a continual 
breeder) were used in this study.  
 4.1 Mink (Mustela vison) 
All mink, purchased from Visonnière St. Damase (St. Damase, QC, Canada), were 
individually caged, kept under natural lighting conditions, and allowed food and water ad 
libitum. After anaesthesia by an intraperitoneal injection of sodium phenobarbital 
(Somnotol) (0.9 ml/kg of body weight) (MTC Pharmaceutical, Cambridge, ON, Canada) 
and of a solution of 0.3g/ml chloral hydrate (MTC Pharmaceutical, Cambridge, ON, 
Canada) in sterile saline (0.15 ml/kg body weight), mink were decapitated and tissues were 
collected. For studies on development, testes were harvested at each 30 day interval 1) 
during the neonatal period (90 days old), 2) puberty (120, 150, 180, 210, and 240 days old), 
and 3) by the onset of adulthood (270 days old). Adult mink testes were collected for each 
30 day interval during the last week of each month throughout the annual reproductive 
cycle from 1-2 year old mink. The dynamics of the germ cell population during 
development and the annual reproductive cycle were identified by the methods of Pelletier 
(Pelletier, 1986), and are depicted in figure 1. Six normal mink per age group were used 
except when testes were small during puberty, when 6-10 mink were used.  
  53 
Fertility was tested as follows: the ejaculated semen recovered from vaginal smears 
was evaluated with a light microscope, and the morphology, motility, and number of 
spermatozoa was assessed by the farmer from Visonnière St. Damase (St. Damase, QC, 
Canada) for each male mink during the mating season in March. 
 4.2 Mice (Mus musculus) 
       4.2 .1 Normal mice 
BALB/c mice were obtained from Charles River Laboratories, St-Constant, QC, 
Canada. Animals were killed at 7 day intervals up to adulthood. The testes were harvested. 
Each age group consisted of no less than 20 animals. The testes of more than 20 mice at 
days 14, 21, 28, 35, 42, and adult were prepared to generate tissue fractions to be used to 
prepare microsomes. All the assays were carried out on enriched tissue fractions rather than 
on whole testis preparations. Therefore, a high number of mice were required in the mRNA, 
protein expression and enzymatic activity measurements.  
 4.2 .2 SR-BI and CD36 and HSL knockout mice 
SRBI and CD36 knockout mice were used as animal models in which a selective 
transporter was blocked. Both, SRBI and CD36, knockout mice were generously supplied 
by Dr. Louise Brissette from Université du Québec a Montréal (UQÀM). For SR-BI 
knockout mice, the SR-BI gene had been inactivated in embryonic stem cells by standard 
homologous recombination methods (Rigotti et al., 1997). A portion of exon 1 and the 
additional sown stream intron was mutated. The mutated locus is expected to encode a 
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transcript that would not translate or would be translated into nonfunctional, 
nonmembranous and presumably unstable, protein. CD36 knockout mice were also 
generated by targeted homologous recombination (Febbraio et al., 1999). 
HSL knockout mice were generously supplied by Dr.Cecilia Klint from Lund 
University in Sweden. In brief, the gene encoding HSL was disrupted in embryonic stem 
cells by homologous recombination. A portion of exon 5, and the entire exon 6, which 
encodes the catalytic domain, was replaced by the cDNA encoding the Aequorea victoria 
green fluorescent protein and a neomycin resistance gene (Grober et al., 2003; Lipsett et al., 
1966; Mulder et al., 2003). 
5. Preparation of seminiferous tubule (STf) and interstitial tissue enriched fractions (ITf)  
The seminiferous tubule-enriched fractions (STf) and the interstitial tissue enriched 
fractions (ITf) were generated according to the method of Akpovi et al., (Akpovi et al., 
2006). Briefly, freshly decapsulated testes were placed in cold PBS (137mM NaCl, 3mM 
KCl, 8mM NA2HPO4, pH 7.4) or in PBS containing protease and phosphatase inhibitors 
(4mM Na3VO4, 80mM NaF, 20mM Na4P2O7 (pH 8.5), 2 mM ethylene glycol-bis-(-
aminoethyl ether)--- N,N,N’, N-tetraacetic acid (EGTA), 5mM leupeptine, 5 mM aprotinin 
and 2 mM phenylmethylsulfonyl (PMSF)). The tissue fractions were generated by 
mechanical techniques. Further separation was achieved by centrifugation at 600 rpm for 
20 min in a GS-6R Beckman centrifuge equipped with a GH 3.8 rotor. The resulting STf, in 
the pellet, and ITf, in the supernatant, were washed three times in the corresponding buffer 
(PBS or PBS containing protease and phosphatase inhibitors). Purity of the enriched 
fractions was evaluated by light microscopy. This represents a modification of a previously 
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published isolation method in which mild enzymatic digestion with collagenase D and 
soybean trysin inhibitor was used to separate tubules from the interstitial tissue (Kabbaj et 
al., 2001). 
6. Epididymal spermatozoa 
Epididymal spermatozoa were obtained by dicing adult mink caudae epididymides 
in cold PBS. The resulting cell suspension was filtered through a 74-mm mesh and 
centrifuged at 2000 rpm for 15 min in a GS-6R Beckman centrifuge to recover 
spermatozoa. The gametes were suspended in Tris buffer (10 mM Tris-HCl, pH 8.0 , 1 mM 
EDTA) for 5 min to lyse contaminating epithelial and blood cells (Herrada & Wolgemuth, 
1997; Kabbaj et al., 2003). 
7. Real time polymerase chain reaction (real time PCR) 
    7.1 Isolation of ribonucleic acid (RNA) 
  Total tissue RNA was isolated using RNeasy Mini kit (Qiagen, Mississauga, OH, 
Canada) according to the manufacturer’s instructions. Briefly, the tissues were 
homogenized in 600 µl RLT buffer (Qiagen, Mississauga, OH, Canada). The homogenates 
were transferred into the RNeasy mini column placed in a 2 ml collection tube with 
addition of 600µl of 70% ethanol. The homogenate was centrifuged 15 sec at 10,000g in a 
micro-centrifuge. The RNeasy columns binding ribonucleic acid (RNA) were washed with 
buffer RW1 and RPE and transferred into a new 1.5 ml collection tube. The RNA was 
dissolved with 40µl RNase-free water and detached from the columns by centrifugation. 
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RNase-free DNase I (10U/µl) at a final volume of 4µl  was added and heated at 75°C for 30 
min. The quality and quantity of isolated RNA were measured using a spectrophotometer. 
The RNA solution was checked for presence of residual amounts of DNA by performing 
PCR amplification.  
    7.2 Preparation of complementary DNA (cDNA) 
Complementary DNA (cDNA) was obtained by reverse transcription in the presence 
of random polydT using Omniscript RT kit. The reaction mixture consisted of a reverse 
transcriptase (RT) buffer (10X), 10 mM oligo-dT, 5mM deoxyribonucleotide triphosphate 
(dNTP) mixture, RNase inhibitor (32,600 U/ml), Omniscript RT enzyme (4 U/ml) and 
RNA samples. The total amount of 5 µg RNA was reverse transcribed into cDNA at 37°C 
for 1h in a 50 µl final volume. 
    7.3 Quantification of gene expression 
 The mRNA expression of HMG-CoA reductase, HSL, ACAT-1 and ACAT-2 were 
measured using primers designed for mouse and mink genes (Table 1). All primers 
sequences were generated using Primer Premier Probe Design Software 5.0 and checked 
for specificity using BLAST analysis on NCBI webiste. All these primers were purchased 
from Invitrogen company. For expression screening, PCR reactions were performed in the 
presence of 0.2 µM dNTP, 0.5 µM of each primer and 2.5 U Taq DNA polymerase (Taq 
PCR core kit) at a final volume of 25 µl. Products of reaction were visualized by 
electrophoresis in a 1.5-3% agarose gel, stained with ethidium bromide and photographed 
under a UV transilluminator.  
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Table1. Specific primers designed for mink and mouse HMG CoA reductase, ACAT-1, 
ACAT-2 and HSL 
Primers 
Gene 
GeneBank 
accession 
numbers 
sense Anti-sense 
Product 
size 
(bp) 
HMG CoA red. (mouse) NM_008255 5’CAGGATGCAGCACAGAATG3’ 5’AGGCAGGCTTGCTGAGGTA3’ 175 
HMG CoA red. (mink) NM_000859 5’CTTCCTCGTGCTTGTGACTC3’ 5’GACGTGCAAATCTGCTCG3’ 105 
ACAT-1 (mouse) NM_009230 5’CTGTAAGATGGGGTTATGTCGC3’ 5’CACTGAAGGGCTCCTGTTTG3’ 126 
ACAT-1 (mink) NM_003101 5’TTGGAATGGCTTTCAACT3’ 5’AAACACGTAACGACAAGTCC3’ 185 
ACAT-2 (mouse) AF078751 5’TGGGAGTGTTCCTGGTGTCT3’ 5’CCCGAAAACAAGGAATAGCA3’ 101 
ACAT-2 (mink) AF059203 5’GCAAGTCCCTGCTTGATGAGC3’ 5’CCAGCGATGAACATGTGGTAGAT3’ 70 
HSL (mouse) NM_010719 5’TTCGCCATAGACCCAGAGTT3’ 5’GACGACAGCACCTCAATCTCA3’ 113 
HSL (mink) NM_0053572 5’GGAGCACTACAAACGCAACG3’ 5’TCTCAAAGGCTTCGGGTG3’ 250 
HPRT-1 NM_013556 5’TGACACTGGCAAAACAATGCA3’ 5’GGTCCTTTTCACCAGCAAGCT3’ 93 
 
 
The real time PCR reactions were performed in the presence of 0.5 µM of each 
primer according to the manufacturer’s instructions (SYBR Premix Ex TaqTM). In all PCR 
reactions, a negative control corresponding to RT reaction without the reverse transcriptase 
enzyme and a blank sample were carried out. Amplification of the housekeeper gene 
hypoxanthine phosphoribosyl transferase 1 (HPRT-1) cDNA was used as internal control to 
quantify the expression of a given gene in real time PCRs. For quantification studies, 
melting curves were performed at the end of the real time PCRs to ensure amplification of a 
single product with the appropriate melting temperature. Quantification was done with the 
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Relative quantification software, version 1.01. The specificity of real time PCR products 
was evaluated through enzymes restriction according to manufacturer’s instructions. 
     7.4 Restriction digestion of PCR and real time PCR products  
To identify the PCR or real time PCR product, the amplified DNA fragments were 
digested with restriction enzymes. Alu I and EcoR II were used to cleave ACAT-2 
amplified fragments in mink STf or mouse STf respectively. The reactions were performed 
in presence of 1U Alu I or ECoR II restriction enzyme, digestion buffer (10 X) and DNA 
fragments at the final volume of 10 µl. The mixture was digested at 37°C overnight. 
Digestion and PCR products were analyzed by electrophoresis in a 3% agarose gel, stained 
with ethidium bromide and photographed under UV transilluminator. 
8. Western Blot Analyses 
    8.1 Protein measurements 
Protein in the tissue enriched fractions were measured according to the method of 
Bradford (1976) by using a dye-binding assay, and BSA as a standard. Samples were 
prepared for electrophoresis by boiling them in the corresponding volume of sample buffer 
2X (8 M urea, 70 mM Tris-HCl pH 6.8, 3% SDS, 0.005% BPB, and 5% β-
mercaptoethanol) for 5 min.   
    8.2 Electrophoresis and transfer 
Proteins (20-40 µg) were resolved on a 10% sodium dodecylsulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) at 70 V to 120V. After migration, the proteins in the gel 
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were electro-transferred at 300 mA for 1.5 h or at 27 V overnight at 4°C onto nitrocellulose 
membranes using a transfer buffer (25mM Tris-HCl pH 8.3, 150mM glycine and 20% (v/v) 
methanol). The nitrocellulose membranes were colored with Ponceau red (0.2% Ponceau 
red and 3% TCA in distilled water) for 10 seconds at room temperature (RT) until the 
bands were visualized and then rinsed with distilled water. The molecular mass of the 
bands corresponding to the proteins of interest was determined by comparison with the 
migration of molecular mass standards (SDS-PAGE Standards, High and Low Range). 
Thereafter, the membranes were washed with PBS at RT for 10-15 minutes under agitation 
to remove the Ponceau red.   
    8.3 Immunoblotting 
 To block nonspecific binding, the membranes were incubated in PBS-containing 
3% skim milk at 37°C for 1 hour. Next, the membranes were incubated with one of the 
following primary antibodies: anti-HMG CoA reductase (1:500), anti- ACAT-1 (1:50), 
anti-ACAT-2 (1:200), anti-HSL (1:500) overnight at 4°C under agitation. After the 
incubation, the membranes were washed with 0.05% Tween20- PBS 15 min each for 4 
times at 37 °C and incubated with the corresponding (anti-rabbit IgG, or anti-mouse IgM) 
secondary horseradish peroxidase-conjugated antibody (1:2000) for 1 h at RT with 
agitation. All antibodies were prepared in 1% skim milk-PBS. The membranes were rinsed 
three times in 0.05% Tween 20-PBS for 15 min and one time in TBS buffer (137 mM 
NaCl, 2.7 mM KCl, 24.8 mM Tris-base, pH 7.4) for 15 min at RT with agitation. 
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Immunoreactive bands were revealed by chemiluminescence and the membrane were exposed 
to film-classic Blue (EBA 45). 
9. Preparation of the microsomal fraction and enzyme activity measurement  
    9.1 Microsome preparation and protein determination 
  Microsomes from mink or mouse seminiferous tubule enriched fractions were 
prepared by differential centrifugation as described by Stalhberg et al. (Stahlberg et al., 
1997). The STf were homogenized with the homogenization solution (15mM Tris-HCl pH 
7.4, 300mM sucrose, 10mM mercaptoethaol, 1mM PMSF, 10mM aprotinin and 10mM 
leupeptin) in a Glass-Col homogenizer on ice. The homogenate was centrifuged at 19,600 g 
for 15 min at 4°C with OptimaTM MAX ultracentrifuge. The upper supernatant layer was 
carefully removed. The pellet was discarded and the microsomes sedimented by 
ultracentrifugation (XL-70 Beckman ultracentrifuge) at 100,000 g for 60 min at 4°C. The 
pellet was resuspended in phosphate buffer (1M K2HPO4, 1M KH2PO4(pH 7.4), 30mM 
EDTA, 5mM dithiothreitol (DTT) and 250 mM NaCl, 1mM PMSF, 10mM aprotinin and 
10mM leupeptin). The microsome protein content was evaluated according to the method 
of Bradford, using BSA as a standard (Bradford, 1976).  
    9.2 Determination of HMG-CoA reductase activity 
Microsomes (200 µg) were added to 150 µl phosphate buffer [50 mM K2HPO4 (pH 
7.4), 30 mM EDTA and 70 mM KCl] and pre-incubated for 5 min at 37°C (Shapiro et al., 
1974). Microsomes pre-heated for 5min at 95°C were used as control. The reaction was 
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triggered by the addition of nicotinamide hypoxanthine dinucleotide phosphate (NADPH) 
generator system (25.3mM glucose-6-phosphate, 1U glucose-6-phosphate dehydrogenase 
and 29 mM NADP and the radioactive substrate [200 µM 3-Hydroxy-3-methylgluatryl 
coenzyme A (HMG-CoA) containing 19 nCi (1.11%) of [14C]-HMG-CoA]. The mixture 
was incubated at 37°C for 15 min, to produce [14C]-mevalonic acid, and stopped by the 
addition of 20 µl of 5 N HCl. The reaction mixture was then incubated for 30 min at 37°C 
to allow lactonization of [14C]-mevalonic acid into [14C]- mevalonolactone (MVL). The 
reaction mixture (100 µl) was evaporated to dryness at RT and then suspended in 150 µl of 
acetonitrile by sonication and centrifuged for 5 min at 13,000g. The suspensions (100 µl) 
were seeded into a silica gel solid-phase extraction (SPE) column (previously conditioned 
with 3 X 1ml of anhydrous petroleum ether). Thereafter, 1ml anhydrous petroleum ether 
was added onto the SPE column, followed by 2X-1ml of THF. All the solutions were 
collected and evaporated to dryness at RT. The scintillation cocktail was added and the 
radioactivity was measured using a β–scintillation counter. The [14C]-HMG-CoA, a polar 
molecule, binds to the silica gel, whereas the [14C]-MVL, a non-polar molecule, is easily 
eluted by petroleum ether and tetrahydrofuran (THF) (Nguyen et al., 1990).  
9.3 Determination of ACAT activity 
9.3.1 Total ACAT enzymatic activity measurement 
Total ACAT enzymatic activity was determined by assessing the production of 
cholesteryl[14C] oleate (Chang et al., 1998; Erickson et al., 1980). The microsome 
preparation (200 µg) was added to 100 µl assay buffer [0.2 mM KH2PO4 (pH 7.4), 2mM 
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DTT] containing 0.4 mg/ml of cholesterol and 6mg/ml of BSA. After a preincubation at 
37°C for 20 min, the reaction was triggered by the addition of 10 µM [14C]-oleyl-CoA 
(specific activity of 56.0 nCi/nmol). Then, the mixture was incubated at 37°C for 25 min 
and the reaction was stopped by addition of 1ml isopropanol-heptane (4:1, v/v). The final 
reaction mixture was vortexed and 0.6 ml heptane and 0.4 ml assay buffer were added. The 
upper heptane phase (100 µl) was transferred into a vial containing liquid scintillation 
cocktail and the radioactivity was measured in a β–scintillation counter. Separation of 
cholesteryl [14C] oleate from residual substrate, [14C] oleoyl-CoA, and side-products was 
performed by solvent partitioning between an upper heptane phase and a lower 
isopropanol-water phase (Jeong et al., 1995). 
  Since some of the radioactivity recovered in the upper phase was due to the 
enzymatic incorporation of radioactive fatty acid into products other than cholesteryl oleate, 
to specifically measure ACAT activity, the partitioned heptane phase was separated by thin 
layer chromatography (TLC) (Silica gel 60 F254) using a solvent mixture made up of n-
hexane-diethyl ether-acetic acid (90:10:1). Cholesteryl ester standard (choleseryl oleate) 
was used on several lanes across each plate in order to identify the region of cholesteryl 
ester. The separated free and esterified cholesterol were visualized by staining with iodine 
vapour and the radioactive content of the excised bands of free and esterified cholesterol 
was determined by scintillation counting.  
  63 
9.3.2 Individual ACAT-2 enzymatic activity measurement and ACAT-1 enzymatic activity 
assay 
 We provide a novel technical approach for the measurement of individual ACAT-2 
enzymatic activity and individually determine the activity of ACAT-1 in seminiferous 
tubules and interstitial tissue during postnatal development and adulthood something which 
had never been reported before. The technique is based on the use of a selective ACAT-1 
inhibitor, K-604. 
The assay buffer (100µl) was the same as in the total ACAT enzymatic activity 
measurement except for the addition of the ACAT-1 inhibitor (K-604) (100 µM diluted in 
5ml of dimethylsulfoxide (DMSO)). The steps to measure the ACAT-2 enzymatic activity 
were the same as in the total ACAT enzymatic activity measurements. The concentration of 
K-604 used in the assay was determined according to a dose-dependent inhibition curve. 
Various concentrations (0-1000µΜ) of inhibitor were added to the assay buffer. A 
concentration-enzymatic activity inhibition curve was established and the inhibitor 
concentration that inhibits all ACAT-1 activity but not ACAT-2 activity was selected for 
the study. 
 Thereafter, ACAT-1 enzymatic activity was calculated by subtracting ACAT-2 
enzymatic activity from total ACAT enzymatic activity. 
 9.4 Determination of HSL activity by spectrophotometric esterase assay 
     To assess the HSL activity, a spectrophotometric esterase assay based on the 
hydrolysis of PNPB was used (Holm & Osterlund, 1999). Kabbaj et al, applied this method 
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to the seminiferous tubules and interstitial tissue during postnatal development and 
adulthood (Kabbaj et al., 2001; Kabbaj et al., 2003). STf were homogenized on ice in 0.25 
M sucrose, 1 mM EDTA, pH 7.0, 1 mM dithioerythreitol, 20 µg/ml leupeptin, 2 µg/ml 
antipain, and 1 µg/ml pepstatin. Aliquots of 10–20 µg of protein of each sample were 
incubated with PNPB (diluted in acetonitrile) and buffer (0.1 M NaH2PO4, pH 7.25, 0.9% 
NaCl, 1 mM dithioerythreitol) at 37°C for 10 min. The reaction was stopped by addition of 
3.25 ml of methanol: chloroform: heptane (10:9:7). After centrifugation at 800×g for 20 
min, solutions were incubated for 3 min at 42°C and the absorbance of the supernatant was 
measured at 400 nm in a light spectrophotometer. The enzymatic activity was expressed in 
units, one unit being equivalent to the release of 1 µmol of p-nitrophenol/min. All samples 
were analyzed in triplicate and the HSL activity was related to the total protein 
concentration of each sample.  
To determine the best protein concentration for the assay, various concentrations (0-
400µg) of protein in the samples were incubated with PNPB. After the reaction was 
completed, a protein concentration enzymatic activity curve was made and the proper 
protein concentration was chosen for the study. 
10. Immunohistochemical analyses 
   10.1 Tissue preparation for immunohistochemistry  
Testes were perfused-fixed through the testicular artery, first with PBS and then 
with Bouin’s fixative, and were immersed for 48 hours in the same fixative at RT as 
described by Pelletier (Pelletier et al., 1995; Pelletier, 1995; Pelletier et al., 1997). Tissues 
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were dehydrated with series of ethanol (70%, 95% and 100%) and xylene. Next, the tissues 
were embedded with paraffin and sectioned to 5 µm thick. The sections were mounted on 
glass slides and dried at 40°C overnight.  
   10.2 Immunolocalization of the enzymes 
The mounted sections were deparaffinized with xylene and rehydrated with series of 
ethanol (100%, 95%, 70%, 50%) followed by water (Pelletier, 1995; Pelletier et al., 1997). 
Then, the sections were boiled in citrate buffer (10mM citric acid, 0.05% Tween 20, pH 
6.0) for 8 min at 95°C and exposed to 0.6% H2O2 in TBS for 10 min to inhibit endogenous 
peroxidase activity and rinsed with TBS containing 0.1% Tween-20 (0.1% TBST). Next, 
the sections were incubated with 0.5% skim milk in TBST for 30 min at RT to block non-
specific binding followed by incubation with anti-HMG-CoA reductase (1:50) or anti-
ACAT1 (1:100) or anti-ACAT2 (1:50) overnight at RT. Subsequently, the sections were 
rinsed and incubated with biotinylated anti-rabbit IgG Fab (1:10,000) for 1 h at RT. All 
antibodies were prepared in 1% skim milk-PBS. After washing, the sections were incubated 
with horseradish peroxidase (HRP)-conjugated streptavidin (1:200 1% milk-PBS) for 1h at 
RT and rinsed. The reaction was detected by 0.05% diaminobenzidine tetrachloride (DAB) 
containing 0.03% H2O2 and counterstained with 0.05% methylene blue. The sections were 
dehydrated with series of ethanol (70%, 95% and 100%) and xylene.  
11. Analysis of data and statistical analysis 
The immunoreactive bands of enzymes in Western blots obtained for each time 
interval studied were scanned with a laser scanner. The values were normalized to the 90 
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day values for developmental studies or to August values for the studies on mink adults; the 
values were also normalized to the 14 day values for the studies of development or the 
wild-type for the mice studies. The data are expressed as the mean ± standard error of the 
mean (SEM). Student’s t-test was used for comparisons between two groups. Differences 
were considered statistically significant as P<0.05.  
Data were expressed as the mean ± SEM for real time PCR and enzymatic activity 
analyses followed by Student’s t-test at a P<0.05 level of significance. All analyses were 
carried out with Sigma plot 7.0 software. 
 Results 
 
1. HMG-CoA reductase 
1.1 Mink 
Measurements in mink were performed in seminiferous tubule-enriched fractions 
(STf) obtained each 30 day- (d) interval throughout postnatal development (from 90d to 
270d after birth), and throughout the twelve-month seasonal reproductive cycle in the 
adult (Fig. 1). The histological changes during postnatal development are similar to 
those of the active spermatogenic phase in mink testis (Pelletier et al., 2009). The 
neonatal period expands from birth to about day 90 days after birth, the puberty from 
day 90 to day 252 after birth; this period includes the completion of spermatogenesis by 
Day 240 after birth and the appearance of spermatozoa in the epididymis some 12 days 
in January (252 days after birth). 
   Here, it must be stressed that the enzymatic activity measurements were carried out 
on microsomes that were obtained from seminiferous tubule-enriched fractions. This 
procedure necessarily requires using much greater numbers of animals or big amount of 
tissues than if the procedure used whole testis extract as is done in most studies. Thus, 
the experiments were not carried out in the interstitial tissue fractions since not enough 
interstitial tissue could be gained.  
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1.1.1 Real time quantitative PCR, Western blot and enzymatic activity measurements in 
STf 
1.1.1.1 mRNA  
 
The mRNA expression profile of HMG-CoA reductase was evaluated by real time 
PCR using total RNA isolated from mink STf during development and the annual 
reproductive cycle.  HPRT-1, a house-keeper gene, was used as internal control since it is 
expressed constitutively and constantly in all samples. It corresponded to a 93bp single 
band (Fig. 2A). HMG-CoA reductase primers (Table 1) amplified a single product with 
an expected size of 105bp by real time PCR (Fig. 2A). The 105bp HMG-CoA reductase 
and the 93bp HPRT-1 product were detected throughout development and the annual 
reproductive cycle (data not shown). A negative control corresponding to RT reaction 
without the reverse transcriptase enzyme was carried out and showed no PCR product 
amplification (data not shown). Figure 2B shows that HMG-CoA reductase mRNA levels 
varied distinctly during development and the annual cycle. The HMG-CoA reductase 
mRNA levels significantly increased toward the end of development. The levels 
increased significantly from 180 to 210 days and then decreased significantly from 240 
to 270 days (Fig. 2B). The levels increased significantly by the end of testicular 
regression in the seasonal cycle. The mRNA levels peaked from April to May, and then 
significantly decreased from June to July (Fig. 2B).  
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1.1.1.2 Protein  
 
Western blot analyses performed with anti-HMG-CoA reductase antibody revealed 
several bands in mink STf during development and the annual reproductive cycle (Fig. 
3A). Adsorption of anti-HMG-CoA reductase with an HMG-CoA reductase peptide 
caused the disappearance of the 90kDa immunoreactive band and a decrease of the 53kDa 
band (Fig. 3A). Because the 53kDa band did not completely disappear with the pre-
adsorption, the 90kDa was considered the HMG-CoA reductase immunoreactive band 
and will be analyzed in our study. Representative Western blots of HMG-CoA reductase 
are shown in Figure 3B. The 90 kDa HMG-CoA reductase expression showed different 
tendencies between development and the reproductive cycle. In addition, the protein level 
profiles (Fig. 3) did not parallel the mRNA level profiles (Fig. 2B). The 90kDa HMG-
CoA reductase significantly increased with the initiation of meiosis particularly from 150 
to 180 days. In the adult, the 90kDa band tended to decrease during testicular regression 
but not significantly. Myosin light chain (MLC) was used as an internal loading control. 
MLC has a molecular mass of 20 kDa, and the intensity of the band did not change in the 
different experimental conditions (data not shown). 
1.1.1.3 Enzymatic activity 
 
The  HMG-CoA reductase enzymatic activity was measured by quantifying its 
reaction product mevalolactone (MVL) using an alternative chromatographic technique 
developed in Dr. Julie Lafond’s lab (Montoudis et al., 2004). HMG-CoA reductase 
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activity tended to increase throughout development (Fig. 4) and this increase does not 
parallel the profile in the levels of the 90 kDa immunoreactive band during development 
and the annual cycle (Fig. 3). The enzymatic activity at 120 days averaged 6.4071e-8 ± 
5.5729e-8 (mean ±SEM) mol/min/µg protein in three group experiments. The enzymatic 
activity was significantly increased from 210 to 240 days, and reached the maximal value 
at 3.6411e-7 ± 3.3718e-9 mol/min/µg protein (mean ±SEM) at 240 days, but significantly 
decreased afterwards (Fig. 4). During the annual reproductive cycle, HMG-CoA 
reductase activity firstly and significantly increased by December and again increased 
significantly from December to January and from January to February. The maximal 
value was at 1.2132e-6 ± 2.9000e-7 mol/min/µg protein (mean ±SEM) by February. 
HMG-CoA reductase enzymatic activity decreased from June to July but not significantly 
(Fig. 4).  
1.1.2 Immunohistochemical localization in the testis 
HMG-CoA reductase positive labeling was found throughout development and the 
annual reproductive cycle within the seminiferous tubules. HMG-CoA reductase–positive 
dots were detected in Sertoli cells, and spermatids. Endothelial cells of capillaries and 
other interstitial tissue cells are also positive (Fig. 5). 
 
  1.2 Mouse 
1.2.1 Real time quantitative PCR, Western blot analyses in ITf 
1.2.1.1 mRNA  
  71 
 
A single product was amplified by real time PCR using HMG-CoA reductase 
primers to mouse (Table 1). The product had the expected size of 175bp (Fig. 6). During 
development, mRNA expression levels were sharply and significantly increased from 21 
to 28 days after birth, and then significantly decreased from 28 to 35 days and from 35 to 
42 days after birth (Fig. 6A).  
1.2.1.2 Protein 
Pre-adsorption of anti-HMG-CoA reductase with the HMG-CoA reductase peptide 
caused the disappearance of the 90 kDa immunoreactive band (Fig. 6B-1). Thus the 90 kDa 
band was considered the HMG-CoA reductase immunoreactive band in our study. The 
90kDa immunoreactive band remained more or less constant throughout development (Fig. 
6B-2) contrary to the mRNA levels (Fig. 6A) which did not.  
 
1.2.2 Real time quantitative PCR, Western blot and enzymatic activity measurements 
in mouse STf 
1.2.2.1 mRNA  
 
In the mouse STf, the size (175bp) of HMG-CoA reductase amplicons was the same 
as the one produced in mouse ITf (Fig. 7A).  The mRNA expression levels significantly 
increased from 14 to 21 days, from 21 to 28 days and again from 35 to 42 days, but 
decreased with adulthood (Fig. 7A).  
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1.2.2.2 Protein  
 
In pre-adsorption experiments, the 90 kDa band almost disappeared, indicating 
that this is the HMG-CoA reductase immunoreactive band (Fig. 7B-1). The 90kDa 
immunoreactive band was detected in the STf (Fig. 7B-2). The 90kDa HMG-CoA 
reductase protein levels in STf increased early during development and the intensity of 
the 90kDa immunoreactive band was the strongest at 28 days, and then tended to decrease 
afterwards (Fig. 7B-2). In epididymal Spz however the 90kDa protein band was detected 
together with a 37kDa band. The 37kDa immunoreactive band has never been reported in 
Spz before. Both the 90kDa and 37kDa immunoreactive bands were absent following pre-
adsorption (Fig. 7B-3).  
 
 1.2.2.3 Enzymatic activity  
 
 The HMG-CoA reductase activity tended to increase from 14 days to 42 days after 
birth and to slightly decrease with adulthood (Fig. 7C). The enzymatic activity ranged 
from 1.73e-7 ± 1.16e-8 (mean ±SEM) mol/min/µg protein (14 days) to 5.19e-7 ± 9.53e-8 
mol/min/µg protein (42 days) (mean ±SEM). The largest increase in the enzymatic 
activity was observed in the 28 day-old mice (Fig. 7C). This time point corresponded to 
the time when the intensity of the 90kDa HMG-CoA reductase immunoreactive band was 
strongest and the mRNA levels were significantly increased. 
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1.2.3 Immunohistochemical localization in the testis 
In the mouse, HMG-CoA reductase was detected in Sertoli cells in all age group 
studied (Fig. 8). HMG-CoA reductase was also found in elongating spermatids. HMG-
CoA reductase was also detected in the interstitial tissue cells (Fig. 8).  
 
2. HSL 
2.1 Mink 
2.1.1 Real time quantitative PCR, Western blot and enzymatic activity measurements in 
STf 
2.1.1.1 mRNA  
 
The mRNA expression of HSL was evaluated by real time quantitative PCR using 
the same cDNA as in HMG-CoA reductase measurements. A single 250bp product was 
amplified (Fig. 9). Quantification of the band during development and the annual 
reproductive cycle showed that the HSL mRNA levels significantly increased from 90 to 
120 days after birth, then the levels slowly went down until 240 days, but HSL mRNA 
levels sharply and significantly increased by 270 days. During the seasonal cycle, the 
HSL mRNA levels showed a tendency to increase from September to October, but the 
changes were not statistically difference (Fig. 9).  
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2.1.1.2 Protein  
Adsorption of anti-hHSL with human adipose tissue caused a major decrease in the 
intensity of the 90kDa immunoreactive bands in mink tissues (Kabbaj et al., 2003), 
demonstrating that the anti-hHSL antibody recognizes the enzyme in mink tissue. It has 
been reported that HSL gene in the testis encodes a protein which is identical to the 
adipocyte HSL (Mairal et al., 2002). We proposed that the 90kDa immunoreactive band 
detected in the testis is HSL. Considering the Western blot experiment in HSL knockout 
mice, only the 90kDa band was not detected, demonstrating that the 90kDa immunoreactive 
band corresponds to HSL. Representative Western blots are shown in Figure 10. The levels 
of the 90kDa HSL immunoreactive band were significantly increased from 150 to 180 days 
and again from 210 to 240 days after birth. The levels decreased slightly afterwards. During 
the annual reproductive cycle, the protein levels significantly increased from December to 
January, and then decreased from March to April and remained low in the following 
months (Fig. 10). HSL protein expression (Fig. 10) was not coincident with its mRNA 
expression (Fig. 9).  
2.1.1.3 Enzymatic activity 
At 90 days, HSL enzymatic activity was 30.56 nM/min/µg protein. HSL activity 
was increased by 8% in 120 days in mink STf compared to 90 days and again from days 
180 to 210 when the spermatocytes differentiate from the preleptotene to prepuberal 
pachytene stages. In 210 days the HSL activity reached 35.61 nM/min/µg protein. During 
the annual reproductive cycle, HSL enzymatic activity increased by November on the onset 
of meiosis but the increase was not significantly different. However, activity levels peaked 
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in February and significantly decreased from February to March, from 40.88 ± 0.08 
nM/min/µg protein to 34.59 ± 0.16 nM/min/µg protein. The increase of HSL activity is 
accompanied with the completion of spermatogenesis during development and in the adult 
during the active phase of the annual reproductive cycle. The enzymatic activity decreased 
more rapidly than the protein levels during the annual reproductive cycle (Fig. 11).  
    2.1.2 Immunohistochemical localization in the testis 
In our lab, Kabbaj et al have reported that HSL immunoreactivity was detected in all 
ages of the seminiferous epithelium (Kabbaj et al., 2003). This enzyme was localized to 
Sertoli cell cytoplasmic processes surrounding germ cells throughout puberty and also was 
detected in elongating spermatids. HSL was also expressed in the epididymal spermatozoa 
(Kabbaj et al., 2003). 
 
2.2 Mouse 
2.2.1 Real time quantitative PCR, Western blot analyses in ITf 
2.2.1.1 mRNA  
 
The mRNA expression of HSL in mouse ITf was evaluated by real time quantitative 
PCR using the same cDNA as in HMG CoA reductase measurements. A single 113bp 
product was amplified (Fig. 12A). Quantification of this band showed that HSL mRNA 
levels significantly increased from 21 to 28 days after birth, they significantly decreased 
from 35 days onwards.  
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2.2.1.2 Protein 
 
Identification of the 90kDa band as being the HSL immunoreactive band was 
performed using HSL knockout mice ITf (see figure 20B). A representative Western blot 
of the 90kDa HSL immunoreactive band is shown in Figure 12B. HSL protein levels 
tended to slightly increase from 28 to 35 days after birth, and then the protein content 
leveled high from 35 to adulthood and this was associated with the significant decrease of 
HSL mRNA levels (Fig. 12B).  
 
2.2.2 Real time quantitative PCR, Western blot and enzymatic activity measurements in 
STf 
2.2.2.1 mRNA  
 
A single 113bp product was amplified by real time PCR with mouse HSL gene (Fig. 
13A). Quantification of this band showed that HSL mRNA levels were significantly 
increased from 14 to 21 days, from 21 to 28 days and from 28 to 35 days after birth, then 
the levels remained high (Fig. 13A).  
2.2.2.2 Protein 
 
A representative Western blot of the 90kDa HSL immunoreactive band is shown in 
Figure 13B. The 90 kDa HSL protein levels were increased steadily with spermatogenic 
activity reaching maximal values with adulthood (Fig. 13B). The 90kDa protein level 
profiles paralleled the HSL mRNA levels.  
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2.2.2.3 Enzymatic activity 
 
HSL enzymatic activity was significantly increased with the onset of puberty from 
14 to 21days after birth, from 10.90 ± 0.38 nM/min/µg protein to 14.61 ± 0.84 
nM/min/µg protein. The activity levels increased until days 42, but significantly 
decreased in the adult, where the averaged value was 9.61 ± 1.73 nM/min/µg protein (Fig. 
13C). The decrease of HSL activity in the adult was coincident with an increase  in both 
HSL mRNA (Fig. 13A) and protein expression (Fig. 13B).  
 
3. ACAT-1 and ACAT-2 
3.1 Mink 
3.1.1 Real time quantitative PCR, Western blot and enzymatic activity measurements in 
STf 
3.1.1.1 mRNA  
 
Up to now, ACAT has been studied mainly in the gut and liver (Chang et al., 1993) 
but never in the testis. Moreover, the role of individual ACAT isoforms of the enzyme in 
the maintenance of cholesterol homeostasis in the gonads has never been addressed. 
The presence of transcripts for ACAT-1 and ACAT-2 genes was evaluated by PCR 
using specific primers respectively. The amplified sequences between ACAT-1 and ACAT-
2 showed no homology in BLAST analyses. One single 185bp sized product of ACAT-1 
and one 70bp ACAT-2 product were amplified (Fig. 14A). The specificity of real time PCR 
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product of ACAT-2 was evaluated by restriction enzymes. Alu I, cleaves the recognition 
site (AG^CT). This sequence was only present in the ACAT-2. Two small DNA fragments 
of 20bp and 50bp respectively were obtained in a 3.5% agarose gel (Fig. 14B).  
ACAT-1 mRNA expression differed greatly from ACAT-2 mRNA expression in mink 
STf during development and the annual reproductive cycle. During mink development, 
ACAT-1 mRNA levels significantly increased from 90 to 120 days and from 240 to 270 
days (Fig. 14C). During the annual reproductive cycle, ACAT-1 mRNA levels significantly 
increased from September to October then significantly decreased from November to 
December before significantly increasing again from April to May and significantly 
decreasing in July (Fig. 14C). On the other hand, ACAT-2 mRNA levels significantly rose 
from 180 to 210 days but decreased significantly from 210 to 240 days during development 
(Fig. 14C). The mRNA levels were significantly elevated from December to January and 
from April to May but they significantly decreased from June to July during the annual 
reproductive cycle (Fig.14C). 
3.1.1.2 Protein  
Western blots performed with anti-ACAT-1 and ACAT-2 antibodies revealed a 
50kDa and a 46kDa band respectively (Fig. 15).  
Although ACAT-1 and ACAT-2 mRNA expression varied differently during 
development (Fig. 15), both ACAT-1 and ACAT-2 protein levels tended to increase and 
reached the highest levels with adulthood (270 days) (Fig. 15). Similarly, during the annual 
reproductive cycle ACAT-1 protein levels increased steadily during the period when 
spermatogenesis was completed in January, February and March and decreased gradually 
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during the periods when spermatogenesis was arrested. In contrast, ACAT-2 levels 
significantly rose from December to January and were maintained high from January to 
March before significantly dropping from March to April (Fig. 15). 
3.1.1.3 Enzymatic activity 
 
Here, we are the first to apply the novel selective ACAT-1 inhibitor, K-604, to the 
measurement of individual ACAT-1 and ACAT-2 enzymatic activity (Chen L., 2008). K-
604 potently and selectively inhibited ACAT1 much more than ACAT2 with IC50 values of 
100 and 1000 µM respectively (Fig. 16A), and the proper inhibitor concentration (100µM) 
that inhibits the activity of ACAT-1 but not the activity of ACAT-2 was selected (Fig. 16A).  
ACAT-1 and ACAT-2 activity was evaluated by the quantification of the reaction 
product (cholesteryl oleate), which is separated from other unspecific products by TLC. 
The weak enzymatic activity or extremely different values between groups obtained could 
be due to an important loss of products during the necessary TLC manipulation (spotting 
and recovery) since the samples used and the method of quantification (evaluation of 
radioactive reaction product) were the same. Therefore, only a representative enzymatic 
activity measurement of ACAT-1 and ACAT-2 is shown in Figure 16 although the 
enzymatic activities were measured in three independent experiments. All experiments 
showed a similar trend. 
Figure 16B shows representative histograms of ACAT-1 and ACAT-2 enzymatic 
activities in mink STf during development and the annual reproductive cycle. ACAT-1 
enzymatic activity showed a steady decrease with development (range from 3140.00 
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CPMB/200µg protein to 43.00 CPMB/200µg protein) (CPMB = scintillated radioactivity), 
reaching minimal values by 270 days after birth. During the reproductive cycle, the levels 
of ACAT-1 enzymatic activity were reduced by 94% during the period when 
spermatogenesis was completed in January (January versus to August) and were increase to  
265% during the regression of spermatogenesis in May ( May to January) (Fig. 16B). In 
contrast, ACAT-2 enzymatic activity remained relatively constant during early 
development and was increased 2.4-fold of the value after day 240 (161.00 CPMB/200µg 
protein to 388.00 CPMB/200µg protein), and was maintained at this elevated level for up to 
day 270 (388.00 CPMB/200µg protein to 1190.00 CPMB/200µg protein). During the 
seasonal cycle, ACAT-2 enzymatic activity sharply increased from December to January 
remaining high from January to March but decreasing afterwards (Fig. 16B). Compared to 
the protein expression of each ACAT isoform, ACAT-1 enzymatic activities was opposite 
to its protein expression, whereas ACAT-2 enzymatic activity paralleled tois coincident 
with its protein levels.  
3.1.2 Immunohistochemical localization in the testis 
We are the first to immunolabel ACAT-1 and ACAT-2 in mink testis (Fig. 17). The 
ACAT-1 was detected only in germ cells of the tubules; it was localized in spermatocytes, 
elongating spermatids and in the acrosome of mature spermatids. ACAT-1 was also labeled 
the interstitial cells. In contrast, the ACAT-2 was only localized to Sertoli cell in the 
seminiferous tubules, and widely distributed in the interstitial cells; ACAT-2 labeled the 
endothelial cells lining blood vessels within the interstitial tissue (Fig. 17). 
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3.2 Mouse 
3.2.1 Real time quantitative PCR, Western blot analyses in ITf 
3.2.1.1 mRNA  
 
We designed the pertinent primers to ACAT-1 and ACAT-2 genes respectively. 
No homologous sequences were found between ACAT-1 and ACAT-2 using BLAST 
analyses. mRNA expression of ACAT isoforms were measured separately by real time 
quantitative PCR. One single 126bp sized product of ACAT-1 and one 101bp sized product 
of ACAT-2 were amplified (Fig. 18A). In order to examine the amplified product of 
ACAT-2, the amplified PCR fragments were digested by restriction enzymes, EcoR II, 
which cut the two recognition sites (^CCWGG) in the ACAT-2 sequence (Fig. 18B). Three 
small DNA fragments of 49bp, 42bp and 10bp sized products were detected in a 3.5% 
agarose gel (Fig. 18B).  
The amplified products of ACAT-1 and ACAT-2 are shown in Figure 18A. ACAT-
1 mRNA level profiles differ from those of ACAT-2 during development. ACAT-1 mRNA 
levels significantly increased from 21 to 28 days after birth and from 35 to 42 days and 
tended to decrease from 42 days to adulthood. On the other hand, ACAT-2 mRNA levels 
showed no significant changes (Fig. 18A).  
3.2.1.2 Protein  
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Western blot analyses revealed a 50kDa ACAT-1 immunoreactive band and a 
46kDa ACAT-2 immunoreactive band (Fig. 18C). The changes in ACAT-1 protein levels 
were opposite to its mRNA levels. ACAT-1 protein levels were reduced with development 
and significantly from 42 to >60 days after birth. However, ACAT-2 protein levels 
remained virtually constant throughout development (Fig. 18C). 
 
3.2.2 Real time quantitative PCR, Western blot and enzymatic activity measurements in 
STf 
3.2.2.1 mRNA  
 
Amplified product of ACAT-1 and ACAT-2 are shown in Figure 19A. One single 
126bp sized product of ACAT-1 and one 101bp sized product of ACAT-2 were amplified. 
In contrast to what we found in the ITf, in the STf, ACAT-1 mRNA levels tended to 
decrease during development whereas ACAT-2 mRNA levels were increased significantly 
from 35 to 42 days after birth (Fig. 19A).  
3.2.2.2 Protein  
50kDa ACAT-1 and 46 kDa ACAT-2 immunoreactive bands were detected in STf 
(Fig. 19B). Moreover, the ACAT-1 immunoreactive band was also detected in epididymal 
Spz; however, no ACAT-2 immunoreactive band was detected even in overexposed 
membranes (Fig. 19B).  
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ACAT-1 protein expression (Fig. 19B) was similar as its mRNA profiles (Fig. 19A); 
the protein levels were markedly reduced with development. In contrast, ACAT-2 protein 
levels were sharply and significantly increased from 21to 28 days after birth, and then 
decreased from 42 to >60 days after birth (Fig. 19B). ACAT-2 protein expression is not 
coincident with its mRNA level changes (Fig. 19A).  
3.2.2.3 Enzymatic activity 
The same technique we have developed and used for mink was used for measuring 
individual ACAT isoform activities in mouse STf. The inhibitor concentration of K-604 
was determined by the dose-dependent inhibition curve (Fig. 19C). One hundred µM of K-
604 was the concentration selected (Fig. 19C). ACAT-1 enzymatic activity and protein 
levels profiles were similar; both decreased with development. The activity values ranged 
from 2776.00 CPMB/200µg protein to 713.00 CPMB/200µg protein. However, ACAT-2 
enzymatic activity increased up to 42 days after birth (ranged from 620.00 CPMB/200µg 
protein to 2173.00 CPMB/200µg protein), and then substantially decreased with adulthood. 
ACAT-1 and ACAT-2 enzymatic activities showed complementary profiles in mouse STf 
during development and reached similar levels by adulthood (Fig. 19D). 
3.2.3 Immunohistochemical localization in the testis 
Immunohistochemistry studies revealed that ACAT-1 and ACAT-2 were both 
present in mouse testis (Fig. 20). In the seminiferous tubules, ACAT-1 only labeled germ 
cells including spermatogonia, spermatocytes and the acrosome of spermatids. In addition, 
ACAT-1 labeled the interstitial cells. Instead, ACAT-2 was only localized to Sertoli cell in 
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the tubules but showed no labeling in the interstitial tissue (Fig. 20). Considering detectable 
but low amount of ACAT-2 protein in interstitial tissue demonstrated by Western blot, we 
think immnunohistochemistry is not a sensitive enough to localize ACAT-2.  
 
 
4. HMG-CoA reductase, ACAT-1, ACAT-2 in HSL knockout mice 
4.1 Validation of HSL knockout mice  
Firstly, real time PCR experiments revealed that STf and ITf from HSL -/- mice 
lack a wild type (wt) transcript with HSL mRNA which codes all forms of the protein (Fig. 
21A). Secondly, Western blot analyses were performed to determine the expression of 
mouse HSL in the testis of wt and HSL-/- mice (Fig. 21B). Epididymal fat was used as 
control. An antibody directed against all forms of HSL recognized multiple protein bands 
between 25 to 150 kDa in fat, STf and ITf of wt mice (Fig. 21B). The 90kDa band, which 
corresponds to the 88 kDa band in human and to the 84 kDa band in rat (Langin et al., 
1993), was detected in the testicular fat pad, STf and ITf in the wt mice but not in the HSL-
/- mice, indicating that the 90kDa band is the HSL immunoreactive band. Although the 
120kDa band was detected in the wt ITf and STf and not in the fat pad, this decreased band 
in the HSL-/- mice was still detectable. Thus, the 120kDa band was not considered as HSL 
immunoreactive band. In addition, the 120kDa protein, named HSLtes (Blaise et al., 2001), 
is encoded by the 3.9kb HSL mRNA in rodent (Holst et al., 1996) and was reported to 
mainly be expressed in haploid germ cells (Osuga et al., 2000).  Therefore, our studies on 
  85 
HSL protein expression in STf and ITf will not focus on the 120kDa protein, while the 
90kDa band has been considered in the Western blot analyses. 
 
4.2 HMG-CoA reductase, ACAT-1 and ACAT-2 in HSL knockout mice 
4.2.1 HMG-CoA reductase mRNA levels and enzymatic activity 
4.2.1.1 ITf 
 
To determine whether HSL deficiency changes the expression of HMG-CoA 
reductase, the essential enzyme in the cholesterol biosynthesis pathway, mRNA levels of 
the enzyme were measured in ITf of the wilde type (wt) and HSL deficient mice. HMG-
CoA reductase mRNA levels mice significantly decreased by 30% in HSL-/- compared to 
wt mice ITf (Fig. 22A).  
4.2.1.2 STf 
 
The down-regulation of HMG-CoA reductase mRNA expression in HSL-/- mice 
was also detected in STf (Fig. 22B). HMG-CoA reductase mRNA levels decreased 
significantly by 57% in HSL-/- compared to wt mice. Furthermore, [14C]- mevalonolactone 
product was measured in both wt and -/- mice STf microsomes to evaluate the enzymatic 
activity of HMG-CoA reducase. HMG-CoA reductase activity in the HSL-/- mice was 
dramatically reduced with respect to wt mice (Fig. 22C).  
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4.2.2  ACAT-1 and ACAT-2 mRNA levels and the enzymatic activity 
 
In order to elucidate whether knocking out the HSL gene cause the changes of 
cholesterol esterification, two isoenzymes involved in this process were analyzed; 
specifically ACAT-1 and ACAT-2 mRNA expression and enzymatic activities were 
measured in wt and HSL-/- mouse ITf and STf. 
4.2.2.1 ITf 
 
HSL deficient mice down regulated ACAT-1 and ACAT-2 mRNA expression (Fig. 
23A) and the decrease was statistically significant. 
4.2.2.2 STf 
 
Contrary to the mRNA expression of ACAT isoforms in ITf, ACAT-1 and ACAT-2 
mRNA levels significantly increased in HSL-/- mice by 1.5-fold and 5.2-fold compared to 
wt mice, respectively (Fig. 23B). The enzymatic activities of ACAT-1 and ACAT-2 
increased by 25% and by 200% respectively when the HSL gene was knockout. The 
enzymatic activity of ACAT-1 averaged 1150.00 CPMB/200 µg protein and that of ACAT-
2 averaged 1276.00 CPMB/200 µg protein in HSL-/- mice STf (Fig. 23C). 
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5. HMG-CoA reductase, HSL, ACAT-1 and ACAT-2 in SR-BI and CD36 knockout 
mice 
 
SR-BI and CD36 are selective cholesterol transporter genes. SR-BI and CD36 
knockout mice were used as animal models in which SR-BI- or CD36-mediated cholesterol 
influx or efflux was blocked. Real time PCR experiments revealed that STf and ITf from 
SR-BI -/- mice or CD36-/- mice lack the wild type (wt) transcript with SR-BI or CD36 
mRNA expression (data not shown). 
5.1 HMG-CoA reductase mRNA levels and enzymatic activity in SR-BI knockout mice and 
in CD36 knockout mice. 
5.1.1 SR-BI knockout mice 
 5.1.1.1 ITf 
 
To determine the changes of HMG-CoA reductase if disrupting SR-BI-mediated 
flux of free cholesterol and HDL, the mRNA expression of the enzyme was measured in 
SR-BI wt and -/- mice ITf. HMG-CoA reductase mRNA levels were decreased by 44% in 
SR-BI-/- mice compared with wt mice (Fig. 24A).  
5.1.1.2 STf 
 
HMG-CoA reductase mRNA levels were 45% lower in SR-BI-/- compared to wt 
mice (Fig. 24B). The enzymatic activity of HMG-CoA reductase was also decreased in the 
SR-BI -/- mice STf (Fig. 24C). The enzymatic activity of HMG-CoA reductase averaged 
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3.19×10-7 mol/min/µg protein for SR-BI-/- mice and 6.94×10-7 mol/min/µg protein for wt 
mice. However, the decrease of HMG-CoA reductase activity was not significant.  
 
5.1.2 CD36 knockout mice 
  To determine whether genetically blocking CD36, another scavenger receptor 
responsible for the uptake of oxidized LDL (oxLDL), causes changes in HMG-CoA 
reductase, the mRNA expression and the activity of the enzyme were measured in CD36 wt 
and knockout mouse testicular fractions. 
5.1.2.1 ITf 
 
In CD36-/- mice ITf, HMG CoA reductase mRNA levels were significantly 
decreased (Fig. 24D), and the down-regulation was decreased by 64% compared to wt mice 
ITf.  
5.1.2.2 STf 
 
HMG-CoA reductase mRNA levels were significantly decreased by 84% in CD36-
/- mice STf compared to wt mice (Fig. 24E). HMG-CoA reductase enzymatic activity also 
tended to decrease in the CD36-/- mice STf, the decrease was not statistically significant 
(Fig. 24 F). The enzymatic activity averaged from 3.5550e-7 ± 1.5750e-7 mol/min/µg 
protein for wt mice to 1.3550e-7 ± 5.9500e-8 mol/min/µg protein for CD36-/- mice.  
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5.2 HSL mRNA levels and enzymatic activity in SR-BI knockout and in CD36 knockout 
mice 
5.2.1 SR-BI knockout mice  
To determine the changes of HSL if knocking out the SR-BI gene, the major 
enzyme for hydrolyzing cholesteryl esters, the mRNA expression and enzymatic activity of 
the enzyme were measured in wt and SR-BI wt and knockout mouse ITf.   
5.2.1.1 ITf 
 
After knocking out the SR-BI gene, the mRNA levels of HSL were significantly 
increased compared to those mRNA levels in the wt mice (Fig. 25A).  
5.2.1.2 STf 
 
Similarly to what we found in ITf, the mRNA levels of the enzyme were 
significantly increased in SR-BI-/- mouse STf, reaching 2.4-fold the value recorded in wt 
mouse STf (Fig. 25B). Coincidently with the increase in the mRNA expression, HSL 
activity was 18.14 nM/min/µg protein for SR-BI -/- mice which represents a 70% increase 
when compared to the activity in SR-BI wt mice (10.69 nM/min/µg protein). However, the 
increase was not statiscally significant. 
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5.2.2 CD36 knockout mice  
To determine the changes of HSL if genetically blocking CD36, the mRNA 
expression and enzymatic activity of the enzyme were measured in CD36 wt and -/-mouse 
ITf.   
5.2.2.1 ITf 
 
In CD36 deficient mouse ITf, HSL mRNA levels were significantly increased 
compared to wt mice ITf (Fig. 25D).  
5.2.2.2 STf 
 
However, HSL mRNA levels in STf were decreased by 30% in CD36-/- mice 
compared to wt mice (Fig. 25E). The discrepancy of transcriptional regulation of HSL 
between ITf and STf show a distinct feedback mechanism in each compartment following 
genetically induced CD36 deficiency. Consistent with the slight reduction of mRNA levels 
in STf, the HSL activity was reduced to 13.23 nM/min/µg protein in CD36-/- mice, which 
is 73% of the value recorded in wt mice (Fig. 25F).  
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5.3 ACAT-1 and ACAT-2 mRNA levels and enzymatic activity in SR-BI knockout mice 
and in CD36 knockout mice 
5.3.1 SR-BI knockout mice 
To  evaluate the impact of the disruption of SR-BI gene on ACAT-1 and ACAT-2, 
the important enzymes in the esterification of free cholesterol, the mRNA expression and 
enzymatic activity of the two isoforms were measured individually in SR-BI wt and -/- 
mice.   
5.3.1.1 ITf 
 
SR-BI deficient mice significantly down regulated ACAT-1 and ACAT-2 (Fig. 
26A). The mRNA levels of ACAT-1 averaged 0.62 in SR-BI-/- mice compared to wt (1 
fold).  On the other hand, ACAT-2 mRNA levels were 0.65 in SR-BI-/- mice compared to 
wt (1 fold). 
5.3.1.2 STf 
 
SR-BI deficient mice significantly down regulated ACAT-1 and ACAT-2 mRNA 
expression. The mRNA levels of ACAT-1 and ACAT-2 decreased by 41% and 51% in SR-
BI-/- compared to wt mice, respectively. ACAT-1 activity is correlated with its mRNA 
expression and decreased from 807.00 CPMB/200 µg protein for SR-BI-/- mice to 341.00 
CPMB/200 µg protein for wt mice (Fig. 26C). However, ACAT-2 activity showed no 
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significant differences in SR-BI-/- compared to wt mice (Fig. 26C), suggesting that ACAT-
2 enzymatic activity may not be regulated at the transcriptional levels.   
 
5.3.2 CD36 knockout mice 
To evaluate the effect on ACAT-1 and ACAT-2 if disrupting of CD36 gene, the 
mRNA expression and enzymatic activity of the isoforms of the enzyme were measured 
individually in CD36 wt and -/- mice.   
 
5.3.2.1 ITf 
 
Both ACAT-1 and ACAT-2 mRNA levels in CD36 knockout mice were 
significantly reduced, reaching half of the value recorded in wild type STf (Fig. 26D).  
5.3.2.2 STf 
 
In CD36 knockout mice STf however, there were no significant differences in 
ACAT-1 mRNA levels and enzymatic activity, indicating that ACAT-1 may not be affected 
by knocking out the CD36 gene (Fig. 26E and F). On the other hand, ACAT-2 mRNA 
levels were significantly decreased by 2.5-fold in CD36-/- mice. The proportional decrease 
of ACAT-2 activity is coincident with the diminution of mRNA expression in CD36-/- 
mice and reached to 257 CPMB/200 µg protein (Fig. 26E and F).  
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Figure 1.  Calendar of the germ cell population in mink testis. 
The variation of cellular composition of the seminiferous epithelium during the annual 
reproductive cycle of adult mink is shown in this figure. The figure depicts the oldest 
generations of germ cells found in the seminiferous epithelium during the last week of 
every month throughout the twelve months of the year. The 12-month reproductive cycle of 
adult mink is divided into two spermatogenic phases: active and inactive. The active phase 
is characterized by an increase in the mitotic and meiotic activities leading to the 
production of more germ cells at various degrees of development. The inactive phase is 
characterized by a decrease in the mitotic and meiotic activities, spermatogenic arrest and 
fewer germ cells. A=type A spermatogonia; B=type B spermatogonia; PL=pre-leptotene 
spermatocyte; P=pachytene spermatocyte; 7=step 7 spermatid; 19=step 19 spermatid (taken 
from Pelletier 1986).  
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Figure 2. HMG-CoA reductase mRNA expression in mink STf during development  
and the annual reproductive cycle. 
A. Total RNA was extracted from mink STf. After the reverse transcription, amplification was 
carried out with 0.5mM of mink HMG-CoA reductase primers (Table 1). Representative 
figures show the expression of HMG-CoA reductase mRNA and HPRT-1 mRNA in mink 
STf. A 105bp single product of HMG-CoA reductase and 93bp HPRT-1 product were 
detected.   
B. All data were normalized to the internal reference HPRT-1 amounts and expressed as an n-
fold increase relative to normalized calibrator value in each region. The results are 
representative of experiments done on three different STf sample preparations from three 
different animals. Data (mean ± SEM) are expressed relative to HMG-CoA reductase 
mRNA expression at 90 days (1 fold) during development or at August (1 fold) during 
annual reproductive cycle. The increase from 180 to 210 days (+ P<0.05) and from April to 
May (** P<0.005) and the decrease from 240 to 270 days (+ P<0.05) and June to July (+ 
P<0.05) were significant. d: days old. Neonatal period: day 90; puberty: 120d, 150d, 180d, 
210d and 240d; adulthood 270d; the seasonal cycle: from August to July.  
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Figure 3. HMG-CoA reductase protein expression in mink STf during development 
and the annual reproductive cycle. 
Thirty µg of protein from STf were subjected to 10% of SDS PAGE and Western blot 
analyses were performed using anti-human HMG-CoA reductase antibody. HMG-CoA 
reductase peptide was used for the pre-adsorption. Ponseau S staining was performed 
before blocking to verify equal loading. The immunoreactive bands were scanned and 
their intensities were quantified using the Scion Image program. Data presented were 
obtained by quantifying the immunoreactive bands in at least three independent 
experiments.  
A. Following adsorption of anti-HMG-CoA reductase with a HMG-CoA reductase peptide, 
the 90kDa immunoreactive band was no longer detected, whereas the 53kDa band 
decreased. 
B. Representative Western blots of the 90kDa immunoreactive bands HMG-CoA reductase 
are shown. The bands were scanned. Data shown are the mean ± SEM and are expressed 
relative to HMG-CoA reductase protein levels at 90 days during development or at 
August during the annual reproductive cycle. The increase from 150 to 180 days after 
birth was significant (+ P<0.05) and the levels slightly decrease afterwards. The protein 
levels tended to decrease after February in the reproductive cycle.  
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Figure 4.  HMG-CoA reductase enzymatic activity in mink STf during development 
and the annual reproductive cycle. 
Two hundred µg of microsomes from STf were used for the enzymatic activity 
measurements. The final reaction mixture was filtered by silica gel SPE column to separate 
the polar (14C-HMG-CoA) from non polar (14C-MVL). The radioactivity in the fractions 
containing the radioactive reaction product (14C-MVL) was evaluated with a β counter. All 
assays were evaluated in triplicates for three distinct microsome preparations obtained from 
three different mink for each age group. Data are expressed as mean ± SEM. The activity 
increased steadily with development except the decrease from 240 to 270 days. The 
increase from 150 to 180 days was significant (+ P<0.05), and from 210 to 240 days was 
significant (** P<0.005) and the decrease from 240 to 270 days was also significant (** 
P<0.005). During the annual reproductive cycle, the HMG-CoA reductase activity 
significantly increased from November to December (+ P<0.05), December to January (+ 
P<0.05) and again from January to February (+ P<0.05). The enzymatic activity of HMG-
CoA reductase reached the maximal value at 1.21× 10-6 mol/min/µg protein by February. 
The activity tended to decrease afterwards. 
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Figure 5.  HMG-CoA reductase immunohistochemical localization in mink testis 
The macrographs show the distribution of HMG-CoA reductase in mink testes taken from 
200 days old and in the adult in March. HMG-CoA reductase localizes to Sertoli cells (thin 
arrows) and germ cells (wide arrow). HMG-CoA reductase also localized to interstitial cells 
(white arrow head). The scale bar equals to 50 µm. 
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Figure 6.  HMG-CoA reductase mRNA and protein expression in mouse ITf during 
development. 
A. Total RNA was extracted from mouse ITf. After the reverse transcription, amplification 
was carried out with 0.5mM of mouse HMG-CoA reductase primers (Table 1). mRNA 
HMG-CoA reductase and HPRT-1 expression in mouse ITf during development is 
shown in the inset. A 175bp single product of HMG-CoA reductase and a 93bp HPRT-
1 product were detected. The relative fold induction was quantified in three independent 
experiments. Data shown are the mean ± SEM and are expressed relative to mRNA 
HMG-CoA reductase expression at 14 days (1 fold). A sharp and significant increase 
occurs from 21 to 28 days after birth (*** P<0.001); this is followed by a significant 
decrease from 28 to 35 days (+ P<0.05) and from 35 to 42 days (* P<0.01).  
B-1. Pre-adsorption of anti-HMG-CoA reductase with a HMG-CoA reductase peptide, the 
90kDa immunoreactive band in ITf disappeared.  
B-2. Representative Western blots of the 90kDa HMG-CoA reductase and the histogram of 
the 90kDa HMG-CoA reductase protein expression are shown. Data shown are the 
mean ± SEM and are expressed relative to HMG-CoA reductase protein expression at 
14 days (1 fold). The intensity of the 90kDa band showed no significant changes.  
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Figure 7.  HMG-CoA reductase mRNA, protein expression and enzymatic activity in 
mouse STf during development. 
A. A two-step real time PCR performed on total RNA of mouse STf using specific 
primers for mouse HMG-CoA reductase gene shows the expression of HMG-CoA 
reductase and of the house keeper gene, HPRT-1. A 175bp single product of HMG-
CoA reductase and a 93bp HPRT-1 product were detected. Experiments were done on 
three different STf sample preparations from testes of three different animals. Data 
shown are the mean ± SEM and are expressed relative to the mRNA HMG-CoA 
reductase levels at 14 days (1 fold). HMG-CoA reductase mRNA levels increased 
from 14 to 42 days. The increases from 14 to 21 days (*** P<0.001), from 21 to 28 
days (*** P<0.001) and from 35 to 42 days (* P<0.01) were significant. The decrease 
from 42 to >60 days (** P<0.005) was also significant. 
 B-1. The 90kDa immunoreactive band in STf disappeared. Other immnunoreactive bands 
did not show noticeably decrease with the pre-adsorption experiments. Thus, the 
90kDa immunoreactive band was the only band to be considered. 
 B-2. A representative Western blot of the 90kDa immunoreactive band of HMG-CoA 
reductase in STf is shown. The intensities of the bands from these independent 
experiments were scanned. Data shown are the mean ± SEM and are expressed 
relative to HMG-CoA reductase protein expression at 14 days (1 fold). HMG-CoA 
reductase protein levels increased from 14 to 35 days. The increases from 14 to 21 
days (+ P<0.05), from 21 to 28 days (+ P<0.05) and the decrease from 35 to 42 days 
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were significant, and then the protein levels dropped to the levels similar to those in 
the 14 days old mice.  
B-3. A representative Western blot showing the 90- and 37kDa immunoreactive bands in 
Spz. Pre-adsorption of anti-HMG-CoA reductase with a HMG-CoA reductase peptide 
shows that the 90- and 37kDa immunoreactive bands completely disappeared.  
 C. Two hundred microgram of microsomes from STf were used to perform HMG-CoA 
reductase enzymatic activity measurements. The enzymatic activity assay in this 
figure is representative of three independent experiments. Data are shown as mean ± 
SEM. The enzymatic activity of HMG-CoA reductase tended to increase from 14 to 
42 days but not significantly. The increase from 21 to 28 days was significant (+ 
P<0.05). The activity levels decreased from 42 to >60days but not significantly.  
  107 
 
  108 
 
Figure 8. HMG-CoA reductase immunohistochemical localization in mouse testis. 
Micrograph in A and B show the distribution of HMG-CoA reductase in the testes taken 
from adult mice. HMG-CoA reductase localizes to Sertoli cells (thin arrows) and germ cells 
(wide arrow). HMG-CoA reductase also localized to interstitial cells (white arrow head). 
The scale bar equals to 50 µm. 
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Figure 9.  HSL mRNA expression in mink STf during development and the annual 
reproductive cycle. 
Real time PCR was performed on the same total RNA of mink STf using specific primers 
for HSL gene. A representative expression of HSL and house-keeper gene HPRT-1 is 
shown. A 250bp and a 93bp sized single product respectively were detected. Data shown 
are the mean ± SEM and are expressed relative to the mRNA HSL expression at 90 days (1 
fold) or at August (1 fold). The results were obtained from three independent experiments. 
The increase from 90 to 120 days (** P<0.005) and from 240 to 270 days (*** P<0.001) 
were significant.  
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Figure 10.  HSL protein expression in mink STf during development and the annual 
reproductive cycle. 
Twenty µg of proteins from mink STf were subjected to 10% of SDS PAGE and Western 
blot analyses were performed using human HSL antibody. Two representative Western blot 
of the 90kDa immunoreactive band HSL are shown. Data shown are the mean ± SEM and 
are expressed relative to HSL protein expression at 90 days (1 fold) or at August (1 fold). 
The data present in this figure are representative of three independent experiments. The 
increase from 150 to 180 days (** P<0.005) and from 210 to 240 days (+ P<0.05) were 
significant. During the annual reproductive cycle, the increase from December to January 
(+ P<0.05) and the decrease from March to April (+ P<0.05) were significant. 
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Figure 11.  HSL enzymatic activity in mink STf during development and the annual 
reproductive cycle. 
Twenty µg of total proteins from STf were subjected to the HSL enzymatic activity 
measurement. The enzymatic activity is expressed in units; one unit being equivalent to the 
release of 1µmol of p-nitrophenol per minute. All assays were evaluated in triplicates for 
three distinct protein preparations from three different animals and HSL activity was related 
to the total protein concentration of the sample. Data are expressed as mean ± SEM. The 
activity averaged from 30.56 ± 0.52 nM/min/µg protein to 36.20 ± 1.12 nM/min/µg protein 
during development and from 29.51 ± 3.36 nM/min/µg protein to 40.88 ± 0.08 nM/min/µg 
protein in the adult. The increase from the 90 to 120 days (+ P<0.05) was significant. The 
noticeable increases occurred from 180 to 210 days during development but it was not 
significantly different. During the annual reproductive cycle, HSL enzymatic activity 
increased noticeably from October to November but showed no significance. The 
enzymatic activity of HSL peaked in February (*** P<0.001), and then it decreased 
significantly from February to March (*** P<0.001). 
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Figure 12.  HSL mRNA, protein expression in mouse ITf during development. 
A. Real time PCR was performed using specific primers for mouse HSL gene. A 
representative HSL expression in mouse ITf during development is shown. An 113bp 
sized product was amplified. Quantitative analyses present the data as relative HSL 
expression ± SEM compared to 14 days (1 fold). The HSL mRNA levels increased 
significantly from 21 to 28 days (+ P<0.05), and then the mRNA levels dropped 
significantly from days 35 to 42 after birth (+ P<0.05).  
B. Western blot analyses were performed using anti-mouse HSL antibody. A representative 
Western blot of 90kDa immunoreactive band is shown. Due to the limited numbers of the 
tissues, the assay was evaluated in one group of protein preparations. Data shown are 
expressed relative to HSL protein expression at 14 days (1 fold). The 90kDa HSL protein 
expression showed a slight increase from 28 to 35 days after birth and levels remained 
high afterwards. 
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Figure 13.  HSL mRNA, protein expression and enzymatic activity in mouse STf 
during development. 
A.  Real time PCR was performed using the specific primers for mouse HSL gene. A 113bp 
(HSL) and a 93bp (HPRT-1) sized products were amplified. Data shown are the mean ± 
SEM and are expressed relative to the mRNA HSL expression at 14 days (1 fold). The 
experiments were done on three different STf sample preparations from the testes of three 
different mice for each age group. The increase from 14 to 21 days (*** P<0.001) and 
from 21 to 28 days (* P<0.01) and from 28 to 35 days (+ P<0.05) were statistically 
significant.  
   B. Western blot analyses were performed using an anti-mouse HSL antibody. A 
representative Western blot of 90kDa immunoreactive band is shown. Data shown are the 
mean ± SEM and are expressed relative to HSL protein expression at 14 days (1 fold). 
Data were obtained from three independent experiments. The 90kDa HSL protein 
expression gradually increased throughout development. 
   C. The enzymatic activity was expressed in units where one unit is equivalent to the release 
of 1 µmol of p-nitrophenol/min.  Data are expressed as mean ± SEM. The data are the 
results of three independent experiments. The increase from 14 to 21 days (+ P<0.05) and 
the decrease from 42 to adulthood (+ P<0.05) were statistically significant. 
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Figure 14.  ACAT-1 and ACAT-2 mRNA expression in mink STf during development 
and the annual reproductive cycle. 
   A. Two-step real time PCR was performed in mink STf using primers for ACAT-1 and ACAT-
2 gene respectively. A representative expression of ACAT-1, ACAT-2 mRNA during 
development and the annual reproductive cycle is shown in the Figure. A 185bp sized 
single product of ACAT-1, a 70bp sized ACAT-2 product and a 93bp HPRT-1 product 
were detected.  
B. The specificity of ACAT-2 amplicons amplified in real time PCR were evaluated by 
restriction enzymes, Alu I. Alu I cleaved the recognition site (AG^CT) which was only 
present in mink ACAT-2 PCR product and released a 20bp and a 50 bp DNA fragments. 
Amplicons with or without restriction enzymes digestion were visualized by electrophoresis 
in a 3.5% agarose gel, stained with ethidium bromide and photographed under a UV 
transilluminator.  
C. All data were normalized to the internal reference HPRT-1 amounts and expressed as an n-
fold increase relative to normalized calibrator value in each region. Data shown are the 
mean ± SEM and are expressed relative to mRNA ACAT-1 or ACAT-2 at 90 days (1 fold) 
or at August (1 fold). Results were obtained from experiments done on three different STf 
samples prepared from three distinct animals per age group. ACAT-1 and ACAT-2 mRNA 
expression differed during development and the annual reproductive cycle. The increase of 
ACAT-1 from 90 to 120 days (*** P<0.001), from 240 to 270 days (** P<0.005), from 
September to October (+ P<0.05) and from April to May (+ P<0.05) as well as the decrease 
from November to December and June to July (+ P<0.05) were significant. The increase of 
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ACAT-2 from 180 to 210 days (+ P<0.05) and December to January (+ P<0.05) were 
significant; the decrease of ACAT-2 from 210 to 240 days (+ P<0.05) and from June to 
July (+ P<0.05) were also significant. 
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Figure 15. ACAT-1 and ACAT-2 protein expression in mink STf during development 
and the annual reproductive cycle. 
 Representative Western blots of ACAT-1 and ACAT-2 are shown. A 50kDa ACAT-1 and 
a 46kDa ACAT-2 immunoreactive band were detected. The intensity of the 
immunoreactive bands was quantified. Data shown are the mean ± SEM and are expressed 
relative to ACAT-1 or ACAT-2 protein expression at 90 days (1 fold) or at August (1 fold). 
Results were obtained from experiments done on three different STf sample preparations 
from three different animals per age group. ACAT-1 and ACAT-2 protein expressionh 
increased steadily with development. During the reproductive cycle, ACAT-1 tended to 
increase and to reach maximal values until January, and then to decrease gradually 
afterwards. However, the variations were not significant. The increase of ACAT-2 from 
December to January (+ P<0.05) and the decrease from March to April (+ P<0.05) were 
significant.   
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Figure 16. ACAT-1 and ACAT-2 enzymatic activity in mink STf during development 
and the annual reproductive cycle. 
 A. Dose-dependent inhibition curve (0-1000µM). A sharp decrease of total ACAT enzymatic 
activity was detected with the addition of 100µM inhibitor, and then total ACAT enzymatic 
activity decreased again with 200µM or more inhibitor. Thus the100µM inhibitor 
concentration was found to inhibit the activity of ACAT-1 but not the activity of ACAT-2 
and this concentration was used to perform the enzymatic measurements. 
 B. All assays for ACAT-1 and ACAT-2 enzymatic activities were evaluated in triplicates 
using three distinct microsome preparations obtained from three distinct animals for each 
age group. Representative histograms of the enzymatic activities are shown. The enzymatic 
activities in different group have the same tendency. The enzymatic activity is expressed as 
CPMB per 200µg protein. The activity of ACAT-1 ranged from 5436.00 CPMB/200µg 
protein to 958.00 CPMB/200µg protein in the adult.  ACAT-1 activity decreased from 180 
to 210 days and from December to January but increased from April to May. ACAT-1 
activity almost disappeared by 270 days compared to 90 days. On the other hand, the 
activity of ACAT-2 ranged from 280.00 CPMB/200µg protein to 2643.00 CPMB/200µg 
protein in the adult.  The increase of ACAT-2 from 210 to 240 days and 240 to 270 days 
and from December to January were noticeable as well as the decrease from March to April.  
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Figure 17.  ACAT-1 and ACAT-2 immunohistochemical localization in mink testis. 
Micrographs show the distribution of ACAT-1 and ACAT-2 in mink testes taken from 150 
day-old, 210 day-old mink and from adult mink killed in January and March.  ACAT-1 was 
detected only in germ cell (wide arrow) and some interstitial cells (thin arrows), whereas 
ACAT-2 was found only in Sertoli cell (white arrowhead) and the endothelial cells of 
capillaries and interstitial cells (thin arrows). The bar is equal to 50 µm. 
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Figure 18. ACAT-1 and ACAT-2 mRNA, protein expression in mouse ITf during 
development. 
A. Real time PCR was performed using specific ACAT-1 and ACAT-2 primers for mouse 
ACAT-1 and ACAT-2 gene respectively. ACAT-1 and ACAT-2 and HPRT-1 showed a 
126bp, a 101bp and a 93bp sized single product. All data were normalized to the internal 
reference HPRT-1 amounts and expressed as an n-fold increase relative to normalized 
calibrator value in each region. Data shown are the mean ± SEM and are expressed 
relative to ACAT-1 and ACAT-2 mRNA expression at 14 days (1 fold). The experiments 
were done on three different ITf sample preparations from three different animals for 
each age group. The increase of ACAT-1 from 21 to 28 days (+ P<0.05) was significant 
but not that of ACAT-2 mRNA.  
B. The specificity of ACAT-2 amplicons amplified in real time PCR were evaluated by 
restriction enzymes, EcoR II for mouse. EcoR II cut the recognition site (^CCWGG) 
which was only expressed in mouse ACAT-2 PCR product and released a 49bp, a 42bp 
and a 10bp DNA fragments. Amplicons with or without restriction enzymes digestion 
were visualized by electrophoresis in a 3.5% agarose gel, stained with ethidium bromide 
and photographed under a UV transilluminator.  
C. Representative Western blots of the 50kDa ACAT-1 and the 46kDa ACAT-2 
immunoreactive bands are shown. The immunoreactive bands were scanned and their 
intensities were quantified. Data shown are the mean ± SEM and are expressed relative to 
ACAT-1 or ACAT-2 protein levels at 14 days (1 fold). Experiments were done on three 
different ITf sample preparations from three different animals for each age group. ACAT-
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1 protein levels decreased steadily with development and significantly from 42 to >60 
days (+ P<0.05). ACAT-2 protein levels were constant.  
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 Figure 19. ACAT-1 and ACAT-2 mRNA, protein expression and enzymatic activity 
in mouse STf during development. 
A. Real time PCR was performed for mouse ACAT-1 and ACAT-2 genes. A 126bp sized 
single product of ACAT-1 and a 101bp sized ACAT-2 product were detected in the STf. 
All data were normalized to the internal reference HPRT-1 amounts and expressed as 
an n-fold increase relative to normalized calibrator value in each region. Data shown are 
the mean ± SEM and are expressed relative to ACAT-1 or ACAT-2 mRNA levels at 14 
days (1 fold). The data were obtained from three independent experiments for each age 
group. ACAT-1 mRNA levels tended to decrease with development but not 
significantly, whereas ACAT-2 levels significantly increase from 35 to 42 days (+ 
P<0.05) and were kept high in the adult. 
B. Representative Western blots results showing that 50kDa ACAT-1 immunoreactive band 
was present in both the STf and Spz, and that the 46kDa ACAT-2 band was only 
detected in the STf. The bands were scanned and their intensities quantified. Data 
shown are the mean ± SEM and are expressed relative to ACAT-1 or ACAT-2 protein 
levels at 14 days (1 fold). Experiments were done on three different STf sample 
preparations from three different animals per age group. The ACAT-1 protein 
expression decreased with the development but not significantly. ACAT-2 protein 
levels increased significantly from 21 to 28 days (+ P<0.05), and the levels remained 
high until 42 days and then decreased from 42 to >60 days but not significantly.  
 C. The figure shows the concentration-enzymatic activity inhibition curve established from 
0-1000µM K-604. A sharp decrease of total ACAT enzymatic activity was detected 
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with the addition of 100µM inhibitor (ACAT-1 activity is inhibited), and then total 
ACAT enzymatic activity decreased again with 200µM or more inhibitor. ACAT-1 and 
ACAT-2 enzymatic activities were blocked. Thus a 100µM inhibitor concentration was 
selected.  
D. A representative histogram of the ACAT-1 and ACAT-2 enzymatic activities of the 
three experiments is shown. ACAT-1 activity gradually decreased from 14 to 42 days 
but increased from 42 to >60 days in contrast to ACAT-2 enzymatic activity which 
increased steady from 14 to 42days and decreased from 42 to >60 days. ACAT-1 and 
ACAT-2 activities varied complementarily.   
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Figure 20.  ACAT-1 and ACAT-2 immunohistochemical localization in mice testis. 
 The micrographs show the distribution of ACAT-1 and ACAT-2 in mouse testes taken 
from 42 day-old and >60 day-old mice. ACAT-1 was detected only in germ cells within the 
seminiferous tubules (wide arrow), and ACAT-1 was plentiful in the interstitial cells (thin 
arrows), whereas ACAT-2 was found only in Sertoli cell (white arrowhead) in the tubule. 
The interstitial cells were not labeled. The bar is equal to 50 µm. 
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    Figure 21. Validation of HSL-/-mice. 
A. A two-step real time PCR was performed on total RNA of HSL knockout mouse ITf 
and STf using specific primers targeted on HSL exons that existed in both testis and 
adipose tissue. HSL mRNA expression in fold induction is shown. Data shown are the 
mean ± SEM in HSL-/- mice and are expressed relative to HSL mRNA expression in 
wild type (wt) mice. The results were obtained from three independent experiments. 
The decrease in HSL-/- ITf compared to wt mice ITf (** P<0.005) and the one in HSL-
/- STf compared to wt mice STf (*** P<0.001) were significant. HSL knockout mice 
lacked a wild type transcript.  
B. Western blot analyses were performed in both HSL -/- and wt mice using anti-HSL 
antibody that recognized all forms of HSL. The testicular fat pad was used as control. 
The 90kDa band was intense in wt fat pad, less intense in ITf and STf, but was not 
detected in HSL-/- mice samples. The 120kDa band was only observed in the mice ITf 
and STf. The intensities were sharply decreased in HSL-/- mice but still detectable. 
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Figure 22.  HMG-CoA reductase mRNA expression and enzymatic activity in HSL-/-  
mice. 
A and B.  mRNA expression: 
Real time PCR was performed on total RNA of HSL-/- mice ITf (A) and STf (B) using 
primers on HMG CoA reductase gene. HMG CoA reductase mRNA expression in fold 
induction is shown and the data are expressed as relative HMG- CoA reductase 
expression ± SEM. The data were obtained from three independent experiments. The 
decrease of HMG CoA reductase mRNA levels in HSL-/- ITf (** P<0.005) (A) and STf 
(** P<0.005) (B) compared to wt mice were significant.  
C. Enzymatic activity: 
Two hundred micrograms of total proteins from wt and HSL-/- mice STf were 
subjected to enzymatic activity measurements. A representative histogram of the HMG 
CoA reductase activity is shown. The HSL activity in the knockout animal was 
significantly reduced. 
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Figure 23. ACAT-1 and ACAT-2 mRNA expression and enzymatic activity in 
HSL-/- mice. 
A and B. mRNA expression: 
Real time PCR was performed on HSL-/- mice ITf (A) and STf (B) using primers on 
ACAT-1 and ACAT-2 genes. ACAT-1 and ACAT-2 mRNA expression in fold 
induction are shown, respectively. Data shown are the mean ± SEM in HSL-/- mice and 
are expressed relative to ACAT-1 and ACAT-2 mRNA expression in wt mice. All 
assays were evaluated in three independent experiments. ACAT-1 and ACAT-2 mRNA 
levels decreased in HSL-/- mice ITf (+ P<0.05) (A). In contrast, the increase of ACAT-
1 in HSL-/- mice STf (+ P<0.05) (B) compared to wt mice STf and the increase of 
ACAT-2 in HSL-/- STf (*** P<0.001) (B) compared to wt mice STf were significant.  
 C. Enzymatic activity:  
A representative histogram of ACAT-1 and ACAT-2 enzymatic activities in HSL-/- 
mice STf is shown. ACAT-1 and ACAT-2 enzymatic activities were both increased in 
HSL-/- mice STf. The increasing of ACAT-2 activity was higher than ACAT-1 in HSL-
/- mice STf. 
  142 
  143 
Figure 24. HMG-CoA reductase mRNA expression and enzymatic activity in SR-
BI and CD36 knockout mice. 
A and B. mRNA expression: 
Real time PCR was performed on total RNA of SR-BI knockout mice ITf (A) and STf 
(B) using primers on HMG CoA reductase gene. HMG CoA reductase mRNA 
expression in fold induction is shown. Data are expressed as relative HMG-CoA 
reductase expression ± S.E.M. in SRBI-/- compared to wt mice (1 fold). The fold 
induction of three independent experiments is shown. The decrease of HMG-CoA 
reductase in SR-BI-/- mice ITf (*** P<0.001) (A) and STf (* P<0.01) was significant 
(B). 
C. Enzymatic activity:  
Two hundred micrograms of total proteins from mice STf were subjected to enzymatic 
activity measurements. Data are expressed as relative HMG-CoA reductase activity ± 
S.E.M. in SR-BI-/- compared to wt mice. HMG-CoA reductase enzymatic activity was 
reduced but not significantly in SR-BI knockout mice STf.  
D and E. mRNA expression: 
Real time PCR was performed on total RNA of CD36 knockout mice ITf (D) and STf 
(E) using primers on HMG-CoA reductase gene. HMG-CoA reductase mRNA 
expression in fold induction is shown. Data are expressed as relative HMG-CoA 
reductase expression ± SEM in CD36-/- compared to wt mice (1 fold). The fold 
induction of three independent experiments is present. The diminution of HMG-CoA 
reductase in CD36-/- ITf (*** P<0.001) (D) and STf (*** P<0.001) was significant (E). 
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F. Enzymatic activity:  
Two hundred micrograms of total proteins from mice STf were subjected to enzymatic 
activity measurements. Data are expressed as relative HMG-CoA reductase activity ± 
S.E.M. in CD36-/- compared to wt mice. HMG-CoA reductase enzymatic activity was 
reduced in CD36 knockout mice STf. The decrease showed no significance. 
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Figure 25. HSL mRNA expression and enzymatic activity in SR-BI and CD36 
knockout mice. 
  A and B. mRNA expression: 
Real time PCR was performed on total RNA of SR-BI-/- mouse ITf (A) and STf (B) 
using primers on HSL gene. HSL mRNA is expressed in fold induction. Data are 
expressed as relative HSL expression ± SEM in SR-BI-/- compared to wt mice (1 fold). 
The data are representative of three independent experiments. The increase of HSL in 
SR-BI-/- (*** P<0.001) compared to wt mice ITf (A) and the increase in the enzyme in 
SR-BI-/- (** P<0.005) compared to wt mice STf (B) are significant.  
C. Enzymatic activity:  
Twenty micrograms of total proteins from SRBI knockout mice STf were subjected to 
the enzymatic activity measurements. Data are expressed as relative HSL expression ± 
S.E.M. The HSL enzymatic activity increased in SR-BI-/- mice STf but the increase 
was not significant. 
D and E. mRNA expression: 
Real time PCR was performed on total RNA of CD36-/- mice ITf (D) and STf (E) 
using primers on HSL gene. HSL mRNA is expressed in fold induction. Data are 
expressed as relative HSL expression ± SEM in CD36-/- compared to wt mice (1 fold). 
The data were obtained from three independent experiments. The increase of HSL in 
CD36-/- (** P<0.005) compared to wt mice ITf (D) is significant, whereas HSL mRNA 
levels decreased in CD36-/- compared to wt mice STf (E) but not significantly.  
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F. Enzymatic activity:  
Twenty micrograms of total proteins from CD36 knockout mice STf were subjected to 
the enzymatic activity measurements. Data are expressed as relative HSL expression ± 
SEM. The HSL enzymatic activity decreased in CD36-/- mice STf but showed no 
significance. 
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Figure 26. ACAT-1 and ACAT-2 mRNA expression and enzymatic activity in SR-BI 
and CD36 knockout mice. 
A and B. mRNA expression: 
Real time PCR was performed on total RNA of SR-BI-/- mice ITf (A) and STf (B) 
using primers on ACAT-1 or ACAT-2 gene. ACAT-1 or ACAT-2 mRNA is expressed 
in fold induction. Data shown are the mean ± SEM in SR-BI-/- mice and are expressed 
relative to ACAT-1 or ACAT-2 expression in wt mice (1 fold). The data are 
representative of three independent experiments. ACAT-1 mRNA levels (*** P<0.001) 
and ACAT-2 mRNA levels decreased (* P<0.01) significantly in SR-BI-/- mice ITf (A). 
Similarly, ACAT-1 (* P<0.01) and ACAT-2 (*** P<0.001) decreased significantly in 
SR-BI-/- mice STf (B).  
C. Enzymatic activity:  
Two hundred micrograms of total microsome proteins from SR-BI-/- mice STf were 
subjected to the enzymatic activity measurements. Two representative histograms of 
ACAT-1 and ACAT-2 activity in SR-BI-/- mice are shown. ACAT-1 activity decreased 
in SR-BI-/- mice STf, whereas ACAT-2 activity showed no change between wt and SR-
BI-/- mice.  
D and E. mRNA expression: 
Real time PCR was performed on total RNA of CD36-/- mice ITf (D) and STf (E) 
using primers on ACAT-1 or ACAT-2 gene. ACAT-1 or ACAT-2 mRNA is expressed 
in fold induction. Data are expressed as relative ACAT-1 or ACAT-2 expression ± 
SEM in CD36-/- compared to wt mice (1 fold). The data were obtained from three 
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independent experiments. ACAT-1 mRNA levels decreased (** P<0.005) and ACAT-2 
mRNA levels decreased (*** P<0.001) significantly in CD36-/- mice ITf (D). In 
contrast, ACAT-1 mRNA levels showed no significance compared to wt mice STf. The 
decrease in ACAT-2 in CD36-/- mice STf (** P<0.005) compared to wt mice STf was 
significant (E).  
F. Enzymatic activity:  
Two hundred micrograms of total microsome proteins from CD36-/- mice STf were 
subjected to the enzymatic activity measurements. Two representative histograms of 
ACAT-1 and ACAT-2 activity in SR-BI-/- mice are shown. ACAT-2 activity decreased 
in CD36-/- mice STf. Conversely, ACAT-1 activity in CD36-/- mice STf showed no 
significant changes. 
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Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
Schematic drawing of HMG-CoA reductase, HSL and ACAT in intracellular 
cholesterol metabolism during normal spermatogenesis. 
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Outline of Discussion 
1. HMG-CoA reductase 
  1.1 Mink 
    1.1.1 HMG-CoA reductase mRNA, protein expression and enzymatic activity in the 
seminiferous tubules during development and annual reproductive cycle  
  1.2 Mouse 
    1.2.1 HMG-CoA reductase mRNA, protein expression in the interstitial tissue during 
development 
    1.2.2 HMG-CoA reductase mRNA, protein expression and enzymatic activity in the 
seminiferous tubules during development  
 
2. HSL 
  2.1 Mink 
    2.1.1 HSL mRNA, protein expression and enzymatic activity in the seminiferous tubules 
during development and annual reproductive cycle  
  2.2 Mouse 
    2.2.1 HSL mRNA, protein expression in the interstitial tissue during development 
    2.2.2 HSL mRNA, protein expression and enzymatic activity in the seminiferous tubules 
during development  
 
3. ACAT-1 and ACAT-2 
  3.1 Mink 
    3.1.1 ACAT-1 and ACAT-2 mRNA, protein expression and enzymatic activity in the 
seminiferous tubules during development and annual reproductive cycle  
  3.2 Mouse 
    3.2.1 ACAT-1 and ACAT-2 mRNA, protein expression in the interstitial tissue during 
development 
    3.2.2 ACAT-1 and ACAT-2 mRNA, protein expression and enzymatic activity in the 
seminiferous tubules during development  
 
4. The mRNA expression and activities of HMG-CoA reductase, ACAT-1 and ACAT-
2 in  HSL-/- male mouse 
4.1 ITf 
4.2 STf 
 
5. The mRNA expression and activities of HMG-CoA reductase, HSL, ACAT-1 and 
ACAT-2 in  SRBI-/- and CD36-/- male mouse 
5.1 SR-BI-/- mice 
5.1.1 ITf 
  5.1.2 STf 
 
5.2 CD36-/- mice 
5.1.1 ITf 
  154 
  5.1.2 STf 
 
6. Intracellular cholesterol homeostasis by the coordination of three key enzymes 
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1. HMG-CoA reductase 
Sertoli cells reportedly have the capacity to synthesize cholesterol from acetate in 
vitro (Wiebe & Tilbe, 1979). If this cholesterol synthesis capacity exists in vivo, then 
HMG-CoA reductase showed contribute to regulate the cholesterol biosynthesis pathway in 
respondse to the metabolic demands of the cyclic production of germ cells. HMG-CoA 
reductase activity was reported to undergo significant changes during testicular 
development in rats (Potter et al., 1981). The enzymatic activity was especially high at the 
prepubertal pachytene stage of spermatogenesis but the regulation of enzyme has not been 
studied. The present study addresses, to our knowledge for the first time, the physiological 
significance of HMG-CoA reductase in the seminiferous tubules. In addition, this is the 
first study of the testicular HMG-CoA reductase that is carried out in seasonal breeders. 
Moreover, this study provides a comprehensive and accurate account of the impact of 
HMG-CoA reductase on testicular cholesterol metabolism by taking measurements every 
30 days, rather than only sporadically as done in most studies that used seasonal breeders as 
their animal model. Furthermore, this study provides new and more precise insights into the 
role and the dynamics of the enzyme in individual cellular compartments of the testis by 
performing measurements in individual seminiferous tubule-enriched fractions and 
interstitial tissue-enriched fractions rather than whole-testis extracts as it is widely done. 
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1.1 mink 
1.1.1 HMG-CoA reductase mRNA, protein expression and enzymatic activity in the 
seminiferous tubules during development and the annual reproductive cycle 
 
Contrary to earlier observations that HMG-CoA reductase mRNA levels in rat testes 
remained constant during development (Ness & Nazian, 1992), we demonstrated that 
HMG-CoA reductase mRNA levels in mink STf during development significantly but 
transiently increased by day 210-240 before decreasing by 270 day in the adult. The mRNA 
levels at 270 day were not significantly different from those were orded in the 90-180 day 
old mink. Moreover, HMG-CoA reductase mRNA levels remained relatively constant 
during the annual reproductive cycle, except in May-June where the mRNA levels nearly  
tripled before significantly decreasing 3-fold in July. The increase in HMG-CoA 
reductase mRNA expression during mink development suggests that transcription may be a 
significant mean of enzyme regulation at the completion of spermatogenesis. However, the 
transcpritionally regulatory mechanism cannot alone explain the observation of the 
transient increase in the mRNA levels in May. Additional regulatory mechanism may be 
involved.  
Western blot analyses performed with anti-HMG-CoA reductase antibody revealed 
several bands in mink STf during development and the annual reproductive cycle. 
Adsorption of anti-HMG-CoA reductase with an HMG-CoA reductase peptide caused the 
disappearance of the 90kDa immunoreactive band and a decrease in the 53kDa band. 
Because the 53kDa band did not completely disappear with the pre-adsorption, the 90kDa 
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was considered the HMG-CoA reductase immunoreactive band. The 90kDa HMG-CoA 
reductase immunoreactive band corresponds to the native monomeric form of the enzyme 
reported as a 97 kDa protein in the rat liver (Istvan et al., 2000). We demonstrated that the 
90kDa HMG-CoA reductase protein levels significantly increased by 180 days after birth. 
The increase in the 90kDa protein levels occured one month prior that in the mRNA levels. 
We speculate that HMG-CoA reductase may have unique regulatory pathway to 
accumulate protein. Previous study in the yeast confirmed that the cell can immediately 
start with proteins translation concerning the proteins that are quickly required in response 
to a stimulus (Beyer et al., 2004). In such situations the usual order of events, with 
transcription and subsequent translation, may be too slow for an appropriate hysiological 
reaction. Instead, the cell might keep a constant level of reservoir mRNA but quick protein 
accumulation. Thus, a remarkably increasing HMG-CoA reductase protein expression by 
180 days after birth may be due to the necessity for relatively fast responses to the demand 
on cholesterol. Moreover, an earlier study in rats reported that the liver, which may have 
sudden demands for large amounts of cholesterol, may use phosphorylation-
dephosphorylation to maintain a reservoir of inactive HMG-CoA reductase that can be 
quickly activated (Ness & Chambers, 2000). Whether phosphorylation-dephosphorylation 
mechanism occurs during the spermatogenic activity in the testis remains to be elucidated.  
In addition, the protein levels of 90kDa HMG-CoA reductase tended to decrease 
from 240-270 days after birth; the 90kDa protein levels decreased from April-July in the 
adult during the seasonal cycle, while in May-June HMG-CoA reductase mRNA expression 
peaked, suggesting that the post-transcriptional regulation is crucial for HMG-CoA 
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reductase expression. It is well documented that post-transcriptional regulation determines 
the fate of the RNAs, including their subcellular localization, stability, and translation 
efficiency (Ross,1995). Thus, post-transcriptional regulation of the enzyme may provide a 
more elaborate regulation of the activity. It has been reported that the monomeric form of 
HMG-CoA reductase protein could be cleaved by proteolysis and the two-third of the 
enzyme COOH- terminal be released into the cytosol while the enzymatic activity increases 
(Jingami et al., 1987). Therefore, it is possible that cleaved HMG-CoA reductase isoform 
may be expressed in STf. A precise measurement of multiple forms of HMG-CoA 
reductase is necessary in followup studies.  
Our enzymatic activity measuements show that the increase in enzymatic activity 
recorded at 180 days was coincident with an increase in the protein levels of the 90kDa 
band. Previous findings reported that the rate of [14 C] acetate incorporation into cholesterol 
was increased 4- to 5-folds as spermatocytes went from preleptotene to pachytene (Hou et 
al., 1990). We show a relationship between the activity of this enzyme and the initiation of 
meiosis as if cholesterol would be required during this phase.  
We found that HMG-CoA reductase activity significantly increased again from 180 
to 240 days, and peaked from December to February. Other studies showed that the rate of 
acetate incorporation into cholesterol decreased and remained low at the end of meiosis, 
and was low in mature spermatozoa (Potter et al., 1981). Our laboratory reported that free 
cholesterol levels in STf were lowered from December to March (Akpovi et al., 2006). It 
would seem unlikely that the high HMG-CoA reductase activity would be responsible for 
the production of the relatively large amounts of mevalonate used for cholesterol synthesis. 
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We speculate that the elevated activity of HMG-CoA reductase may have a yet unknown 
physiological role in these special periods. A recent study has indicated that HMG-CoA 
reductase may contribute in the production of high concentration of cholesterol 
intermediates in mature spermatozoa (Tacer et al., 2002). Their observations showed that 
rat male germ cells lack a coordinate transcriptional control over the cholesterol 
biosynthetic pathway (Tacer et al., 2002). These authors reported that high expression of 
HMG-CoA reductase gene was correlated to the low expression of post meiosis-activating 
sterol (MAS) genes in the cholesterol biosynthesis pathway, causing the accumulation of 
the meiosis signaling sterol testis-MAS (T-MAS) during the maturation of male germ cells 
(Tacer et al., 2002). The high concentration of T-MAS in spermatozoa may contribute to 
completion of the second meiotic division of the oocyte (Byskov et al., 1999). Accordingly, 
we suggest that the role of HMG-CoA reductase may be not only to synthesize cholesterol 
but in addition, to produce the intermediate molecule, T-MAS, in the cholesterol 
biosynthetic pathway.  
 
1.2 Mouse 
1.2.1 HMG-CoA reductase mRNA, protein expression in the interstitial tissues during 
development 
Our observations demonstrated that HMG-CoA reductase mRNA levels were 
significantly increased by 28 days after birth but decreased steadily after until adulthood in 
the ITf. Between days 28 and 35, a major increase in the number of Leydig cells per testis 
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has been reported (Vergouwen et al.,1993). Since Leydig cells are the major cells being 
involved in the biosynthesis of cholesterol and testosterone (Ewing et al.,1981), one would 
expect that the more Leydig cells, the more cholesterol and testosterone. This would lead to 
the conclusion that HMG-CoA reductase may contribute in the modulation of the 
biosynthesis of the cholesterol to be used for testosterone production by the Leydig cells. 
Earlier immunocytochemical studies located HMG-CoA reductase protein not only 
in Leydig cells (Hegardt, 1999; Royo et al., 1993) but also in macrophages (Chen et al., 
2002). It has been documented that testicular macrophages can convert cholesterol into 25-
hydroxycholesterol which strongly stimulates Leydig cell testosterone production (Chen et 
al., 2002). Moreover, the number of macrophages in the testicular interstitium has been 
shown to increase significantly throughout puberty (Hutson,1990; Vergouwen et al.,1991). 
Therefore, our finding of an increase of HMG-CoA reductase mRNA level during puberty 
is compatible with the contribution of the enzyme to testosterone production. However, the 
enzyme protein expression remained more or less constant throughout development, 
contrary to the mRNA levels that decreased, the precise mechanism of HMG-CoA 
reductase is participated in testosterone synthesis will require additional investigation, such 
as to elucidate whether the phosphorylation-dephosphorylation mechanism occurs during 
the spermatogenic activity.  
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 1.2.2 HMG-CoA reductase mRNA, protein expression and enzymatic activity in the 
seminiferous tubules during development 
Contrary to HMG-CoA reductase expression pattern in the interstitial tissue, we 
show that HMG-CoA reductase mRNA and 90 kDa protein expression profiles increased 
simultaneously from 14 to 28 days in the seminiferous tubules. However, HMG-CoA 
reductase mRNA levels peaked by 42 days before decreasing while the protein levels 
tended to decrease steadily. Here, we show that the increase in HMG-CoA reductase 
mRNA and protein levels and activity in mouse STf was coincided with the apprearance of 
round spermatids in the tubules, suggesting a role of HMG-CoA reductase in the meiosis. 
However, previous studies showed that the rate of acetate incorporation into cholesterol 
decreased and remained low at the end of meiosis, and was low in mature spermatozoa 
(Potter et al., 1981). It is possible that HMG-CoA reductase have an unique physiological 
function besides synthesizing cholesterol. In addition, the 90kDa HMG-CoA reductase 
protein levels decreased significantly by 42 days after birth, which is in contrast to the 
enzyme mRNA expression. Since the enzymatic activity levels reached maximal values by 
42 days, coincidentally with a peak in the mRNA levels, we speculate that post-
transcriptional regulatory mechanism of the enzyme may exist during this period. The 
spermatozoa were present in the tubules by 42 days, and significantly we found that a 
37kDa HMG-CoA reductase immunoreactive band was expressed in spermatozoa in 
addition to the 90kDa immunoreactive band. Whether the 37kDa band is the product of 
post-transcriptional modulation and whether it would be involved in the regulation of 
HMG-CoA reductase activity requires additional investigation.  
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2. HSL 
 An earlier report showed that seminiferours tubules could not contribute the 
majority of the cholesterol required for spermatogenesis through the biosynthesis pathway 
in vitro (Wiebe & Tilbe, 1979). Thus, other enzymes besides HMG-CoA reductase should 
regulate cholesterol to levels that are consistent with the production of viable and fertile 
male germ cells in the tubules. Previous reports showed that HSL activity was positively 
correlated with free cholesterol to esterified cholesterol ratios in the seminiferous tubules 
(Kabbaj et al., 2003). Furthermore, the physiological significance of HSL in testis is 
highlighted by the report that HSL knockout male mice are sterile due to the toxicity effect 
caused by the over-accumulation of esterified cholesterol (Osuga et al., 2000). The present 
study addresses the physiological significance of HSL in each compartment of mink and 
mouse testis. Our studies confirm previous findings by showing that HSL protein levels and 
HSL activity increased in parallel in STf until 240 days. We are the first to detect that HSL 
activity in STf was modulated at the transcriptional levels during mouse development. In 
addition, we demonstrated that 90 kDa HSL protein levels tended to increase from 35 days 
to adulthood, while HSL mRNA expression significantly decreased in mouse interstitial 
tissue. Because HSL is assumed to hydrolyze esterified cholesterol and to provide available 
free cholesterol to fullfil the needs of cells (Holm et al., 2000), HSL high expression and 
activity in the developemental tubules and interstitum is likely responsible for regulating 
cholesterol concentration. 
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2.1 Mink 
2.1.1 HSL mRNA, protein expression and enzymatic activity in the seminiferous 
tubules during development and annual reproductive cycle 
This study demonstrated that HSL mRNA levels in mink STf during development 
significantly increased once by day 120 and again by 270, but not during the annual 
reproductive cycle. The increase of HSL mRNA expression during mink development 
suggests that transcription may be a significant means of enzyme regulation at the initiation 
of spermatogenesis. However, the transcriptionally regulatory mechanism can not alone 
explain the observation of low HSL protein level at 120 day or decreased HSL protein 
expression by 270 days after birth.  Earlier study showed that post-transcriptional 
regulation determines the fate of the RNAs and modulates the translation efficiency 
(Ross,1995). Therefore, post-transcriptional regulation of HSL may provide a more 
elaborate regulation of the enzymatic activity. However, this remains to be determined. 
 Adsorption of anti-hHSL with human adipose tissue caused a major decrease in the 
intensity of the 90kDa immunoreactive bands in mink tissues (Kabbaj et al., 2003), 
demonstrating that the anti-hHSL antibodies recongnizes the enzyme in mink tissue. In the 
present study, the detection of a mink tubular HSL with larger molecular mass (120 kDa) 
and another smaller form of HSL (90kDa), is in agreement with the results of studies in 
other species (Kabbaj et al., 2001; Mairal et al., 2002; Vallet-Erdtmann et al., 2004). Except 
the “well recognized” testicular HSL isoform (120 kDa) which is only expressed in 
postmeiotic germ cells, the 90 kDa HSL isoform was studied in our study. This specific 
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HSL isoform was reported in interstitial and tubular Sertoli cells as well as premeiotic germ 
cells, but not in postmeiotic germ cells (Mairal et al., 2002). Thus, the measurement of 
90kDa HSL protein expression in STf provides new insights into the study of HSL in the 
particular phases of testicular development. The present study recorded one increase of 
90kDa HSL protein expression by day 180- and a second increase by 240 days as well as in 
January, which is independent of the enzyme mRNA expression. Therefore, HSL may have 
regulatory pathway to accumulate protein rather than transcriptional regulation. Earlier 
studies showed that the yeast cells could immediately started with protein translation if the 
corresponding protein is rapidly needed (Beyer et al., 2004). In such situation the mRNA 
abundance may not need to change much more drastically to achieve a significant change 
of protein concentrations. Therefore, the 90kDa HSL protein increases which are anterior to 
the mRNA level increase may be due to the necessity for relatively fast responses to the 
cholesterol demand. In addition, it has been documented that lipolytic and anti-lipolytic 
hormones regulate HSL activity in adipose tissue via reversible HSL protein 
phosphorylation mediated by protein kinase A (PKA) (Yeaman, 1990). HSL activity in STf 
may be influenced via reversible HSL phosphorylation of serine residues mediated by PKA. 
It would be interesting to identify changes in phosphorylation sites of the HSL protein that 
could account for putative changes in HSL activity in STf.  
The enzymatic activity in this study using PNPB as the substrate reflects the activity 
of HSL in STf. The results showed that HSL activities gradually increased duing 
development and the period from August to February. HSL activity peaked in the adult and 
in February but it significantly decreasd from March-May. The current study substantiates 
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previous reports that HSL activity varied in STf and reached maximal values in the adult 
during the period of maximal spermatogenic activity (Kabbaj et al., 2003). Combining the 
earlier finding of a strong correlation of the free cholesterol/esterified cholesterol ratios 
with HSL activity in the tubules, we support the notion that HSL may be the cholesterol 
esterase, which maintains the cholesterol homeostasis in the tubules. To be noted, the 
increase of HSL activity followed the 90kDa HSL protein accumulation by180-, 240- days 
after birth as well as January in the seasonal cycle, suggesting that 90 kDa HSL protein 
accumulations could be the crucial mechanism in the regulation of HSL activity. 
Additionally, the present study recorded the elevation in HSL activity in STf, which is 
independent of the enzyme mRNA and protein expression. The finding entails distinct 
cholesterol regulatory mechanism in the seminiferous tubules.  
 
2.2 Mouse 
2.2.1 HSL in the interstitial tissue (ITf) 
The present study recorded a sharp increase of HSL mRNA expression by 28 days 
after birth followed by a significant decrease by 42 days in mouse ITf. The observation 
agrees with the earlier report that HSL mRNA level is 25-fold increased in rat testis during 
puberty (Kraemer et al.,1991). It has been documented that 90kDa HSL is expressed in 
interstitial tissue (Mairal et al., 2002); and the enzyme is localized in the macrophages of 
interstitial tissue (Kabbaj et al.,2003). Since the number of macrophages/units area 
increased significantly during puberty (Hutson,1990; Vergouwen et al.,1991), we put 
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forward the view that macrophage HSL may free cholesterol from esterified cholesterol to 
be converted into 25-hydrocholesterol taken up by Leydig cells to synthesize testosterone 
during spermatogenesis. The present study further suggests that the modulation of HSL 
activity in ITf is at the transcriptional level.  
The current study first reported the variation of 90kDa HSL protein expression in 
mouse ITf during development. The results showed that the 90kDa HSL protein level 
tended to increase from 35 days onwards. The observation is in agreement with other 
reports that a delay between mRNA and protein appearance is characteristic of many genes 
expression in the testis (Blaise et al.,1999; Blaise et al.,2001). The finding of an increased 
HSL mRNA level and 90kDa HSL protein expression is compatible with the contribution 
of testosterone production. Combining the fact that the increase of HSL expression 
corresponded to a decrease in esterified cholesterol levels in ITf (Akpovi et al, unpublished 
data), we suggest that HSL is involved in the cholesterol metabolism while contributing to 
testosterone production in the interstitial tissue. Remarkably, HSL mRNA levels decreased 
in adulthood, while its protein levels increased. The results suggest a regulation of HSL 
protein expression in ITf during adulthood different from that during development.  
 
2.2.2. HSL mRNA, protein expression and enzymatic activity in the seminiferous 
tubules during development 
Our observations showed three successive significant increases in HSL mRNA 
levels in STf one by 21, then by 28, and again by 35 days. The HSL mRNA expression 
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pattern was accompanied by a steady elevation of HSL protein expression throughout 
development. The finding of a different HSL mRNA and protein expression in the 
seminiferous tubules and interstitial tissue entails distinct cholesterol regulatory 
mechanisms in individual compartment of the testis. Such elevation seems to be testis-
specific and species-specific since this change was not observed in the adipose tissue and 
HSL mRNA levels remained constant in rat testis during development (Kraemer et al., 
1991).  
The present study demonstrated that HSL activity as well as the enzyme expression 
was increased in parallel in STf throughout development, except in the STf of the adult, in 
which a significant decrease of HSL activity is associated with an increase of HSL mRNA 
and protein level. The results suggest HSL activity is regulated on the transcriptional level 
during development. They also suggest a regulation of HSL activity during adulthood was 
different from that during development. In addition, the current finding recorded a 
significant increase in HSL activity in STf that coincided with period (i.e., the 21-day-old) 
characterized by numerous pachytene spermatocytes in the tubules, reflecting intense 
meiotic activity. Moreover, the present study showed an increased HSL activity during the 
period when the spermatognesis was completed during development. Combining with the 
previous finding in Guinea pig that HSL accumulated near the base of Sertoli cells in stages 
following the release of spermatids (Kabbaj et al., 2003), we suggest a role of HSL in the 
processing of lipids borne by residual bodies. 
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3. ACAT-1 and ACAT-2 
ACAT reduces cholesterol solubility in the cell membrane and promotes storage of 
cholesterol ester in the lipid droplets within the cytoplasm by esterifying cholesterol 
(Suckling & Stange,1985). Thus, normal ACAT activity prevents potential accumulation of 
excess free cholesterol which might jeopardize vital cellular functions (Warner et al.,1995). 
Two distinct isoforms of ACAT have been documented: ACAT-1 and ACAT-2. ACAT-1 
converts cholesterol into cholesteryl ester in response to cholesterol abundance inside the 
cells (Chang et al., 1993); and ACAT-2 appears to provide cholesteryl esters for transport 
in lipoproteins (Buhman et al., 2000; Cases et al., 1998a). The contribution of individual 
ACAT isoforms to cholesterol homeostasis in the male gonads has never been reported. 
The current study, for the first time, demonstrated that ACAT-1 and ACAT-2 are both 
expressed in the interstitial tissue and seminiferous tubules, and showed that the ACAT-1 
enzymatic activity is complementary to ACAT-2 in the seminiferous tubules. 
3.1 mink 
3.1.1 ACAT-1 and ACAT-2 mRNA, protein expression and enzymatic activity in the 
seminiferous tubules (STf) during development 
ACAT-1 has been well documented in the steroid hormone-producing Leydig cells 
and macrophages of testis, while ACAT-2 was claimed to be absent from testis (Dove et al., 
2006; Dove et al., 2005; Lee et al., 2000; Rudel et al., 2001). Our observation argued with 
this report by showing that not only ACAT-1 but also ACAT-2 was present in mink testis. 
The present immunohistochemistry studies showed for the first time that ACAT-1 and 
ACAT-2 both localized in the mink seminiferous tubules: ACAT-1 to the germ cells, 
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ACAT-2 to the Sertoli cells. These differences in the cellular localization of ACAT-1 and 
ACAT-2 suggest different functions of the two isoforms. Previous studies demonstrated 
that ACAT-1 maintains free cholesterol equilibrium in by storing excess of cholesterol as 
cholesterol esters (Chang et al., 1997). ACAT-2 is thought to provide cholesterol esters for 
very low density lipoprotein (VLDL) assembly in specific tissues (Cases et al., 1998a; 
Joyce et al., 1999). Thus, we attempted to address the hypothesis that, ACAT-1 may be 
associated with the cholesterol esterification and store the lipid droplet content in the 
seminiferous tubules, whereas ACAT-2 may participate in the removal of excessive 
cholesterol from the tubules. Our data provided the besis in support of this view.  
Our results showed the presence of transcripts and protein expression of ACAT-1 and 
ACAT-2 in mink seminiferous tubules, and confirmed the specificity of the PCR products 
by the restriction enzyme, Alu I. We found that ACAT-1 mRNA expression levels followed 
a profile similar to that of its protein levels during development but not during the seasonal 
reproductive cycle. Conversely, ACAT-2 mRNA expression levels followed protein levels 
during the annual reproductive cycle but not the end of development. ACAT-2 mRNA 
expression was high while its protein levels were low in the 240 and 270 days samples. 
This indicates that different regulatory mechanisms are involved in these two ACAT 
isoforms despite their structural and functional similarities. Evidence shows that post-
transcriptional regulation is crucial for gene expression in all organisms (Ross,1995). The 
post-transcriptional regulation determines the fate of the RNAs, including their subcellular 
localization, stability, and translation efficiency (Ross,1995). Thus, ACAT isoforms during 
distinct period of spermatogenesis could be regulated at post-transcriptional level, which 
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might provide a more elaborate regulation of ACAT-1 or ACAT-2 activity for cellular 
cholesterol homeostasis.  
Our results showed that ACAT-1 mRNA levels were significantly increased during 
early development when numerous type A0 spermatogonia were seen arising apparently 
from divisions of spermatogonia stem cells (by 120 days after birth) or in October; and (by 
270 days) with the appearance of the mature spermatids, suggesting an active participation 
of ACAT-1 in germ cells during mitosis and spermiogenesis. We recorded another increase 
in ACAT-1 mRNA expression in May when meiosis was arrested and elongated spermatids 
have left and great amount of lipid droplets were present in the tubules (Pelletier & Vitale, 
1994). This association of ACAT-1 mRNA expression with the lipid content in the tubules 
suggests that ACAT-1 participates in the cholesterol esterification and in the increase in 
cholesterol ester contents in the tubules. On the other hand, the increased ACAT-2 mRNA 
levels by 210 days and in January following the release of mature spermatids and the 
accumulation of residual bodies, suggest a contribution of ACAT-2 in Sertoli cells and an 
active participation of Sertoli cells in the removal of residual body-borne lipids.  
The enzymatic activities of both ACAT-1 and ACAT-2 in the testis were never 
reported and the physiological significance of having two ACAT isoforms in different cells 
of seminiferous tubules remains elusive. The experimental inhibition of individual ACAT 
enzymes was believed to be a useful strategy to identify ACAT-1 and ACAT-2 respective 
activity. However, most ACAT inhibitors inhibit both ACAT-1 and ACAT-2. After the 
ACAT genes were identified, investigators began to develop ACAT isotype-selective 
inhibitors (Cho et al., 2003; Ikenoya et al., 2007; Lee et al., 2004). Manassantin B, which 
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has been isolated from the methanol extracts of Saururus chinensis root, exhibited 
significant human ACAT (hACAT) inhibitory activity (Lee et al., 2004). However, 
Manassantin B mainly inhibited hACAT-1 but not hACAT-2 (Lee et al., 2004). 
Pyripyropene A is another ACAT inhibitor that selectively inhibits ACAT-2 in insect cells 
transfected with either ACAT-1 or ACAT-2, while pyripyropene A inhibited only the 
hACAT-2 but not hACAT-1(Cho et al., 2003). K-604, a novel ACAT inhibitor highly 
selective for ACAT-1 (Ikenoya et al., 2007), was reported to inhibit cholesterol 
esterification in human macrophages and to suppress the formation of macrophage-enriched 
fatty streak in fat-fed hamsters (Ikenoya et al., 2007). The present study provides a novel 
technical approach for individual ACAT-1 and ACAT-2 enzymatic activity measurements 
in the STf based on the use of K-604. K-604 potently and selectively inhibited ACAT1 
activity with IC50 values of 100µM. With the increase of IC50 to 1000 µM, both ACAT 1 
and 2 activities were inhibited. Thus, we used 100µM K-604 selectively inhibit ACAT-1 
activity and measure ACAT-2 enzymatic activity directly. Thereafter, we calculate ACAT-
1 activity by substracting ACAT-2 activity from total ACAT activity. We have detected 
dramatic alterations of ACAT-1 and ACAT-2 activities during mink development and the 
annual reproductive cycle. The present studies showed high ACAT-1 activity while ACAT-
2 activity was low. Conversely, at times when mature spermatids were present and the 
residual bodies released and phagocytosed by Sertoli cells, ACAT-2 activity increased, 
while ACAT-1 activity decreased. Considering the distinct individual localization of 
ACAT-1 and ACAT-2 in the seminiferous epithelium, we speculate that ACAT-1 may be 
involved in modulation of cholesterol delicate equilibrium in the tubules. On the other hand, 
  172 
ACAT-2 was related to cholesterol metabolized by the Sertoli cells following phagocytosis 
of residual bodies and apoptotic cells. 
This study showed that ACAT-1 activity in mink was not coincident with its mRNA 
and protein expression. The phenomenon was reported previously in other tissues. In 
Nagase hypoalbuminemic rat liver-ACAT-1 mRNA and protein contents did not change 
but the enzymatic activity was mildly elevated (Roberts et al., 2004). Lee also demonstrated 
that rat hepatic ACAT-1 activity was increased with a high diet in fat, which was not 
paralleled by the alterations seen in ACAT-1 mRNA and protein (Lee & Carr, 2004). 
Together, these results support the concept that ACAT-1 activity may not be regulated on 
transcriptional or translational levels. In fact, a recent study showed that unlike other 
enzymes or proteins involved in the cellular cholesterol metabolism, ACAT-1 expression is 
not regulated by the transcription factor sterol regulatory element binding protein (SREBP) 
(Chang et al., 2000; Liu et al., 2005). The authors concluded this after the sterol-regulatory 
element could not be identified within the ACAT-1 promoter (Li et al., 1999). Instead, the 
enzyme is regulated by cholesterol via an allosteric activation mechanism (Chang et al., 
2000). The activation of the enzyme is not due to an increase in ACAT-1 protein content, 
but in part to an increase in cholesterol content in the endoplasmic reticulum of human 
macrophages where ACAT-1 resides (Liu et al., 2005). Therefore, the down-regulation of 
ACAT-1 activity in the STf reflects the decreased cholesterol concentration in the germ 
cells with the degree of spermatogenic activity.   
Our findings showed that ACAT-2 enzymatic activity as well as its protein level 
were high when large numbers of mature spermatids were present in the seminiferous 
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tubules. During this period, spermatozoa are released into the lumen and residual bodies are 
phagocytosed by the Sertoli cells. Our observations are suggestive that ACAT-2 may be 
involved in storing excessive cholesterol and in recycling of the cholesterol contained in the 
residual bodies. Previous studies revealed that ACAT-2 may not only participate in forming 
cholesteryl ester lipid droplet, but be mainly involved in supplying the cholesteyl ester for 
lipoprotein (i.e. VLDL) assembly in human hepatocytes and intestinal enterocytes (Chang 
et al., 2001b). If ACAT-2 has similar capacity in the testis then, Sertoli cells could express 
lipoprotein receptors such as VLDL receptor that could uptake the lipoproteins assembled 
in the lumen of endoplasmic reticulum of Sertoli cells. Evidence shows that a novel 
lipoprotein receptor designated apolipoprotein E receptor 2 (apoE-2), consists of five 
functional domains resembling the VLDL receptor, and is highly expressed in rabbit Sertoli 
cells (Kim et al., 1996). Other receptors could also be expressed in the testis that could 
favor removal of cholesteryl ester from the Sertoli cells. The report of a significant decrease 
in the esterified cholesterol levels from December to March in adult tubules (Akpovi et al., 
2006) reinforces the notion that ACAT-2 is activated to protect against toxicity resulting 
from excessive cholesterol levels. The most striking finding in the current study was that 
the increase of ACAT-2 enzymatic activity was correlated with the decrease of ACAT-1 
enzymatic activity during mink development. In this regard, we suggest that ACAT-1 and 
ACAT-2 isoforms are functioning complementarily so as to complete the translocation of 
cholesterol in excess from mature germ cells to Sertoli cells. This could be tested by 
elucidating the contribution of ACAT isoforms in testicular cholesterol homeostasis in 
mouse where individual ACAT-1 or ACAT-2 would be genetically impeded. 
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3.2 Mouse 
 
Before this study, identification of ACAT-2 as one of the principal ACAT enzymes 
in mouse testis had not been reported. Additionally, the expression of both ACAT-1 and 
ACAT-2 in the seminiferous tubules or interstitial tissue had not been addressed. We 
showed for the first time that the presence of ACAT isoforms transcripts and protein 
expression in mouse seminiferous tubules and interstitium, and the specificity of ACAT-2 
transcripts were confirmed by restriction enzymes-ECoR II. Different ACAT-1 and ACAT-
2 mRNA and protein expression pattern were detected in the seminiferous tubules and 
interstitial tissue. The immunohistochemistry studies demonstrated that ACAT-2 was 
located in Sertoli cells and ACAT-1 in germ cells.  
3.2.1 ACAT-1 and ACAT-2 mRNA, protein expression in the interstitial tissue during 
development 
Our observation showed that not only ACAT-1 but also ACAT-2 was present in 
mouse ITf. The differences in mRNA expression and protein levels of ACAT-2 were not 
significant during development in ITf. The existence of ACAT-2 and its enzymatic activity 
in ITf needs further investigation. Our results further demonstrated that ACAT-1 mRNA 
levels had a profile opposite that of the protein levels, increasing throughout development 
and peaking by 42 days. The mRNA expression pattern of ACAT-1 suggested that the post-
transcriptional regulation is crucial for ACAT-1 expression. As already noted, post-
transcriptional regulation determines the fate of the RNAs, including their subcellular 
localization, stability, and translation efficiency (Ross,1995). Thus, post-transcriptional 
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regulation of ACAT-1 might provide a more elaborate regulation of the enzymatic activity. 
The regulatory mechanism requires further investigation.  
ACAT-1 was reportedly present in Leydig cells as well as macrophages (Sakashita 
et al.,2000). Our immunohistochemisty study confirmed that ACAT-1 was plentiful in the 
interstitial cells, suggesting a possible involvement of ACAT-1 in converting cholesterol 
into cholesteryl ester in response to cholesterol abundance inside the cells. It has been 
reported that the testicular macrophages contain HSL (Kabbaj et al.,2003), which 
contributes a 25-hydroxycholesterol for testosterone production in Leydig cells. Thus, the 
presence of both ACAT-1 and HSL in the interstitial cells suggests that ACAT-1 and HSL 
may regulate cholesterol homeostasis in complementary manners. Macrophage HSL frees 
cholesterol from the esterified form before converting it into 25- hydroxycholesterol which 
is then used by Leydig cells to synthesize testosterone. On the other hand, ACAT-1 
esterifies excess cholesterol in macrophages or Leydig cells to maintain cholesterol 
homeostasis for testosterone production. Based on this information, a future area of interest 
is to identify whether ACAT-1 is present or active in the interstitial macrophages, and 
whether it participate to the removal of excessive cholesterol in these cells.   
 
3.2.1 ACAT-1 and ACAT-2 mRNA, protein expression and enzymatic activity in the 
seminiferous tubules during development 
ACAT-1 and ACAT-2 were also expressed in the seminiferous tubules. However, 
ACAT-1 mRNA expression pattern in mouse STf differed from that in the ITf. In fact, our 
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findings show that unlike the constant expression of ACAT-2 mRNA and protein in ITf, 
ACAT-2 mRNA levels were increasing throughout development in STf, which had an 
opposite profile that of the protein levels, suggesting another regulatory mechanism of the 
enzyme in STf. The significance of ACAT-2 expression pattern in STf remains to be 
determined. On the other hand, ACAT-1 mRNA and protein levels were both decreased 
throughout development. These results suggest ACAT-1 is regulated on the transcriptional 
levels in the tubules. Previous studies demonstrated that ACAT-1 and ACAT-2 genes are 
located on distinct chromosomes (Cases et al., 1998a; Li et al., 1999; Uelmen et al., 1995). 
Thus, the differences in the transcriptional regulation of ACAT-1 and ACAT-2 in STf may 
be caused by independent regulatory mechanism. 
Previous reports found that sterol regulatory elements, present in the promoters of 
many cholesterol-regulated genes. However, the sterol regulatory elements have not been 
identified within the ACAT-1 or ACAT-2 (Chang et al., 2001b; Li et al., 1999). Thus, the 
main mode of sterol-dependent regulation of ACAT activity may not be at transcriptional 
but at translational levels. Change et al. (1997) reported that ACAT-1 and ACAT-2 are 
allosteric enzymes with two types of sterol-binding sites. One substrate site is able to 
accommodate a wide variety of sterols, while another activator site may only recognize 
cholesterol (Chang et al., 1997). 
The present study also applied the novel selective ACAT-1 inhibitor, K-604, to the 
measurements of individual ACAT-1 and ACAT-2 enzymatic activity in mouse 
seminiferous tubules. K-604 potently and selectively inhibited adult mouse ACAT1 much 
more than ACAT2 with IC50 values of 100 and 1000 µM respectively. The proper inhibitor 
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concentration (100µM) that inhibits the activity of ACAT-1 but not the activity of ACAT-2 
was selected, and applied to the measurement of ACAT-1 and ACAT-2 enzymatic 
activities in mouse seminiferous tubules. Dramatic alterations of ACAT-1 and ACAT-2 
activities during mouse development were detected. Our observations showed that ACAT-1 
enzymatic activity was high in new borns and decreased in adults, and that ACAT-2 
activity was low in newborns but high in adults. Yet, the enzymatic activity of ACAT-1 and 
ACAT-2 reached comparable levels in the adult. Considering the distinct individual 
localization of ACAT-1 and ACAT-2 in the seminiferous tubules, we speculated that 
ACAT-1 may be involved in modulation of cholesterol delicate equilibrium in the 
developing germ cells. On the other hand, ACAT-2 was related with the removal of 
accumulated cholesterol in the Sertoli cells by phagocytosis of residual bodies and 
apoptotic cells. 
 
Summary for HMG-CoA redcutase, HSL, ACAT-1 and ACAT-2: 1) HMG-CoA 
redcutase, HSL and ACAT-2 showed similar enzymatic activity profiles. They increased 
during development but decreased in adulthood, and their activities varied in parellel with 
development and germ cells development. These results suggest that all three enzymes 
work in synchrony and they may get involved in the spermatogenetic activity. 2) On the 
other hand, ACAT-1 activity showed an opposite tendency to the other enzymes. It is high 
in newborn, but decreased afterwards. ACAT-1 acitivity is complementary to ACAT-2. 
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4. The mRNA expression and activities of HMG-CoA reductase, ACAT-1 and ACAT-
2 in HSL-/- male mouse  
The most striking phenotype of HSL knockout mice is male sterility caused by 
oligospermia (Osuga et al., 2000). It has been demonstrated that the absence of HSL in the 
testis resulted in a 2.3-fold increase in testicular cholesterol ester (Osuga et al., 2000). 
Therefore, we questioned whether the disruption of HSL geen could effect on other 
enzymes (HMG-CoA redcutase, ACAT-1 and ACAT-2) mRNA and protein expression and 
enzymatic activity, and thus causing cholesteryl esters over-accumulated in the testis.  
Real-time quantitative PCR analysis revealed that STf and ITf from HSL -/- testis 
lack a wild type (wt) transcript with HSL mRNA which codes all forms of the protein. 
Western blot analyses showed no 90kDa immunoreactive HSL protein in testis from HSL-
/- mice. The 90kDa band, which corresponds to the 88 kDa band in human adipocyte and to 
the 84 kDa band in rat fat (Langin et al., 1993), is reported to be expressed in interstitial 
and tubular somatic cells as well as premeiotic germ cells (Blaise et al., 2001; Mairal et al., 
2002). To test the hypothesis of a differential HSL-meidated modulation of cholesterol 
metabolism in Sertoli cells, germ cells and testicular macrophages, changes in protein 
expression of 90kDa HSL were measured in STf and ITf. 
4.1 ITf 
  Previous study in testis supported the notion that interstitial macrophage HSL 
could free cholesterol from esterified cholesterol to be converted into 25-hydrocholesterol 
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taken up by Leydig cells to synthesize testosterone (Kabbaj et al., 2003). It is also reported 
that HSL overexpression in macropahges stimulates cholesterol ester hydrolase activities 
(Escary et al., 1998). Therefore, it appears HSL is responsible for cholesterol ester 
hydrolase activities in macropahges, and play crucial role in supporting steroidogenesis. 
Our findings in HSL knockout mice ITf demonstrated that HMG-CoA reductase mRNA 
levels were decreased in HSL knockout mice ITf as well as ACAT-1 and ACAT-2 mRNA 
levels, indicating that the disruption of the HSL gene in mice caused changes in the mRNA 
expression of several enzymes in ITf. However, these changes did not seem to affect the 
physiological function of the interstitial tissue due to the fact that HSL knockout mice have 
normal plasma levels of testosterone, follicle-stimulating hormone and luteinizing hormone 
(Osuga et al., 2000). The observations suggest that other lipases might be involved in the 
physiological events of the interstitial tissue, and could at least in part compensate for the 
lack of HSL. It is also possible that other sources of cholesterol come from the blood 
circulation. In this concern, the possible source of cholesterol from de novo cholesterol 
synthesis was reduced due to the suppression of HMG-CoA reductase mRNA expression. 
Since HMG-CoA reductase is an integral membrane proteins present in the endoplasmic 
reticulum (ER) (Ness & Nazian, 1992), Down-regulation of HMG-CoA reductase 
expression could cause the decrease of cholesterol pool in ER. It has been documented that 
cholesterol is the activator for ACAT isoforms in ER. Upon stimulation by low 
concentration of cholesterol, ACAT isoforms expression could be decreased.  
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4.2 STf 
Because HSL knockout mice have normal plasma levels of testosterone, follicle-
stimulating hormone, and luteinizing hormone (Osuga et al., 2000), thus oligospermia does 
not result from hypogonadism. Instead, the testes completely lost neutral cholesterol ester 
activities and included increased amounts of cholesterol ester (Osuga et al., 2000). Osuga et 
al. (2000) reported extensive vacuolation within the seminiferous epithelium of HSL 
knockout mice; and Oli Red O staining of tissue sections suggested that these vacules are 
actually filled with lipids (Haemmerle et al., 2003). The remarkable accumulation of 
cholesterol esters in the tubules leads to the question of whether mutations in the HSL gene 
may cause tubular cholesterol inquilibrium due to the interruption of the enzyme expression 
and activity. Our results in HSL-/- mice STf showed that HMG-CoA reductase mRNA 
levels as well as the enzymatic activity were decreased in HSL-/- mice STf. Conversely, 
ACAT-1 and ACAT-2 mRNA levels and their respective enzymatic activities were 
significantly increased. Thus, HSL deficiency caused a change in other enzymes (HMG-
CoA redcutase, ACAT-1 and ACAT-2) expressions and activities in STf.  Since numerous 
immature germ cells were present in the epididymis of the HSL knockout mice (Vallet-
Erdtmann et al., 2004); Sertoli cells are involved in the phagocytosis of these apoptptic 
germ cells and accumulate stacks of cholesterol-rich cellular debris in lysosomes (Pelletier 
& Vitale, 1994), we believe that the increased ACAT-1 and ACAT-2 activities could 
contribute to the removal of accumulated cholesterol in cell debris-borne cholesterol. The 
excess cholesterol that comes from the cell debris-born-lipids could suppress the 
biosynthesis pathway and activity of the rate-limiting HMG-CoA reductase expression. Our 
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finding demonstrates that the variation of HMG-CoA reductase, ACAT-1 and ACAT-2 
expression and activity are the consequence of the absence of corrected HSL transcription 
in testis. Further studies are needed to clarify the mechanism by which HSL deficiency 
causes abnormal spermatids development. 
 
Summary of HSL-/- mice: HSL gene deletion caused a cascade of physiological responses 
on HMG-CoA reductase and ACAT isoforms, which could be the pivotal response that 
modifies cholesterol homeostasis in testis.  
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5. The mRNA expression and activities of HMG-CoA reductase, HSL, ACAT-1 and 
ACAT-2 in SR-BI and CD36 knockout mice  
 
5.1 SR-BI-/- mice: 
Scavenger receptor class B type I (SR-BI) mediates the selective uptake of HDL 
cholesterol (Kozarsky et al., 1997; Temel et al., 1997). In addition, SR-BI selectively 
removes cholesteryl esters from the HDL to which it binds (Kozarsky et al., 1997; Temel et 
al., 1997) and contributes to the HDL-mediated cellular cholesterol efflux (Ji et al., 1997). 
Experimetnal deficiency of SR-BI is accompanied by abnormal structure, composition, and 
abundance of lipoproteins because of defective cholesterol efflux from cells to lipoprotein 
particles (Miettinen et al., 2001). The SR-BI deficient male mice exhibit a reduction in their 
number of homozygous offspring relative to wild-type offspring from F1 heterozygous 
intercrosses although the mice were fertile (Rigotti et al., 1997). Therefore, abnormalities in 
cholesterol metabolism in SR-BI knockout male mice might cause the reduction of male 
offspring numbers. To assess how the enzymatic system in the regulation of cholesterol 
metabolism is affected by shutting SR-BI-dependent cellular flux, the mRNA expression 
and the activity of HMG-CoA reductase, HSL, ACAT-1 and ACAT-2 in individual 
compartments of SR-BI knockout mouse testis were measured.  
SR-BI gene deficit caused a significant decrease in HMG-CoA reductase, ACAT-1 
and ACAT-2 mRNA expression, while causing a remarkable increase of HSL mRNA level 
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in ITf and STf. Similarly, HMG-CoA reductase and ACAT-1 enzymatic activities were 
significantly reduced, while HSL activity was significantly elevated in SR-BI KO 
seminiferours tubules.  These observations suggest at the absence of SR-BI receptor leads 
to the consequent functional changes of the major enzymes regulating cholesterol 
metabolism in testis, which is regulatd at the level of transcription. Given that SR-BI 
deficiency impaired the cholesterol efflux from the cells in the interstitial tissue or 
seminiferous tubules, this could cause an increased cholesterol level inside of cells. 
Excessive cholesterol may directly inhibit the transcription of one or more of the enzyzmes 
in the cholesterol biosynthetic pathway (i.e. HMG-CoA reductase) and decrease the 
enzymatic activity(s) in testis. Since HMG-CoA reductase is an integral membrane proteins 
present in the endoplasmic reticulum (ER) of the cells (Ness & Nazian, 1992), down-
regulation of HMG-CoA reductase expression and activity will cause the decrease of the 
cholesterol pool in ER. It has been documented that cholesterol pool in ER is the activator 
for ACAT isoforms (Liu et al., 2005). Thus, low level of cholesterol could inhibit ACAT 
isoforms expression and activities. However, ACAT-2 activity was not decresed although 
its mRNA expression significantly reduced. These results suggest that ACAT-2 may have 
other regulatory mechanism in modulating the cholesterol esterification, and ACAT-2 may 
be the only esterase that converts of cholesterol to cholesterol ester in SR-BI KO male testis.  
In addition, since the origin of cholesterol from the biosynthesis pathway was reduced due 
to the decreased HMG-CoA reductase activity, the increasing HSL expression and activity 
could contribute cholesterol to ensure normal spermatogenesis.     
.   
  184 
5.2 CD36-/- mice: 
CD36 belongs to the class B scavenger receptor family, which is responsible for the 
selective uptake of cholesterol esters (Febbraio et al., 2001). CD36, expressed in Sertoli 
cells, was claimed to be involved in the phagocytosis process of the residual bodies shed 
from spermatozoa lipid (Gillot et al., 2005). A null mutation in CD36 was not reported to 
affect the fertility of mutant animals but reveals crucial roles of CD36 in fatty acid and 
cholesterol metabolism (Febbraio et al., 1999; Febbraio et al., 2002). To assess how the 
enzymatic system in the regulation of intracellular cholesterol metabolism is affected by 
shutting CD36-dependent cholesterol uptake, the mRNA expression and the activity of 
HMG-CoA reductase, HSL, ACAT-1 and ACAT-2 in individual compartments of CD36 
knockout mouse testis were measured.  
This study showed, for the first time, a significant decrease of HMG-CoA reductase, 
ACAT-2 mRNA in the interstitial tissue and seminiferous tubules together with a decrease 
in HMG-CoA reductase and ACAT-2 activity but not in ACAT-1 in CD36 deficient mice 
testis in comparison to wild type. Conversely, CD36 gene deficit caused a significant 
increase of HSL mRNA expression, while causing a decrease of ACAT-1 mRNA 
expression in the interstitial tissue.  
The results show that blocking the gene expression of CD36 leads to the consequent 
mRNA expression variation of the major enzymes regulating cholesterol metabolism in the 
interstitial tissue. It is hypothesized that this modification reflects in part the effect of CD36 
on the transport of cholesterol to the Leydig cells. In the seminiferous tubules, it has been 
claimed that CD36 is expressed in Sertoli cells and that the protein localized in the residual 
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bodies shed from mature spermatids (Gillot et al., 2005). Thus, it is possible that CD36-
mediated phagocytosis of residual bodies could be one of the processes involved in the 
cholesterol exchange between Sertoli cells and germ cells. Our results in CD36 deficient 
mice showed ACAT-2 mRNA expression and enzymatic activity significantly decreased in 
the CD36 null mice, suggesting that ACAT-2 may be closely related to the expression of 
CD36 in the tubules. Gillot et al. (2005) suggested that CD36 may be involved in lipid 
recycling from the residual bodies. Thus, ACAT-2 may participate in the removal of 
cholesterol stored in the residual bodies. Sertoli cells may function as a recycling centre, 
where lipid content in the residual bodies would be reused and thus providing the 
cholesterol required for normal spermatogenesis. However, ACAT-1 mRNA expression 
and enzymatic activity showed no significant changes in tubules of CD36 null mice. 
Considering the fact that ACAT-1 is localized in germ cells, while CD36 was said to be 
expressed in Sertoli cells (Gillot et al., 2005), it is possible that ACAT-1 may be not closely 
associated to the expression of CD36 in the tubules, thus may not be inflenced by blocking 
out CD36 gene. Given that CD36 deficiency impaired the removal of the residual bodies in 
Sertoli cells, this could cause the accumulation of cholesterol-rich, germ cell-born 
membranes, which might directly inhibit the transcription of one or more of the enzyzmes 
in the cholesterol biosynthetic pathway (i.e. HMG-CoA reductase) and decrease the 
enzymatic activity(s) in the tubules. On the other hand, HSL could play an important role in 
the regulation of CD36 expression (Chung et al., 2001). However, our results in CD36-
deficient mice demonstrated that no significant changes of the HSL mRNA expression and 
enzymatic activity in the seminiferous tubules. It is possible that the remaining scavenger 
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receptors could account for CD36 deficiency, for instance, SR-BI may replace CD36 thus, 
preserving the function of HSL. It would be interesting to identify the changes of the 
enzymes in SR-BI and CD36 double knockout mice testes. 
 
 
Summary of SR-BI-/- or CD36-/- mice: Genetically blocking SR-BI or CD36 affects the 
regulation of the enzymes (HMG-CoA reductase, HSL and ACAT-1 and ACAT-2) 
expression and activities. 
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6. Relationship of intracellular enzymes in the cholesterol metabolism in each 
compartment of testis 
Cellular cholesterol homeostasis is a tightly regulated system in which the amount 
of unesterified cholesterol within the cells is controlled by the rate of cholesterol uptake, 
synthesis, esterification, and hydrolysis of cholesterol esters. Thus, a series of 
enzymatic factors are required in cholesterol metabolism to maintain the concentration 
of unesterified cholesterol within narrow physiological limits. Recent advances have 
mainly focused on the intracellular enzyme, HSL. These observations noted that HSL 
knockout mice were sterile (Hermo et al., 2008; Osuga et al., 2000; Vallet-Erdtmann et 
al., 2004). Alterations in the testis of HSL-deficient mice are associated with decreased 
sperm counts, motility, and fertility (Hermo et al., 2008). In this present study we build 
on the previous work, by discussing more detailed mechanisms of additional enzymes 
HMG-CoA reductase, ACAT-1 and ACAT-2 as well as HSL in cholesterol ester cycle; 
furthermore, we particularly emphasize the cooperation of these enzymes in achieving 
and maintaining cholesterol homeostasis in the individual compartments of the testis.  
Under physiological conditions, the completion of spermatogenesis in seasonal 
breeders was associated with elevated HMG-CoA reductase mRNA levels and 
enzymatic activity, increased HSL protein expression and activity, up-regulated ACAT-
2 mRNA levels and activity, but decreased ACAT-1 activity. These findings point to 
increased cholesterol biosynthesis and hydrolysis of cholesterol esters and recycling of 
lipids as well as impaired cholesterol esterification. This suggests that the main 
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enzymes act cooperatively in the regulation of intracellular cholesterol during the 
completion of spermatogenesis to maintain adequate cholesterol concentration. As 
demonstrated using a mouse model, the spermatogenetic activity is accompanied with 
increased HMG-CoA reductase, elevated HSL, and up-regulated ACAT-2 but impaired 
ACAT-1. These observations may reflect an increased hydrolysis and deesterification 
of intracellular cholesteryl esters and an elevated cholesterol biosynthesis. Thus, 
unesterified cholesterol would be produced when spermatogenesis is active. During the 
testicular regression period, all three enzyme’s (HMG-CoA reductase, HSL and ACAT-
2) activities were down-regulated, while ACAT-1 activity was increased. The findings 
may reflect the response to a decrease in free cholesterol. The results suggest that the 
three main enzymes control the cholesterol ester cycle and thereby, decrease the supply 
of cholesterol to tubules and remove excess cholesterol in lipid droplets.  
Under pathological condition, interruption of the cholesteryl ester cycle by 
knocking out HSL, which causes a decrease in HMG-CoA reductase but an increase in 
ACAT-1 and ACAT-2, may result in the decrease of unesterified cholesterol and the 
accumulation of cholesterol ester-rich lipid droplets. In agreement with our findings, 
previous studies have shown a 2-fold elevation in the ratio of esterified to free 
cholesterol in testis (Wang et al., 2004). In addition, cholesteryl ester hydrolase activity 
was almost completely blocked in HSL-deficient testis (Vallet-Erdtmann et al., 2004). 
Moreover, the finding that HSL null male mice were spermatozoa-deficient (Osuga et 
al., 2000) demonstrates one level at which the HSL can affect the cascade of 
physiological responses. This finding, that the enzymes function in coordination in the 
  189 
cholesterol ester cycle, may be the pivotal pathological response that destroys the 
cholesterol homeostasis in the tubules. On the other hand, in the absence of SR-BI or 
CD36, the increased HSL was accompanied by decreased ACAT isoforms and HMG-
CoA reductase. Since SR-BI or CD36 deficient mice did not display interrupted fertility 
compared with wild-type male mice (Febbraio et al., 1999; Rigotti et al., 1997), and 
SR-BI or CD36 null mice did not affect the rate of cholesterol in testis (Akpovi et al., 
data not shown), we assume that either SR-BI or CD36 deficiencies respond to an up-
regulation of extratubular cholesterol uptake by certain compensatory pathways. These 
results indicate that the main enzymes in cholesterol ester cycle not only function in 
coordination in the intratubular cholesterol metabolism and control the proper 
cholesterol distribution, but also response to the variation from extratubular cholesterol 
pool. The enzymes interconnect with the transporters, contributing to the preservation 
of the intratesticular cholesterol homeostasis. 
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Conclusion 
Our results suggest: 
   1. This study showed that the three enzymes participate together in the regulation of 
cholesterol metabolism in testis.  
  2.  Our results suggest that dysfunction in the action of individual enzymes or transporters 
affect the activities of remaining enzymes and their contribution to cholesterol 
homeostasis in tubules.  
Our results suggest that this coordination in the action of enzymes may represent the basis 
of a system that helps to maintain constant cholesterol levels in the testis.  
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Appendix 
Table 2. Reaction mixture for reverse transcription PCR 
Component Volume (25µ l) 
RT buffer (10×) 2.5 µl 
dNTP (5mM) 2.5 µl 
Oligo dT (10µM) 2.5 µl 
Enzyme RT 1.25µl 
RNase inhibitor 0.4µl 
RNA 2.5 µg 
H2O  
 
 
Table 3. Reaction mixture for PCR 
Component Volume (25µ l) 
10× QIAGEN PCR buffer 2.5 µl 
5×Q-solution    5 µl 
dNTP mix (10mM each) 0.5 µl 
Primer sense 1.25µl 
Primer anti-sense 1.25µl 
Taq DNA polymerase                           0.125 µl 
Distilled water                          12.375 µl 
Template DNA 2.5 µl 
 
 
 
 
  
II 
II 
Table 4. PCR standard protocol 
Stages Condition 
Stage I: initial denaturation ( Reps:1) 95°C 5min 
 
Stage II: PCR (Reps:40) 
95°C 1min 
60°C 45sec. 
72°C 1min 
Stage III: Extension 72°C 7min 
Stage IV: Cooling 4°C ∞ 
 
 
Table 5. Reaction mixture for real time PCR (SYBR Premix Ex TaqTM) 
Component Volume (20µ l) 
SYBR Premix Ex TaqTM (2×) 10 µl 
PCR forward primer (10µM) 0.4 µl 
PCR reverse primer (10µM) 0.4 µl 
Template (<100ng)     2µl 
H2O  7.2µl 
 
Table 6. Shuttle PCR standard protocol 
Stages Condition 
Stage I: initial denaturation ( Reps:1)   95°C 30sec. 20°C/sec. 
Stage II: PCR (Reps:40) 95°C 5sec. 20°C/sec. 
 60°C 30sec. 20°C/sec. 
 
Stage III: Melting curve analysis 
95°C 0sec. 20°C/sec. 
 65°C 15sec. 20°C/sec. 
95°C 0sec. 20°C/sec. 
 
  
III 
III 
Table 7. Three-step PCR standard protocol 
Stages Condition 
Stage I: initial denaturation ( Reps:1)   95°C 30sec. 20°C/sec. 
Stage II: PCR (Reps:40) 95°C 5sec. 20°C/sec. 
 58°C 20sec. 20°C/sec. 
72°C 15sec. 20°C/sec. 
 
Stage III: Melting curve analysis 
95°C 0sec. 20°C/sec. 
 65°C 1min. 20°C/sec. 
95°C 0sec. 20°C/sec. 
 
Table 8. Gel for separation (10%) 
Component Volume (8ml) 
H2O   1.6ml 
1M Tris-0.5M Glycine (0.2M-0.1M)   1.6ml 
10% SDS 0.32ml 
50% Glycerol   0.8ml 
25% Acrylamide/0.25% Bis   3.2ml 
4% Persulphate of ammonium   0.4ml 
10% TEMED 0.08ml 
 
 
 
 
 
 
 
 
  
IV 
IV 
Table 9. Gel for concentration (4%) 
Component Volume (8ml) 
H2O 1.68ml 
0.5M Tris-HCl pH 6.7 0.56ml 
50mM EDTA pH 6.7 0.32ml 
50% Glycerol   0.4ml 
25% Acrylamide/0.25% Bis 0.64ml 
4% Persulphate of ammonium   0.2ml 
10% TEMED 0.04ml 
 
 
